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Two new cascade transformations of α,β-unsaturated thioesters catalyzed by amidine-
based catalysts have been developed. First, a reagent-free transformation of o-formylaryl 
cinnamoyl thioesters catalyzed by HBTM-2 to produce 2-substituted thiochromenes achieved high 
enantioselectivities and yields while forming carbon dioxide as the only byproduct. Second, a 
highly diastereo- and enantioselective tandem rearrangement of less reactive enone thioesters into 
tricyclic thiochromanes in the presence of electron-rich amidine-based catalysts was developed. 
These catalysts were designed with the help of DFT calculations. H-PIP, the first chiral amidine-
based catalyst synthesized in our group, performed the best overall in the thiochromane synthesis. 
The second chapter of this thesis describes the design of chiral ligands using the Cl-PIQ 
structure as a building block. A new class of fused imidazoline ligands was synthesized from 2-
chloro-3-quinolinecarboxaldehyde, and their efficacy was demonstrated by their performance in 
the asymmetric Henry reaction. 
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CHAPTER 1: Cascade Reactions of Thioesters1 
1.1 Introduction. 
Enantioselective acyl transfer catalysis has become an essential tool of asymmetric 
synthesis. Several types of Lewis bases, such as 4-amino-pyridines (e.g., DMAP, PPY), N-
alkylimidazoles (e.g., NMI), N-heterocyclic carbenes (NHCs), and trialkylphosphines (e.g., PBu3) 
are known to catalyze nucleophilic acyl substitution reactions by the mechanism called acyl 
transfer.2 This mode of catalysis operates primarily under three basic pathways shown in Figure 
1.1.3 In the first pathway, activation of the carbonyl, the Lewis base catalyst (:Cat) attacks an acyl 
donor (1.01) to form a reactive ion pair (1.02) that can then react with a nucleophile (H-Y) to 
displace the catalyst and form the final product 1.03. The second pathway, activation of the 
conjugate system, consists of the Lewis base catalyst (:Cat) attacking an acyl donor containing an 
-unsaturated double bond (1.04) to form an ion pair intermediate (1.05) that is activated as 
either a Michael acceptor (Figure 1.1, b) or as a dienophile (Figure 1.1, c) which ultimately reacts 
with a nucleophile (H-Y) to turn over the catalyst. The final pathway, activation of the -carbon, 
occurs when the initial cationic species undergoes deprotonation to form a zwitterionic, 
acylammonium enolate (1.12), which can attack various electrophiles followed by displacement 
of the catalyst by a nucleophile. These basic catalytic pathways offer rich opportunities in 
enantioselective acyl transfer. 




Figure 1.1: Basic catalytic pathways involving acyl transfer. 
 
Many research groups have developed chiral variants of Lewis bases known to catalyze 
acyl transfer reactions. This approach was more difficult to implement than anticipated. 
Introducing chiral groups on the carbon next to the nucleophilic nitrogen in catalysts such as 
DMAP or NMI renders the catalyst inactive in acyl group transfer. Conversely, placing the chiral 
groups more remote from the nucleophilic nitrogen produces poor enantioselectivity in many 
cases. Some of the best enantioselective acyl transfer catalysts developed by other groups are 
shown in Figure 1.2.4-13 Many of these catalysts still suffer from a limited substrate scope or work 




Figure 1.2: Best enantioselective acyl-transfer catalysts developed by other groups. 
 
Our group took a different approach to designing enantioselective acyl transfer catalysts. 
Rather than preparing a chiral variant of a known Lewis base, we sought to discover a new class 
of Lewis bases that would have nucleophilicity toward acyl groups but would allow for 
synthetically easier introduction of chirality. This led us to develop amidine-based catalysts 
(ABCs) shown in Figure 1.3.14 Although there were no prior reports of amidine catalysts for acyl 
transfer, simple resonance structures suggest the nitrogen atom would be highly nucleophilic and 
form resonance stabilized N-acylammonium intermediates. Additionally, the easily introduced 
chiral carbon adjacent to the nucleophilic nitrogen atom would allow for effective enantiofacial 
discrimination without creating too much steric encumbrance around the nitrogen. Subsequently, 
our group developed new generations of ABCs shown in Figure 1.3 eventually leading to the 
discovery of chiral isothioureas (ITUs) such as benzotetramisole (BTM) and the 
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homobenzotetramisole (HBTM, HBTM-2) catalysts. These chiral isothioureas containing a sulfur 
atom were the most active catalysts yet, which has been attributed to non-bonding S∙∙∙O 
interactions with the acyl carbonyl.14d 
  
Figure 1.3: Evolution of amidine-based catalyst design in our group. 
 Our group focused on the development of reactions from pathway (a) in Figure 1.1, 
activation of the carbonyl.15 For example, our early studies dealt with the non-enzymatic kinetic 
resolution of secondary alcohols by ABCs. Due to the π-stacking ability of the catalysts, ABCs 
were found to give good to excellent selectivity factors for benzylic, allylic, and propargylic 
alcohols as well as 2-phenylcycloalkanols shown in Figure 1.4.15a Pathways (b)-(e) have been 
explored by other groups.16,17 
 




1.2  Asymmetric synthesis of thiochromenes. 
1.2.1 New acyl donors operating in a rearrangement mode.  
One of the limitations of existing acyl transfer catalysts is the need to match the reactivity 
of acyl donors to the reactivity of the catalysts. These activated substrates in turn may be unstable 
to long term storage or may need to be formed in situ. An additional draw back to acyl transfer 
catalysis is that many processes are not atom economical. For example, if an acyl donor is viewed 
as two separate parts (Figure 1.5), the leaving group is simply lost in most acyl transfer processes. 
 
Figure 1.5: Parts of an acyl donor. 
Our goal was to develop a new tandem reaction that consists of an acyl donor operating in 
a rearrangement mode. Before we began our studies, few reports of this type of acyl donor could 
be found in the literature. In 2009,18a Lupton disclosed an NHC (1.34) catalyzed rearrangement 
reaction where enol ester 1.33 underwent acyl transfer to free an enolate that performed a Michael 
addition followed by proton transfer and acylation of the enolate to form 1.35 and free the catalyst 
as shown in Figure 1.6. Later, Lupton developed an acyl transfer-Diels-Alder-lactonization 
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cascade18b also shown in Figure 1.6. During this process, an NHC catalyst (1.37) displaced enol 
ester 1.36 to free an anionic diene which underwent a Diels-Alder reaction followed by the 
formation of -lactone 1.38. 
 
Figure 1.6: Acyl donors operating in a rearrangement mode. 
 We set out to accomplish a tandem transformation using α,β-unsaturated thioesters (1.39) 
as acyl donors (Figure 1.7).  In the presence of a Lewis base catalyst, 1.39 was anticipated to 
undergo acyl transfer to form ion pair 1.40 and give rise to zwitterionic enolate 1.41 following 
sulfa-Michael addition. Enolate 1.41 can be considered a potential precursor to a variety of formal 
cycloadditions such as nucleophilic addition to an electrophile with subsequent displacement of 
the catalyst. Conceptually, the transformation of 1.39 into 1.41 can be thought of as its 1,3-




Figure 1.7: Proposed tandem transformation. 
We envisioned experimentally that this type of tandem process could be achieved with 
thioester 1.44a in the presence of an acyl transfer catalyst to produce thiochromene 1.45a with 
carbon dioxide as the only byproduct (Figure 1.8). 
 
Figure 1.8: Proposed thiochromene synthesis. 
1.2.2 Michael addition reactions catalyzed by isothioureas.  
In 2013, Romo reported an isothiourea catalyzed Michael-Aldol-Lactonization cascade19a to 
form -lactone fused cyclopentanes 1.48 shown in Figure 1.9. The process starts with the 
deprotonation of the acidic carbon of 1.46 followed by the C-C bond forming Michael addition to 
the -unsaturated intermediate of (S)-HBTM and 1.47. The resulting acyl ammonium enolate 
proceeds to do an intramolecular aldol on the methyl ketone forming an alkoxide which then 
displaces the catalyst to form 1.48. In 2015, Matsubara reported an enantioselective net [4+3] 
cycloaddition to form 1,5-benzothiazepines 1.51.19b In the presence of (R)-BTM, -unsaturated 
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carbonic anhydrides (1.50) undergo sulfa-Michael addition followed by lactamization by 2-
aminothiophenols (1.49) with excellent yields and enantioselectivities as shown in Figure 1.9. 
These Michael-additions catalyzed by isothiourea catalysts suggested that our proposed 
rearrangement could be highly enantioselective with isothiourea catalysis. 
 
Figure 1.9: Michael additions catalyzed by isothioureas. 
1.2.3 Previous asymmetric approaches to thiochromenes.  
2-substituted thiochromenes and thiochromanes have drawn interest due to their potential 
in drug design and their occurrence as natural products (Figure 1.10).20 Unfortunately, previously 
reported asymmetric catalytic methods produce thiochromenes with an undesirable electron-
withdrawing group at C3 (Figure 1.11).21 The iminium catalyzed process developed independently 
and concurrently by Wang and Cordova relies on an -unsaturated aldehyde (1.53) as a handle 
for the chiral iminium catalyst for a sulfa-Michael-aldol condensation cascade bringing about a 
thiochromene with an aldehyde on C3 (1.55). A similar sulfa-Michael-Horner-Wadsworth-
Emmons cascade reported by Mukherjee relies on hydrogen-bond donor catalyst 1.57 but leaves 




Figure 1.10: 2-substituted thiochromane derivatives. 
 






1.2.4 Our approach to thiochromenes.  
Based on our long-standing interest in amidine-based catalysts (ABCs), we wanted to 
explore their ability to activate thioesters via nucleophilic acyl substitution.1a Taking this into 
account, we prepared thioester 1.44a bearing an o-aldehyde group which would serve two 
purposes. First, the electron-withdrawing nature of the aldehyde would activate the thioacyl 
carbonyl beyond that of a simple phenyl thioester. Second and most importantly, the aldehyde 
would serve as an electrophile to trap the putative zwitterionic enolate 1.60a and produce 2-
phenylthiochromene 1.45a with carbon dioxide as the only byproduct.  
 
Figure 1.12: New synthesis of thiochromenes. 
To our delight, this model substrate underwent the desired transformation into 2-
phenylthiochromene (1.45a) in 94% yield when subjected to DHPB (1.63a)22 (Figure 1.13). A 
further survey of achiral catalysts revealed other Lewis bases to be poorly suitable for this reaction 




Figure 1.13: Achiral Lewis base catalysts. 
Table 1.1: Achiral catalyst survey.a 
 
entry catalyst conversion, % yield, % 
1 1.62 80 44 
2 1.63a  100 94 
3 1.64 0 0 
4 1.65 0 0 
5 1.66 8 8 
6 1.67 13 12 
7 1.68 58 32 
8 1.69 100 37 
9 1.70 100 45 




Chiral ABCs were then screened for the enantioselective reaction. All the chiral ABCs 
shown in Figure 1.14 catalyzed this reaction with excellent enantioselectivity (Table 1.2). HBTM 
(1.32a)14e and its derivatives HBTM-2 (1.32b)14f and HBTM-2.1 (1.32c)23 showed the best overall 
combination of catalytic activity and enantioselectivity (entries 7-9). Based on its availability in 
our lab, (R)-HBTM-2 (1.32b) was chosen for the ensuing study. 
 










Table 1.2: Chiral catalyst survey.a 
 
entry catalyst yield, % ee, % 
1 (R)-1.29a  45 99 (R) 
2 (R)-1.30 47 98 (R) 
3 (S)-1.71 25 98 (S) 
4 (S)-1.31 63 99 (S) 
5 (S)-1.32a 98 >99 (R) 
6 (R)-1.32b 99 >99 (S) 
7 (R)-1.32c 99 >99 (S) 
aConditions: 0.2 M 1.44a, 0.02 M catalyst, CDCl3, rt. 
A series of S-cinnamoyl derivatives of 2-mercaptobenzaldehyde (1.44) were prepared with 
a wide range of substituents and subjected to 1.32b to produce 2-substituted thiochromenes (1.45) 
(Figure 1.15). A substrate with an ortho group produced an excellent yield and ee (1.45c).  
Although they affected the reaction rate, both electron-withdrawing and electron-donating groups 
on the aryl substituent R1 gave excellent yields and ee values as well (1.45d-h). An additional p-
aldehyde group in the substrate still allowed for a clean and enantioselective reaction (1.45f). 
Heterocyclic analogues also produced excellent enantioselectivity though the yields were 
somewhat lower (1.45i, j). Finally, a substrate with an alicyclic R1 group produced a similar 
outstanding result (1.45k), which was somewhat surprising considering ABCs usually fail when 
the substituents are not  systems. Shown in Figure 1.16, the core of the thiochromene could also 
be modified with relative ease, but a steep drop in yield was observed when electron-withdrawing 
14 
 
groups were introduced. This was like due to a reduction of nucleophilicity in more stabilized 
thiolates (1.45l-m and 1.45p-q). 
 




Figure 1.16: Substrate scope: variation of the thiochromene core. 
To predict the absolute configuration at C2, we proposed the transition state model 1.72a 
shown in Figure 1.17, where the conjugate addition of the thiolate proceeds from the opposite face 
of the phenyl group on the catalyst.  An additional transition state model to consider would be to 
treat this as a hetero-Diels-Alder reaction with the C—S and C—C bonds forming in a concerted 
fashion (1.72b). 1.45q was crystalline and its anomalous diffraction X-ray structure24 (Figure 1.18) 
provided experimental verification of our prediction although this does not distinguish whether the 
absolute configuration arises from transition states 1.72a or 1.72b.  
 




Figure 1.18: X-ray structure of 1.45q. The absolute configuration was determined from the Flack 
parameters.24 
Unfortunately, more challenging variations to 1.44 resulted in slow or no reaction (Figure 
1.19). Replacing the aldehyde with a ketone (1.73) gave less than 5% conversion in 24 hours when 
subjected to DHPB. Substituting a fluorine in the -position proceeded to form the desired 3-
fluoro-2-phenyl thiochromene (1.76) but in a lousy 28% yield after 3 days. Although refluxing in 
benzene provided slightly higher conversions, the requirement of such forcing conditions would 
not lend itself to the development of an asymmetric version, our end goal. 
 
Figure 1.19: Problematic substrates in thiochromene synthesis. 
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Following the publication of our synthesis of thiochromenes, Mukherjee reported a sulfa-
Michael/Julia-Kocienski approach to thiochromenes.25 This iminium catalyzed method allowed 
thiochromenes (1.45) to be produced without an electron-withdrawing group at C3 like our method 
albeit with lower yields and more undesirable byproducts. 
 
 Figure 1.20: Mukherjee’s approach to C3 unsubstituted thiochromenes. 
1.2.5 Alternative mode of catalysis. 
 During the investigation of the thiochromene synthesis catalyzed by ABCs, an interesting 
observation was made. When 1.44a was prepared by direct acylation of 2-mercaptobenzaldehyde 
(1.52) with cinnamoyl chloride, thiochromene 1.45a formed as a byproduct comprising as much 
as 30% of the material. Follow up experiments showed an uncatalyzed form of the reaction can be 
promoted by the addition of one equivalent of 2-mercaptobenzaldehyde (1.52) and triethylamine 
as shown in Figure 1.21. 
 
Figure 1.21: Thiolate promoted synthesis of thiochromenes. 
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 Although this method gave only a 45% yield, this discovery suggests a different mode of 
catalysis could be exploited to perform the same transformation. Shown in Figure 1.22, we propose 
that the reaction is initiated by uncatalyzed thiolate addition to 1.44a to form enolate 1.79a, which 
can then undergo the aldol-lactonization cascade freeing additional thiolate for subsequent cycles. 
 
Figure 1.22: Proposed mechanism of thiolate promoted pathway. 
 Matsubara reported a similar thiol promoted reaction of -unsaturated thioesters in the 
presence of a bifunctional thiourea catalyst (1.82) shown in Figure 1.23.26 While the ee values 
were only modest, this mode of catalysis would reasonably apply for the 2-mercaptobenzaldehyde-




Figure 1.23: Thiol promoted reaction of -hydroxy--unsaturated thioesters. 
1.3 Asymmetric synthesis of thiochromanes. 
1.3.1 Shortcomings of DHPB. 
Early in our enantioselective synthesis of 2-substituted thiochromenes, we realized enone 
substrate 1.84a could be easily prepared via Wittig reaction of 1.44a. After the encouraging results 
of the thiochromene synthesis, we set out to develop a related process that would proceed via a 
formal [4+2] cycloaddition (Figure 1.24).1b When the enone substrate 1.84a was treated with 
DHPB 1.63, the expected tricyclic ene-lactone 1.85a formed with good diastereoselectivity. 
However, the reaction advanced excruciatingly slowly, reaching only 35% conversion after 5 days. 
With such low conversions, the asymmetric variant of this process was not promising, and the 




Figure 1.24: New tandem transformation. 
1.3.2 Rational design of new catalysts using computational chemistry. 
We hypothesized that two steps in the new tandem may be slowing the reaction to the point 
of impracticality: activation of the thioester (Figure1.24, Step 1) and the Michael addition of the 
zwitterionic enolate to the enone moiety (Figure 1.24, Step 3). Further corroborating our 
hypothesis, a highly activated, bis(trifluoromethyl) enone 1.84g underwent clean conversion to 
ene-lactone 1.85g in 48 h when subjected to DHPB (1.63) as shown in Figure 1.25. Fearing 1.85g 
would be unstable to chromatography, it was treated with methanol for an additional 48 h to give 





Figure 1.25: Successful rearrangement and methanolysis of activated enone 1.84g. 
This result suggested the acyl transfer step was likely the limiting step in our new tandem 
process. Rather than tailor make more activated enone substrates to overcome this limitation, we 
chose to design more active catalysts using DFT calculations. These new catalysts would hopefully 
be effective for a broader range of reactions and substrates. With the difficult acyl transfer step in 
mind, we computed the enthalpies of the isodesmic acyl transfer reaction between N-acetyl-DHPB 
cation (1.90) and several types of achiral ABCs (Figure 1.26).27 As expected, adding electron-
donating substituents to the benzene ring on DHPB (1.63b-e) gave strongly negative values. 
Bicyclic isothioureas 1.91a and 1.92a reported recently by Okamoto et al.28 and their electron-rich 
derivatives (1.91b-d, 1.92b-d) displayed considerably higher predicted Lewis basicities than 
DHPB itself while following the same trend of increasingly negative values with increasing 
electron-donating groups. Finally, the most negative enthalpy was calculated for DHIP 1.93. This 
also happened to be the very first ABC that served as the starting point for designing this entire 




Figure 1.26: Relative acylation enthalpies of some achiral ABCs. 
1.3.3 Achiral catalyst survey. 
With these computations in hand, we synthesized the catalysts shown in Figure 1.26 and 
undertook a kinetics study of the rearrangement of thioester 1.84a. Electron-rich derivatives of 
DHPB 1.63b-e produced increased reaction rates in comparison to unsubstituted DHPB (Table 1, 
entries 2-5 vs. 1). Bicyclic isothioureas 1.91 and 1.92 (entries 6-13) turned out to be even more 
active leading to as much as a 574-fold increase in the relative reaction rate (entry 8) even though 
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some DHPB derivatives gave similar computed acylation enthalpies (see, e.g., 1.91b vs. 1.63c or 
1.92c vs. 1.63d). Given the fact that catalysts 1.91a-c and 1.92a performed slower than DHPB 
1.63a in the acetylation of 1-phenylethanol with anhydrides in Okamoto’s study,28 it was somewhat 
surprising that these catalysts performed the best in our new tandem. This can be rationalized by 
the difference in mechanisms between the reactions studied. The earlier mentioned experiment 
with a more active enone thioester (1.89, Figure 1.25) demonstrated that acyl transfer (Figure1.24, 
Step 1) is likely our limiting step. O-acylation of enolate 1.88 (Figure 1.24) to displace the catalyst 
is expected to be relatively fast. In contrast, Okamoto may have observed a slower reaction rate 
due to slower deacylation of the catalyst with increasing Lewis basicity in their simple acetylation 
of 1-phenylethanol.  Finally, in sharp contrast to its poor performance in the acetylation of alcohols 
observed in previous studies: several hundred times slower than DHPB,13b DHIP 1.93 displayed 
catalytic activity comparable to the fastest bicyclic isothioureas (entry 14). Although this dramatic 
reversal in the relative activity of the two catalysts can be rationalized similarly to above mentioned 












Table 1.3: Achiral catalyst survey.a 
 
entry catalyst t1/2, min relative rate dr 
Computed Relative 
HAc, kcal 
1 1.63a NDb 1 ND 0 
2 1.63b 7600 3.20 ND -1.73 
3 1.63c 998 22.6 ND -3.65 
4 1.63d 841 31.3 ND -4.36 
5 1.63e 77 221 97:3 -7.36 
6 1.91a 92 210 95:5 -4.53 
7 1.91b 54 308 96:4 -5.20 
8 1.91c 27 574 96:4 -6.23 
9 1.91d 28 537 96:4 -6.38 
10 1.92a 184 98 93:7 -4.10 
11 1.92b 96 180 93:7 -4.79 
12 1.92c 40 392 92:8 -6.10 
13 1.92d 33 509 91:9 -6.19 
14 1.93 38 431 96:4 -8.70 
aConditions: 0.1 M 1.84a, 0.01 M catalyst, CDCl3, rt. 





1.3.4 Chiral catalyst survey and substrate scope. 
Excited by these findings, we synthesized chiral catalysts 1.94-1.95 and 1.29b and 
evaluated their efficacy in the asymmetric version of the rearrangement (Table 1.4). Although it 
gave the highest enantioselectivity, catalyst 1.94, the dimethylamino derivative of HBTM-2 
(1.32b, Figure 1.14) required 5 days to complete the tandem reaction (entry 1). Despite having the 
fastest achiral analog (Table 1.3, entry 8), catalyst 1.95 displayed the worst reactivity of the chiral 
series of catalysts stalling at 4 days with a disappointing 32% yield. The enantioselectivity 
produced by 1.95 was also dreadfully poor. Delightfully, both 1.9628 and H-PIP 1.29b13a produced 
excellent enantioselectivity and good activity (entries 3 and 4). Since 1.29b was the most 
synthetically accessible of the four catalysts requiring only two steps, we selected it to explore the 
substrate scope of the enantioselective rearrangement (Figure 1.27). 
First, varying the R2 substituents on the enone while the R1 position remained an 
unsubstituted phenyl, the transformation proceeded successfully with electron-deficient and 
electron-rich aryl groups (1.85a-e, g, j) as well as with a methyl group (1.85f). Next, the R1 position 
of the enone was varied with a combination of R2 substituents (1.85a-f). Substrates with an 
electron-deficient aryl (1.85g and h), as well as a cyclohexyl group (1.85j and k) also reacted 
smoothly regardless of R2. Due its deactivating effect on the thioacyl carbonyl, a substrate with a 
p-methoxyphenyl group at R1 displayed a loss of reactivity reaching only 20% conversion in 5 
days (1.85i). Excellent diastereoselectivities (d.r. ca. 20:1) were observed in all thiochromanes 
produced in the reaction. The enantioselectivity of the reaction was also excellent providing 90% 
ee or above in all but one thiochromane (1.85f). Strangely, tetrakis(trifluoromethyl) substrate 1.84l 
underwent a subsequent migration of the ene-lactone double bond into conjugation with the lactone 
ester to form 1.97. The mechanism of this unexpected transformation has yet to be explored but 
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high enantioselectivity was observed nonetheless. Finally, the rearrangement was carried out with 
1 g (2.7 mmol) of substrate 1.84a, and an 86% yield and 95% ee were obtained demonstrating the 
scalability of our tandem transformation. 
Table 1.4: Chiral catalyst survey.a 
 
entry catalyst time % yield dr % ee 
1 
 
5d 77 97:3 -99 
2 
 
4d 32 ND -35 
3 
 
17h 83 98:2 96 
4 
 
17h 93 97:3 95 









Due to its success in this study, we chose to revisit the thiochromene synthesis with H-PIP 
(1.29b). Surprisingly, it produced only modest enantioselectivity (Figure 1.27) despite the 
achieving great results in the synthesis of 1.85. Demonstrated by its fast reaction time (3 hours), 
this diminished enantioselectivity is likely due to the increased reactivity of the o-formylaryl 
thioester (1.44a) compared to enone thioesters (1.84), which further supports the concept that acyl 
donors need to match the reactivity of the catalysts. 
 
Figure 1.28: Thiochromene synthesis with 1.29b. 
While our work on this rearrangement was under consideration for publication, a paper by 
Xu et al.29 describing the same transformation promoted by an NHC catalyst (1.98) was published 
(Figure 1.29). The NHC catalyzed process proceeds with good to excellent yields as well as 
excellent enantioselectivity and diastereoselectivity.  
 
Figure 1.29: NHC catalyzed synthesis of thiochromanes. 
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1.4 Conclusion and future directions. 
 In conclusion, we have developed two highly enantioselective cascade transformations of 
thioesters into rearranged products. First, the synthesis of chiral, 2-substituted thiochromenes and 
their heterocyclic analogues exhibited a broad substrate scope without requiring additional 
reagents and producing only carbon dioxide as byproduct. This was the first example of acyl 
transfer catalysts activating thioesters, which have proven to be chromatographically stable, 
moderately reactive acyl donors. Additionally, we have developed a new highly enantioselective 
and atom-economical tandem reaction of thioesters into fused thiochromanes. This study 
necessitated the rational design of more electron-rich ABCs for moderately reactive acyl donors. 
Surprisingly, the best results were achieved with H-PIP 1.29b, the very first chiral ABC 
synthesized in our lab. The original study of this catalyst in our group took place 13 years ago and 
focused on the acylation of benzylic alcohols with anhydrides. Since it performed poorly in the 
simple acylation of alcohols, H-PIP served as only a beginning to the design of more electron-
deficient derivatives (e.g., CF3-PIP 1.29a, Figure 1.3) at the time.  Its success in the present study 
underscores the concept of matching acyl donors to the reactivity of the catalyst as well as the 
potential of electron-rich ABCs to activate additional moderately reactive acyl donors including 
less reactive alkyl thioesters. 
 Our development of cascade processes of -unsaturated thioesters described in this 
chapter paves the way for further investigation into transformations previously considered 
impossible by acyl transfer catalysis. For example, initial studies of problematic thiochromene 
substrates 1.72 and 1.74 utilizing electron-rich ABCs are underway (Figure 1.30). By simply using 
a dimethylamino derivative of DHPB (1.63), a facile synthesis of 3-fluorothiochromenes appears 
likely. Studies in this direction are being pursued in our group by Mr. Matthew Straub with 
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promising results already. He will also be pursuing the systematic electronic tuning of H-PIP based 
on further computational studies. Furthermore, it will be interesting to observe the reactivity of 
ABCs or NHCs with even more negative calculated acylation enthalpies to test the limits of acyl 
group activation.   
 









1.5  Experimental. 
All reagents were obtained commercially and used as received unless specified otherwise. 
Catalysts 1.29a-b,14a 1.30,14b 1.31,14c 1.32a,14e 1.32b,14f 1.32c,23 1.63a,22 1.9314a were prepared as 
previously described. Chloroform, dichloromethane, and N,N-dimethylacetamide were freshly 
distilled from calcium hydride. THF was freshly distilled from sodium and benzophenone. 
Solvents used for chromatography were ACS or HPLC grade, as appropriate. Reactions were 
carried out under argon and monitored by thin layer chromatography (TLC) and by 1H NMR. 
Uniplate HLF (250 μm) silica gel plates were used for TLC analyses. Flash column 
chromatography was performed over Sorbent Technologies silica gel (40-63 mm). HPLC analyses 
were performed on a Shimadzu LC system using Chiralcel OD-H, analytical chiral stationary 
phase column (4.6x250 mm, Chiral Technologies, Inc.) with a UV detector at 254 nm and a 1.0 
mL/min flow rate. 1H and 13C NMR spectra were recorded on a Mercury 300 MHz and DD2 500 
MHz Agilent spectrometer.  The chemical shifts are reported as values (ppm) relative to TMS 
using residual CHCl3 peak (7.26 ppm) as the reference. Melting points were measured on a Stuart 
SMP10 melting point apparatus. High-Resolution mass spectral analyses were performed at 
Washington University MS Center on a Bruker MaXis QTOF mass spectrometer using 
Electrospray Ionization (ESI) and Electron Impact (EI) methods.30 Infrared spectra were recorded 




1.5.1 Synthesis of 2-formylthioester substrates, 1.44. 
 
General procedure A for the synthesis of substrates 1.44a-l.31 A round bottom flask equipped 
with a magnetic stir bar was charged with an -unsaturated acid (1.0 equiv), N,N'-
dicyclohexylcarbodiimide (0.5 equiv), and THF (0.2 M). The mixture was cooled to 0 °C, stirred 
for 15 min, treated with PPh3 (0.6 equiv) and disulfide 1.99a or b
32,33 (0.5 equiv) added in one 
portion, and allowed to slowly warm to rt. The mixture was stirred for 12 h, filtered, and 
concentrated under reduced pressure. The residue was purified by flash chromatography using the 
eluent indicated to afford the corresponding o-formyl thioester 12. 
S-(2-formylphenyl) (E)-3-phenylprop-2-enethioate (1.44a). Prepared from trans-cinnamic acid 
(108 mg, 0.728 mmol) and 1.99a. White solid (103 mg, 53% yield, 
1→5% EtOAc/hexanes).  1H NMR (300 MHz, CDCl3): 10.27 (s, 1H), 
8.08 (dd, J1 = 7.2 Hz, J2 = 2.0 Hz, 1H), 7.72 (d, J = 15.8 Hz, 1H), 7.68-
7.55 (m, 5H), 7.45-7.30 (m, 3H), 6.83 (d, J = 15.8 Hz, 1H); 13C NMR (75 MHz, CDCl3): 191.03, 
186.68, 143.11, 137.28, 136.75, 134.36, 133.89, 131.37, 131.10, 130.56, 129.30, 128.87, 123.64; 
IR (cm-1): 3061, 3027, 3016, 2866, 1681, 1613, 1264, 1198, 985, 751, 691; MS: HR-ESI 
calculated for [C16H12O2S+Na]
+: 291.0450, found: 291.0443; mp: 86-88 °C. 
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S-(2-formylphenyl) (E)-3-(naphthalen-2-yl)prop-2-enethioate (1.44b). Prepared from (E)-3-(2-
naphthyl)acrylic acid (130 mg, 0.656 mmol) and 1.99a. White 
solid (153 mg, 73% yield, 2→10% EtOAc/hexanes). 1H NMR 
(300 MHz, CDCl3): 10.30 (s, 1H), 8.09-8.06 (m, 1H), 7.95 (s, 
1H), 7.88-7.81 (m, 4H), 7.67-7.48 (m, 6H), 6.91 (d, J = 15.7 Hz, 1H); 13C NMR (75 MHz, CDCl3): 
190.96, 186.52, 143.06, 137.20, 136.66, 134.72, 134.29, 133.37, 131.45, 131.28, 131.11, 130.45, 
129.20, 129.07, 128.86, 127.99, 127.9, 127.07, 123.61, 123.52; IR (cm-1): 3052, 2919, 2870, 1692, 
1673, 1604, 1355, 1285, 1265, 1200, 1024, 960, 831; MS: HR-ESI calculated for [C20H14O2S+H]
+: 
319.0787, found: 319.0789; mp: 135-136 °C. 
S-(2-formylphenyl) (E)-3-(naphthalen-1-yl)prop-2-enethioate (1.44c). Prepared from (E)-3-(1-
naphthyl)acrylic acid (65 mg, 0.328 mmol) and 1.99a. Yellow oil (72 
mg, 69% yield, 2→6% EtOAc/hexanes). 1H NMR (300 MHz, 
CDCl3): 10.32 (s, 1H), 8.55 (d, J = 15.5 Hz, 1H), 8.15 (d, J = 8.2 
Hz, 1H), 8.10-8.07 (m, 1H), 7.94-7.79 (m, 3H), 7.67-7.46 (m, 6H), 6.91 (d, J = 15.5 Hz, 1H); 13C 
NMR (75 MHz, CDCl3): 190.96, 186.57, 139.81, 137.21, 136.64, 134.32, 133.86, 131.80, 
131.65, 131.05, 131.01, 130.51, 129.24, 129.03, 127.39, 126.59, 125.80, 125.64, 125.59, 123.25; 
IR (cm-1): 3059, 1673, 1599, 1570, 1345, 1264, 1198, 1042, 1021, 826, 793, 762, 706, 598, 500; 
MS: HR-ESI calculated for [C20H14O2S+Na]
+: 341.0607, found: 341.0610. 
S-(2-formylphenyl) (E)-3-(3,5-bis(trifluoromethyl)phenyl)prop-2-enethioate (1.44d). 
Prepared from (E)-3,5-bis(trifluoromethyl)cinnamic acid (186 mg, 
0.656 mmol) and 1.99a. White solid (125 mg, 47% yield, 1→3% 
EtOAc/hexanes). 1H NMR (300 MHz, CDCl3): 10.24 (s, 1H), 
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8.06 (dd, J1 = 7.2 Hz, J2 = 1.6 Hz, 1H), 7.98 (s, 2H), 7.91 (s, 1H), 7.70 (d, J = 15.8 Hz, 1H), 7.66-
7.55 (m, 3H) 6.94 (d, J = 15.8 Hz, 1H); 13C NMR (75 MHz, CDCl3): 190.65, 186.20, 138.88, 
137.16, 136.67, 136.10, 134.49, 133.56, 132.89 (q, J = 33.8 Hz), 130.87, 130.15, 129.74, 128.30, 
127.12, 124.92, 124.22, 121.30; IR (cm-1): 3055, 2922, 2853, 2753, 1689, 1615, 1467, 1379, 1282, 
1172, 1113, 1022, 983, 947, 908, 846, 818, 754; MS: HR-ESI calculated for [C18H10F6O2S+H]
+: 
405.0378, found: 405.0379; mp: 135-136 °C. 
S-(2-formylphenyl) (E)-3-(2,5-difluorophenyl)prop-2-enethioate (1.44e). Prepared from (E)-
2,5-difluorocinnamic acid (81 mg, 0.438 mmol) and 1.99a. White solid 
(89 mg, 67% yield, 2→4% EtOAc/hexanes). 1H NMR (300 MHz, 
CDCl3): 10.25 (s, 1H), 8.07 (dd, J1 = 7.1 Hz, J2 = 1.4 Hz, 1H), 7.73 
(d, J = 16.0 Hz, 1H), 7.67-7.54 (m, 3H), 7.27-7.22 (m, 1H), 7.11-7.07 
(m, 2H), 6.89 (d, J = 16.0 Hz, 1H); 13C NMR (75 MHz, CDCl3): 190.79, 186.58, 160.03(dd, J1 
= 66.2 Hz, J2 = 2.1 Hz), 156.76 (dd, J1 = 73.3 Hz, J2 = 2.1 Hz), 137.16, 136.65, 134.40, 134.24, 
130.68, 130.59, 129.43, 126.96, 126.87, 123.21 (dd, J1 = 14.1 Hz, J2 = 8.1 Hz), 119.24 (dd, J1 = 
24.4 Hz, J2 = 9.1 Hz), 117.78 (dd, J1 = 25.0 Hz, J2 = 8.5 Hz), 115.31 (dd, J1 = 24.5 Hz, J2 = 3.1 
Hz); IR (cm-1): 3116, 3074, 3023, 1689, 1668, 1612, 1585, 1566, 1486, 1434, 1398, 1323, 1267, 
1186, 1028, 972, 856, 752, 718, 633, 579, 443; MS: HR-ESI calculated for [C16H10F2O2S+Na]
+: 
327.0262, found: 327.0266; mp: 99-102 °C. 
 S-(2-formylphenyl) (E)-3-(4-formylphenyl)prop-2-enethioate (1.44f). Prepared from (E)-4-
formylcinnamic acid (116 mg, 0.656 mmol) and 1.99a. White 
solid (112 mg, 57% yield, 10:10:80 EtOAc/CH2Cl2/hexanes). 1H 
NMR (300 MHz, CDCl3): 10.24 (s, 1H), 10.03 (s, 1H), 8.06 (dd, 
35 
 
J1 = 7.3 Hz, J2 = 1.7 Hz, 1H), 7.91 (d, J = 8.2 Hz, 2H), 7.72-7.54 (m, 6H), 6.91 (d, J = 15.8 Hz, 
1H); 13C NMR (75 MHz, CDCl3): 191.46, 190.76, 186.46, 140.98, 139.47, 137.84, 137.17, 
136.65, 134.42, 130.73, 130.51, 130.41, 129.54, 129.23, 126.37; IR (cm-1): 3062, 3050, 2864, 
2815, 2716, 1694, 1680, 1609, 1583, 1565, 1199, 1022, 985, 884, 811, 746; MS: HR-ESI 
calculated for [C17H12O3S+Na]
+: 319.0399, found: 319.0427; mp: 142-144 °C. 
S-(2-formylphenyl) (E)-3-(4-methoxyphenyl)prop-2-enethioate (1.44g). Prepared from (E)-4-
methoxycinnamic acid (58 mg, 0.328 mmol) and 1.99a. White 
solid (86 mg, 88% yield, 5→10% EtOAc/hexanes). 1H NMR 
(300 MHz, CDCl3): 10.26 (s, 1H), 8.05 (d, J = 7.3 Hz, 1H), 
7.64-7.51 (m, 6H), 6.91 (d, J = 8.5 Hz, 2H), 6.69 (d, J = 15.7 Hz, 1H), 3.84 (s, 3H); 13C NMR (75 
MHz, CDCl3): 191.12, 186.47, 162.36, 142.91, 137.29, 136,74, 134,28, 131.43, 130.72, 130.40, 
129.13, 126.53, 121,016, 121.16, 114.77, 55.64; IR (cm-1): 3064, 3011, 2878, 1700, 1665, 1599, 
1569, 1512, 1315, 1288, 1180, 1026; MS: HR-ESI calculated for [C17H14O3S+Na]
+: 321.0556, 
found: 321.0550; mp: 108-110 °C. 
S-(2-formylphenyl) (E)-3-(3,4,5-trimethoxyphenyl)prop-2-enethioate (1.44h). Prepared from 
(E)-3,4,5-trimethoxycinnamic acid (235 mg, 0.656 mmol) and 
1.99a. White solid (212 mg, 90% yield, 10→20% EtOAc). 1H 
NMR (300 MHz, CDCl3): 10.24 (s, 1H), 8.04 (dd, J1 = 7.7 Hz, 
J2 = 1.9 Hz, 1H), 7.64-7.52 (m, 4H), 6.77 (s, 2H), 6.70 (d, J = 15.6 Hz, 1H); 13C NMR (75 MHz, 
CDCl3): 190.96, 186.36, 153.68, 143.08, 141.10, 137.19, 136.68, 134.3, 131.06, 130.47, 129.26, 
129.22, 122.78, 106.02, 61.16, 56.38; IR (cm-1): 3008, 2940, 2838, 2755, 1706, 1690, 1649, 1612, 
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1577, 1505, 1465, 1421, 1324, 1251, 1191, 1120, 1026, 964, 828, 757; MS: HR-ESI calculated 
for [C19H18O5S+H]
+: 359.0948, found: 359.0949; mp: 133-135 °C. 
S-(2-formylphenyl) (E)-3-(pyridin-3-yl)prop-2-enethioate (1.44i). Prepared from (E)-3-
(pyridin-3-yl)acrylic acid (42.7 mg, 0.286 mmol) and 1.99a. White solid 
(43.8 mg, 57% yield, 10% EtOAc/CH2Cl2). 1H NMR (300 MHz, 
CDCl3): 10.24 (s, 1H), 8.77 (d, J = 2.1 Hz, 1H), 8.62 (dd, J1 = 4.8 Hz, 
J2 = 1.6 Hz, 1H), 8.05 (dd, J1 = 7.3 Hz, J2 = 2.0 Hz, 1H), 7.87 (ddd, J1 = 8.0 Hz, J2 = 2.0 Hz, J3 = 
2.0 Hz, 1H), 7.70 (s, 1H), 7.65-7.54 (m, 3H), 7.34 (dd, J1 = 8.0 Hz, J2 = 4.8 Hz, 1H), 6.87 (d, J = 
15.8 Hz, 1H); 13C NMR (75 MHz, CDCl3): 190.82, 186.37, 151.87, 150.40, 139.16, 137.19, 
136.69, 134.83, 134.43, 130.73, 130.53, 129.75, 129.53, 125.49, 124.07; IR (cm-1): 3104, 3058, 
3011, 2923, 1687, 1629, 1602, 1200, 1051, 1019, 981; MS: HR-ESI calculated for 
[C15H11O2NS+Na]
+: 292.0403, found: 292.0421; mp: 139-142 °C.  
S-(2-formylphenyl) (E)-3-(furan-3-yl)prop-2-enethioate (1.44j). Prepared from (E)-3-(3-
furyl)acrylic acid (91 mg, 0.659 mmol) and 1.99a. White solid (60 mg, 
35% yield, 2→10% EtOAc/hexanes). 1H NMR (300 MHz, CDCl3): 
10.24 (s, 1H), 8.05 (d, J = 5.7 Hz, 1H), 7.77-7.34 (m, 6H), 6.61 (d, J = 
1.6 Hz, 1H), 6.53 (d, J = 15.6 Hz, 1H); 13C NMR (75 MHz, CDCl3): 171.78, 140.10, 140.05, 
133.27, 133.16, 129.13, 128.72, 128.69, 128.19, 128.16, 128.21, 127.41, 127.39, 77.86, 45.44, 
17.56; IR (cm-1): 3138, 3118, 2866, 2846, 2757, 1689, 1667, 1611, 1301, 1268, 1206, 1157, 1028, 
979, 846, 795, 746; MS: HR-ESI calculated for [C14H10O3S+H]




S-(2-formylphenyl) (E)-3-cyclohexylprop-2-enethioate (1.44k). Prepared from (E)-3-
cyclohexyl-2-propenoic acid (101 mg, 0.656 mmol) and 1.99a. 
Greenish-yellow oil (62 mg, 34% yield, 1→5% EtOAc/hexanes). 1H 
NMR (300 MHz, CDCl3): 10.21 (s, 1H), 8.03 (dd, J1 = 7.1 Hz, J2 = 
2.1 Hz, 1H), 7.63-7.48 (m, 3H), 6.97 (dd, J1 = 15.7 Hz, J2 = 6.8 Hz, 1H), 6.15 (dd, J1 = 15.7 Hz, 
J2 = 1.4 Hz, 1H ) 2.20-2.15 (m, 1H) 1.80-1.66 (m, 5H) 1.38-1.09 (m, 5H); 13C NMR (75 MHz, 
CDCl3): 191.10, 187.06, 153.42, 137.28, 136.74, 134.27, 131.31, 130.39, 129.09, 125.16, 40.87, 
31.70, 26.02, 25.82; IR (cm-1): 3062, 2924, 2858, 2743, 1694, 1623, 1587, 1447, 1385, 1263, 1197, 
1131, 1115, 1098, 1011, 963, 915, 888, 815, 758; MS: HR-ESI calculated for [C16H18O2S+Na]
+: 
297.0920, found: 297.0933. 
S-(3-chloro-2-formylphenyl) (E)-3-phenylprop-2-enethioate (1.44l). Prepared from trans-
cinnamic acid (56 mg, 0.380 mmol), and 1.99b.33 White solid (63 mg, 
0.208 mmol, 55% yield, 2→5% EtOAc/hexanes). 1H NMR (300 MHz, 
CDCl3): 10.42 (s, 1H), 7.68 (d, J = 15.8 Hz, 1H), 7.57-7.45 (m, 5H), 
7.43-7.36 (m, 3H), 6.77 (d, J = 15.8 Hz, 1H); 13C NMR (125 MHz, CDCl3):  190.05186.25, 
142.93, 137.04, 135.38, 135.13, 133.96, 133.13, 132.15, 131.31, 130.99, 129.28, 128.85, 123.87; 
IR (cm-1): 3060, 3027, 2956, 2923, 1705, 1679, 1612, 1572, 1557, 1495, 1448, 1435, 1394, 1327, 
1302, 1277, 1206, 1184, 1128, 1093, 1073, 1031, 1018, 998, 974, 883, 844; MS: HR-ESI 
calculated for [C16H11ClO2S+Na]
+: 325.0060, found: 325.0062; mp: 108-110 °C. 
S-(2-formylphenyl) (E)-3-phenylprop-2-enethioate (1.75). Prepared from (Z)-2-fluoro-3-
phenylacrylic acid (285 mg, 1.72 mmol)34 and 1.99a. White solid (151 
mg, 31% yield, 1→5% EtOAc/hexanes).  1H NMR (500 MHz, CDCl3): 
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10.27 (s, 1H), 8.11 (dd, J = 7.6, 1.7 Hz, 1H), 7.76 – 7.61 (m, 4H), 7.58 (dd, J = 7.5, 1.4 Hz, 1H), 
7.44 (dd, J = 5.2, 2.0 Hz, 3H), 6.88 (d, J = 36.6 Hz, 1H); 13C NMR (125 MHz, CDCl3): 190.57, 
183.82 (d, J = 38.7 Hz), 151.49 (d, J = 270.4 Hz), 137.57, 137.00, 134.48, 131.13, 131.08 (d, J = 
29.1 Hz), 130.64 (d, J = 2.8 Hz), 130.55 (d, J = 4.3 Hz), 129.54, 129.34 (d, J = 5.1 Hz), 129.17, 
115.20 (d, J = 4.3 Hz); IR (cm-1): 1697, 1636, 1585, 1494, 1448, 1265, 1228, 1197, 1153, 944, 
825, 750, 689, 555, 437; MS: HR-ESI calculated for [C16H11FO2S+Na]
+: 287.0537, found: 
287.0593; mp:  90-93 °C. 
 
Synthesis of S-(2-formyl-4-nitrophenyl) (E)-3-phenylprop-2-enethioate (1.44m). A mixture of 
S-2-formyl-4-nitrophenyl N,N-dimethylcarbamothioate 1.10035 (74 mg, 0.291 mmol), aqueous 
NaOH (3M, 1.16 mL, 3.48 mmol, 12.0 equiv), and MeOH (2.30 mL, 56.9 mmol) was refluxed for 
3 h, cooled and diluted with H2O. The aqueous layer was acidified to pH 3 with 10% HCl and 
extracted with CH2Cl2. The combined organic layers were washed with brine, dried over Na2SO4, 
filtered, and concentrated under reduced pressure. To the crude residue was added CH2Cl2 (1.45 
mL) followed by NEt3 (48 µL, 0.349 mmol). The mixture was cooled to –78 °C, treated with trans-
cinnamoyl chloride (58 mg, 0.349 mmol) in THF (3 mL) added dropwise, allowed to slowly warm 
to 23 °C, and quenched with H2O. The aqueous layer was extracted with CH2Cl2. The combined 
organic phase was washed with H2O and brine, dried over Na2SO4, filtered, and concentrated under 
reduced pressure. The residue was purified by flash chromatography (5→10% EtOAc/hexanes) to 
afford 1.44l as a white solid (57 mg, 63% yield). 1H NMR (300 MHz, CDCl3): 10.21 (s, 1H), 
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8.86 (d, J = 2.6 Hz, 1H), 8.43 (dd, J1 = 8.5 Hz, J2 = 2.6 Hz, 1H), 7.80 (d, J = 8.5 Hz, 1H), 7.76 (d, 
J = 15.6 Hz, 1H), 7.60-7.57 (m, 2H), 7.47-7.39 (m, 3H), 6.82 (d, J = 15.6 Hz, 1H); 13C NMR (75 
MHz, CDCl3): 188.51, 184.61, 149.12, 144.67, 138.26, 138.14, 137.67, 133.51, 131.88, 129.43, 
129.07, 127.72, 124.02, 122.98; IR (cm-1): 3091, 3075, 3060, 2919, 2851, 1693, 1672, 1600, 1573, 
1521, 1449, 1342, 1300, 1245, 1187, 1033, 994, 913, 882, 847, 817, 755, 741, 689, 570; MS: HR-
ESI calculated for [C16H11O4NS+H]
+: 314.0482, found: 314.0476; mp: 152-154 °C. 
 
General procedure B for the synthesis of 1.44n-q. A mixture of a 2-haloaldehyde 1.101 (1.50 
mmol), sodium sulfide nonahydrate (432 mg, 1.80 mmol, 1.2 equiv), and N,N-dimethylacetamide 
(0.3 M, 5 mL) was stirred at the temperature indicated until completion by TLC, then cooled to 
0 °C, and treated with cinnamoyl chloride (375 mg, 2.25 mmol, 1.5 equiv) in THF (0.45 M, 5 mL). 
The mixture was stirred for 15 min and quenched with H2O. The aqueous layer was extracted with 
Et2O. The combined organic phase was washed with H2O and brine, dried over Na2SO4, filtered, 
and concentrated under reduced pressure. The residue was purified by flash chromatography using 
the eluent indicated to afford the corresponding o-formyl thioester 1.44. 
S-(3,6-dibromo-2-formylphenyl) (E)-3-phenylprop-2-enethioate (1.44n). Prepared from 3,6-
dibromo-2-fluorobenzaldehyde (423 mg, 1.50 mmol, 1 h at 23 °C). 
White, crystalline solid (207 mg, 32% yield, 2% EtOAc/hexanes). 1H 
NMR (300 MHz, CDCl3): 10.14 (s, 1H), 7.70 (d, J = 15.8 Hz, 1H), 
7.69 (d, J = 8.6 Hz, 1H), 7.59-7.54 (m, 3H), 7.43-7.36 (m, 3H), 6.77 (d, J = 15.8 Hz, 1H); 13C 
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NMR (75 MHz, CDCl3): 190.47, 184.40, 143.69, 140.34, 137.01, 136.34, 133.71, 131.46, 
131.28, 131.07, 129.26, 128.90, 123.37, 122.05; IR (cm-1): 3070, 3056, 3004, 1697, 1671, 1610, 
1573, 1545, 1449, 1418, 1400, 1326, 1305, 1278, 1199, 1158, 1115, 1068, 1021, 976, 884, 812, 
756, 690, 573, 482; MS: HR-ESI calculated for [C16H10Br2O2S+Na]
+: 446.8660, found: 446.8667; 
mp: 120-123 °C. 
S-(6-formyl-2,3-dimethoxyphenyl) (E)-3-phenylprop-2-enethioate (1.44o). Prepared from 2-
chloro-3,4-dimethoxy-benzaldehyde (301 mg, 1.5 mmol, 30 min 
at 80 °C). White solid (60 mg, 12% yield, 2→20% 
EtOAc/hexanes). 1H NMR (300 MHz, CDCl3): 10.16 (s, 1H), 
7.86 (d, J = 8.7 Hz, 1H), 7.70 (d, J = 15.8 Hz, 1H), 7.58-7.55 (m, 2H), 7.41-7.38 (m, 3H), 7.11 (d, 
J = 8.7 Hz, 1H), 6.85 (d, J = 15.8 Hz, 1H), 3.96 (s, 3H), 3.83 (s, 3H); 13C NMR (75 MHz, CDCl3): 
190.19, 186.50, 158.07, 150.00, 142.81, 133.97, 131.24, 130.66, 129.26, 128.82, 126.18, 125.65, 
123.79, 113.76, 61.41, 56.35; IR (cm-1): 3082, 3016, 2989, 2942, 1673, 1610, 1573, 1482, 1464, 
1327, 1302, 1279, 1254, 1214, 1171, 1015, 974, 932, 883, 826, 751, 687, 566, 497, 480; MS: HR-
ESI calculated for [C18H16O4S+H]
+: 329.0842, found: 329.0838; mp: 164-166°C. 
S-(3-formylquinolin-2-yl) (E)-3-phenylprop-2-enethioate (1.44p). Prepared from 2-chloro-3-
quinolinecarboxaldehyde (287 mg, 1.50 mmol, 30 min at 80 °C). 
White solid (162 mg, 34% yield, 10:6:84 EtOAc/CH2Cl2/hexanes). 
1H NMR (300 MHz, CDCl3): 10.27 (s, 1H), 8.85 (s, 1H), 8.17 
(d, J = 8.5 Hz, 1H), 8.01 (dd, J1 = 8.2 Hz, J2 = 1.0 Hz, 1H), 7.86 (ddd, J1 = 8.6 Hz, J2 = 6.9 Hz, J3 
= 1.4 Hz, 1H), 7.75 (d, J = 15.8 Hz, 1H), 7.66 (ddd, J1 = 8.6 Hz, J2 = 6.9 Hz, J3 = 1.4 Hz, 1H), 
7.58-7.55 (m, 2H), 7.44-7.37 (m, 3H), 6.85 (d, J = 15.8 Hz, 1H); 13C NMR (75 MHz, CDCl3): 
41 
 
190.09, 186.90, 151.50, 150.32, 143.95, 138.69, 133.73, 133.00, 131.51, 130.82, 129.80, 129.71, 
129.30, 128.95, 128.88, 127.44, 123.70; IR (cm-1): 3048, 3032, 1689, 1666, 1607, 1575, 1486, 
1447, 1368, 1302, 1165, 1022, 975, 913, 888, 807, 771, 749, 690, 574, 467; MS: HR-ESI 
calculated for [C19H13O2NS+Na]
+: 342.0559, found: 342.0572; mp: 154-156 °C dec. 
S-(3-formyl-6-methoxyquinolin-2-yl) (E)-3-phenylprop-2-enethioate (1.44q). Prepared from 
2-chloro-6-methoxyquinoline-3-carboxaldehyde (332 mg, 
1.50 mmol, 30 min at 80 °C). Yellow solid (140 mg, 27% 
yield, 5:20:75 EtOAc/CH2Cl2/hexanes). 1H NMR (300 
MHz, CDCl3): 10.25 (s, 1H), 8.70 (s, 1H), 8.04 (d, J = 9.2 Hz, 1H), 7.73 (d, J = 15.8 Hz, 1H), 
7.57-7.53 (m, 2H),  7.48 (dd, J1 = 9.2 Hz, J2 = 2.7 Hz, 1H), 7.40-7.38 (m, 3H), 7.19 (d, J = 2.7 Hz, 
1H), 6.84 (d, J = 15.8 Hz, 1H), 3.93 (s, 3H); 13C NMR (75 MHz, CDCl3): 190.38, 187.20, 159.46, 
148.37, 146.73, 143.70, 136.99, 133.77, 131.42, 131.07, 131.00, 129.26, 128.90, 126.17, 123.73, 
110.16, 106.33, 55.97; IR (cm-1): 3055, 3042, 3025, 3002, 1687, 1647, 1617, 1596, 1574, 1493, 
1449, 1421, 1395, 1371, 1331, 1233, 1130, 1057, 1023, 969, 926, 842, 810, 748; MS: HR-ESI 
calculated for [C20H15O3NS+H]
+: 350.0845, found: 350.0848; mp: 159-162 °C dec. 
 
Synthesis of S-(2-acetylphenyl) (E)-3-phenylprop-2-enethioate (1.73). A mixture of 1-(2-
mercaptophenyl)ethan-1-one 1.10236 (457 mg, 3.0 mmol) and NEt3 (0.63 mL, 4.5 mmol) in CH2Cl2 
(5 mL) was cooled to 0 °C, treated with trans-cinnamoyl chloride (750 mg, 4.5 mmol) in CH2Cl2 
(5 mL) added dropwise, allowed to slowly warm to 23 °C, and quenched with H2O. The aqueous 
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layer was extracted with CH2Cl2. The combined organic phase was washed with H2O and brine, 
dried over Na2SO4, filtered, and concentrated under reduced pressure. The residue was purified by 
flash chromatography (5→10% EtOAc/hexanes) to afford 1.73 as a white solid (381 mg, 45% 
yield). 1H NMR (500 MHz, CDCl3): 7.71 – 7.68 (m, 1H), 7.66 (d, J = 15.8 Hz, 1H), 7.64 – 7.60 
(m, 1H), 7.57 – 7.46 (m, 4H), 7.44 – 7.33 (m, 3H), 6.79 (d, J = 15.8 Hz, 1H), 2.61 (s, 3H); 13C 
NMR (125 MHz, CDCl3):  200.92, 187.26, 143.20, 141.96, 136.71, 134.00, 131.27, 130.96, 
129.45, 129.11, 128.64, 128.59, 125.88, 124.16, 29.44; IR (cm-1): 1675, 1611, 1448, 1247, 1122, 
1016, 997, 883, 753, 690, 594, 573; MS: HR-ESI calculated for [C17H14O2S+H]
+: 283.0787, 
found: 283.0843; mp: 125-128 °C. 
1.5.2 Achiral catalyst survey, synthesis of 1.45a. 
 
A mixture of 1.44a (32 mg, 0.119 mmol), achiral catalyst (10 mol%), and chloroform (0.6 mL, 0.2 
M) was stirred at room temperature for 24 h and concentrated under reduced pressure. The residue 
was purified by flash chromatography (0.5% EtOAc/hexanes) to afford thiochromene 1.45a. The 






1.5.3 Chiral catalyst survey, synthesis of 1.45a. 
 
A mixture of 1.44a (32 mg, 0.119 mmol), chiral catalyst (10 mol%), and chloroform (0.6 mL, 0.2 
M) was stirred at room temperature for 15 h and concentrated under reduced pressure. The residue 
was purified by flash chromatography (0.5% EtOAc/hexanes) to afford thiochromene 1.45a, which 
was analyzed by chiral stationary phase HPLC (see Appendix). The results are summarized in 
Table 1.2. 
1.5.4 Enantioselective synthesis of thiochromenes, general procedure. 
 
The reaction was carried out as described above using (R)-HBTM-2 (1.32b) as a catalyst and 
monitoring the progress by TLC. The mixture was stirred at room temperature for 2-48 h and then 
concentrated under reduced pressure. The residue was purified by flash chromatography using the 
eluent indicated. The absolute stereochemistry of 1.45q was determined by X-ray structure (see 





1.5.5 Detection of carbon dioxide. 
Thioester 1.44f (48 mg, 0.16 mmol) was subjected to the usual reaction conditions in the presence 
of 10 mol % of (R)-HBTM-2 (1.32b). During the reaction, a slow stream of argon was passed over 
the mixture and, via cannula, through an aqueous solution of barium hydroxide in a separate flask. 
Formation of a heavy white precipitate was observed. After 5 h, the precipitate was collected, 
rinsed with deionized water, and dried in an oven for 4 h.  Barium carbonate thus obtained was 





IR Spectrum of BaCO3 
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1.5.6 Characterization data for the thiochromene products. 
(S)-2-phenyl-2H-thiochromene (1.45a). Prepared from 1.44a (32 mg, 0.119 mmol). Colorless oil 
(26.4 mg, 99% yield, 15 h, 0.5% EtOAc/hexanes). 1H NMR (300 MHz, 
CDCl3): 7.35-7.21 (m, 5H), 7.13-7.06 (m, 4H), 6.65 (dd, J1 = 10.2 Hz, J2 = 
1.5 Hz, 1H), 6.00 (dd, J1 = 10.2 Hz, J2 = 5.2 Hz, 1H), 4.87 (dd, J1 = 5.2 Hz, J2 = 1.5 Hz, 1H); 13C 
NMR (75 MHz, CDCl3):  142.08, 131.26, 130.83, 128.98, 128.94, 128.59, 128.38, 127.96, 
127.81, 127.02, 125.80, 125.76, 43.20; IR (cm-1): 3061, 3030, 2977, 2930, 1733, 1152, 743, 698; 
MS: HR-ESI calculated for [C15H12S+Na]
+: 247.0552, found: 247.0562; HPLC: (0.25% 
isopropanol/hexanes): (R)-enantiomer: 17.8 min; (S)-enantiomer: 19.5 min; >99% ee; 
[α]
D
23=+158° (c=1.28, CH2Cl2). 
(S)-2-(naphthalen-2-yl)-2H-thiochromene (1.45b). Prepared from 1.44b (70 mg, 0.22 mmol). 
White solid (57.1 mg, 95% yield, 24 h, 0.5% EtOAc/hexanes). 1H NMR 
(300 MHz, CDCl3): 7.80-7.73 (m, 4H), 7.52-7.42 (m, 3H), 7.17-7.08 
(m, 4H), 6.71 (dd, J1 = 10.2 Hz, J2 = 1.2 Hz, 1H), 6.08 (dd, J1 = 10.2 Hz, J2 = 5.3 Hz, 1H), 5.04 
(dd, J1 = 5.3 Hz, J2 = 1.2 Hz, 1H); 13C NMR (75 MHz CDCl3): 139.15, 133.42, 133.08, 131.20, 
130.72, 129.20, 128.89, 128.65, 128.43, 128.17, 127.83, 127.04, 126.42, 126.40, 126.24, 126.04, 
125.78, 125.48, 43.33; IR (cm-1): 2254, 1265, 905, 726, 650; MS: HR-ESI calculated for 
[C19H14S+Na]
+: 297.0708, found: 297.0726; mp: 90-92 °C; HPLC: (0.25% isopropanol/hexanes): 
(R)-enantiomer: 30.0 min; (S)-enantiomer: 38.4 min; >99% ee; [α]
D
24=+93.3° (c=1.76, CH2Cl2). 
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(S)-2-(naphthalen-1-yl)-2H-thiochromene (1.45c). Prepared from 1.44c (14 mg, 0.044 mmol). 
Colorless oil (11.1 mg, 92% yield, 24 h, 0.5% EtOAc/hexanes).1H NMR 
(300 MHz, CDCl3): 8.20 (d, J = 8.5 Hz, 1H), 7.87 (dd, J1 = 7.9 Hz, J2 = 
1.5 Hz, 1H), 7.76 (d, J =8.3, 1H), 7.59-7.47 (m, 3H), 7.37 (dd, J1 = 8.1 Hz, J2 = 7.3 Hz, 1H), 7.18-
7.13 (m, 1H), 7.10-7.07 (m, 3H), 6.77 (dd, J1 = 10.2 Hz, J2 = 1.7 Hz, 1H), 6.10 (dd, J1 = 10.2 Hz, 
J2 = 5.1 Hz, 1H), 5.72 (dd, J1 = 5.1 Hz, J2 = 1.7 Hz, 1H); 13C NMR (75 MHz, CDCl3): 136.43, 
134.42, 131.36, 131.24, 130.62, 129.78, 129.29, 128.62, 128.58, 128.53, 127.24, 126.69, 126.59, 
125.99, 125.85, 125.69, 123.52, 39.05; IR (cm-1): 3057, 2920, 2851, 1686, 1623, 1509, 1469, 1439, 
1324, 1264, 1233, 1072, 777, 757, 736; MS: HR-ESI calculated for [C19H14S+Na]
+: 297.0708, 
found: 297.0720; HPLC: (0.25% isopropanol/hexanes): (S)-enantiomer: 56.1 min; (R)-
enantiomer: 62.5 min; 99% ee; [α]
D
24=+24° (c=7.7, CH2Cl2). 
(S)-2-(3,5-bis(trifluoromethyl)phenyl)-2H-thiochromene (1.45d). Prepared from 1.44d (24.5 
mg, 0.0606 mmol). Colorless oil (21.5 mg, 99% yield, 2 h, 0.5% 
EtOAc/hexanes). 1H NMR (300 MHz, CDCl3): 7.78 (s, 2H), 7.74 (s, 
1H), 7.18-7.10 (m, 4H), 6.77 (dd, J1 = 10.2 Hz, J2 = 1.3 Hz, 1H), 6.02 
(dd, J1 = 10.2 Hz, J2 = 5.7 Hz, 1H), 4.90 (dd, J1 = 5.7 Hz, J2 = 1.3 Hz, 1H); 13C NMR (75 MHz, 
CDCl3): 144.57, 132.12 (q, J = 33.3 Hz), 130.85, 130.50, 129.26, 129.17, 128.67, 127.99 (m), 
127.28, 126.42, 125.18, 123.45, 121.86 (sep, J = 3.8 Hz), 121.56, 41.88; IR (cm-1): 3063, 1623, 
1469, 1439, 1370, 1274, 1165, 1124, 1072, 897, 841, 783, 703, 681; MS: HR-ESI calculated for 
[C17H10F6S+H]
+: 361.0480, found: 361.0481; HPLC: (0.25% isopropanol/hexanes): (R)-
enantiomer: 16.5 min; (S)-enantiomer: 18.9 min; 97% ee; [α]
D
23=+150° (c=3.12, CH2Cl2). 
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(S)-2-(2,5-difluorophenyl)-2H-thiochromene (1.45e). Prepared from 1.44e (38 mg, 0.125 
mmol). Colorless oil (28.6 mg, 88% yield, 15 h, 2% EtOAc/hexanes). 1H 
NMR (300 MHz, CDCl3): 7.15-7.08 (m, 4H), 7.02-6.95 (m, 2H)6.90-6.82 
(m, 1H), 6.74 (dd, J1 = 10.2 Hz, J2 = 1.2 Hz, 1H), 5.95 (dd, J1 = 10.2 Hz, J2 
= 6.2 Hz, 1H), 5.06 (d, J = 6.2 Hz, 1H); 13C NMR (125 MHz, CDCl3): 158.89 (dd, J1 = 242.6, 
Hz, J2 = 2.4 Hz), 155.14 (dd, J1 = 243.2 Hz, J2 = 2.5 Hz), 138.80, 130.69 (dd, J1 = 16.2 Hz, J2 = 
7.3 Hz), 130.14, 129.72, 128.96, 128.64, 127.41, 126.11, 123.08, 116.68 (dd, J1 = 24.9 Hz, J2 = 
8.6 Hz), 116.13 (dd, J1 = 25.3 Hz, J2 = 3.6 Hz), 115.72 (dd, J1 = 24.3 Hz, J2 = 8.6 Hz), 34.61; IR 
(cm-1): 3064, 2921, 2850, 1623, 1589, 1488, 1438, 1423, 1272, 1241, 1176, 872, 816, 765, 752, 
734; MS: HR-ESI calculated for [C15H10F2S+Na]
+: 283.0363, found: 283.0370; HPLC: (0.25% 
isopropanol/hexanes): (R)-enantiomer: 12.4 min; (S)-enantiomer: 13.8 min; >99% ee; 
[α]
D
23=+222° (c=0.89, CH2Cl2). 
(S)-4-(2H-thiochromen-2-yl)benzaldehyde (1.45f). Prepared from 1.44f (41 mg, 0.138 mmol). 
Colorless oil (26.3 mg, 99% yield, 5 h, 6% EtOAc/hexanes). 1H NMR 
(300 MHz, CDCl3): 9.94 (s, 1H), 7.78 (d, J = 2.2 Hz, 2H), 7.48 (d, J 
= 2.2 Hz, 2H), 7.15-7.08 (m, 4H), 6.71 (dd, J1 = 10.2 Hz, J2 = 1.2 Hz, 1H), 6.01 (dd, J1 = 10.2 Hz, 
J2 = 5.6 Hz, 1H), 4.86 (dd, J1 = 5.6 Hz, J2 = 1.2 Hz, 1H); 13C NMR (75 MHz, CDCl3): 191.84, 
148.69, 135.92, 131.01, 130.38, 129.90, 129.65, 128.88, 128.53, 128.31, 127.15, 126.07, 124.34, 
42.62; IR (cm-1): 3057, 3031, 2920, 2827, 2734, 1698, 1604, 1576, 1469, 1305, 1209, 1167, 1072, 
809; MS: HR-ESI calculated for [C16H12OS+Na]
+: 275.0501, found: 275.0519; HPLC: (1% 
isopropanol/hexanes): (R)-enantiomer: 35.0 min; (S)-enantiomer: 42.4 min; 99% ee; 
[α]
D
22=+270° (c=2.63, CH2Cl2). 
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(S)-2-(4-methoxyphenyl)-2H-thiochromene (1.45g). Prepared from 1.44g (23 mg, 0.077 mmol). 
Colorless oil (19.3 mg, 99% yield, 48 h, 0.5% EtOAc/hexanes). 1H 
NMR (300 MHz, CDCl3): 7.24-7.21 (m, 2H), 7.10-7.04 (m, 4H), 
6.79 (d, J = 8.4 Hz, 2H), 6.61 (d, J = 10.2 Hz, 1H), 5.96 (dd, J1 = 10.2 Hz, J2 = 5.2 Hz, 1H), 4.82 
(d, J = 5.2 Hz, 1H), 3.74 (s, 3H); 13C NMR (75 MHz, CDCl3): 159.39, 134.18, 131.27, 130.91, 
128.93, 128.79, 128.54, 128.32, 127.05, 126.12, 125.68, 114.31, 55.49, 42.62; IR (cm-1): 3057, 
3029, 3004, 2954, 2928, 2834, 1606, 1581, 1507, 1466, 1438, 1302, 1245, 1173, 1109, 1071, 1031, 
880, 832, 787, 763, 737; MS: HR-ESI calculated for [C16H14OS+H]
+: 255.0838, found: 255.0840; 
HPLC: (0.5% isopropanol/hexanes): (R)-enantiomer: 16.9 min; (S)-enantiomer: 19.6 min; >99% 
ee; [α]
D
24=+171° (c=1.48, CH2Cl2). 
(S)-2-(3,4,5-trimethoxyphenyl)-2H-thiochromene (1.45h). Prepared from 1.44h (61 mg, 0.17 
mmol). Colorless oil (50.6 mg, 95% yield, 48 h, 0.5% EtOAc/hexanes).  
1H NMR (300 MHz, CDCl3): 7.15-7.06(m, 4H), 6.64(dd, J1 = 10.2 
Hz, J2 = 1.4 Hz, 1H), 6.56(s, 2H), 5.99(dd, J1 = 10.2 Hz, J2 = 5.1 Hz, 
1H), 4.97(dd, J1 = 5.1 Hz, J2 = 1.4 Hz, 1H), 3.80(s, 3H), 3.77(s,6H); 13C NMR (75 MHz, CDCl3): 
153.46, 137.74, 137.46, 131.23, 130.85, 129.01, 128.65, 128.26, 127.07, 125.98, 125.86, 104.81, 
61.01, 56.23, 43.64; IR (cm-1): 1265, 904, 726, 650; MS: HR-ESI calculated for [C18H18O3S+Na]
+: 
337.0869, found: 337.0897; HPLC: (5% isopropanol/hexanes): (R)-enantiomer: 14.9 min; (S)-
enantiomer: 18.5 min; >99% ee; [α]
D
24=+45.4° (c=2.60, CH2Cl2). 
(S)-3-(2H-thiochromen-2-yl)pyridine (1.45i). Prepared from 1.44i (21 mg, 0.0932 mmol). 
Colorless oil (16.9 mg, 80% yield, 24 h, 0.5% EtOAc/hexanes). 1H NMR 
(300 MHz, CDCl3): 8.55 (d, J = 2.3 Hz, 1H), 8.47 (dd, J1 = 4.8 Hz, J2 = 1.6 
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Hz, 1H), 7.63 (ddd, J1 = 7.9 Hz, J2 = 2.3, J3 = 1.6 Hz, 1H), 7.20-7.07 (m, 5H), 6.71 (dd, J1 = 10.2 
Hz, J2 = 1.3 Hz, 1H), 6.00 (dd, J1 = 10.2 Hz, J2 = 5.7 Hz, 1H), 4.80 (dd, J1 = 5.7 Hz, J2 = 1.3 Hz, 
1H); 13C NMR (75 MHz, CDCl3): 149.09, 148.87, 137.76, 135.34, 131.10, 129.76, 128.91, 
128.54, 127.27, 126.13, 124.24, 123.83, 40.24; IR ( cm-1): 3051, 3030, 1574, 1469, 1422, 1071, 
1025, 777, 710; MS: HR-ESI calculated for [C14H11NS+H]
+: 226.0685, found: 226.0689; HPLC: 
(20% isopropanol/hexanes): (S)-enantiomer: 12.1 min; (R)-enantiomer: 15.4 min; 99% ee; 
[α]
D
22=+195° (c=1.39, CH2Cl2).  
(S)-3-(2H-thiochromen-2-yl)furan (1.45j). Prepared from 1.44j (23.9 mg, 0.0925 mmol). 
Colorless oil (15.2 mg, 77% yield, 24 h, 0.5% EtOAc/hexanes). 1H NMR 
(300 MHz, CDCl3): 7.30 (dd, J1 = 1.7 Hz, J2 = 1.7 Hz, 1H)7.25 (dd, J1 = 
1.7 Hz, J2 = 0.8 Hz, 1H), 7.18-7.05 (m, 4H), 6.60 (d, J = 10.1 Hz, 1H), 6.33 (dd, J1 = 1.7 Hz, J2 = 
0.8 Hz, 1H), 6.03 (dd, J1 = 10.1 Hz, J2 = 5.7 Hz, 1H), 4.68 (d, J = 5.7 Hz, 1H); 13C NMR (75 
MHz, CDCl3): 143.69, 140.21, 131.53, 130.54, 128.82, 128.48, 128.32, 127.53, 125.99, 125.87, 
125.08, 109.89, 34.01; IR (cm-1): 3058, 2919, 2850, 1585, 1501, 1469, 1438, 1371, 1278, 1156, 
1135, 1071, 1021, 872, 800, 784, 735; MS: HR-ESI calculated for [C13H10OS+H]
+: 215.0525, 
found: 215.0526; HPLC: (0.25% isopropanol/hexanes): (R)-enantiomer: 19.3 min; (S)-
enantiomer: 23.7 min; >99% ee; [α]
D
23=+23.8° (c=1.60, CH2Cl2). 
(R)-2-cyclohexyl-2H-thiochromene (1.45k). Prepared from 1.44k (10 mg, 0.0365 mmol). 
Colorless oil (8.3 mg, 99% yield, 24 h, 0.5% EtOAc/hexanes). 1H NMR (500 
MHz, CDCl3): 7.17 sJ = 7.7 Hz7.08-6.99 (m, 3H), 6.48 (d, J = 10.3 
Hz, 1H), 5.88 (dd, J1 = 10.3 Hz, J2 = 6.0 Hz, 1H), 3.41 (ddd, J1 = 7.1 Hz, J2 = 6.0 Hz, J3 = 1.1 Hz, 
1H), 1.88-1.85 (m, 1H), 1.74-1.49 (m, 5H), 1.19-1.00 (m, 5H); 13C NMR (125 MHz, CDCl3): 
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131.94, 131.93, 128.32, 128.10, 128.01, 127.03, 125.54, 125.23, 45.18, 44.21, 29.70, 29.39, 
26.59, 26.39, 26.34; IR (cm-1): 3054, 3026, 3011, 2923, 2851, 1470, 1440, 1073, 778; MS: HR-
ESI calculated for [C15H18S+H]
+: 231.1202, found: 231.1201; HPLC: (0.05% 
isopropanol/hexanes): (R)-enantiomer: 18.2 min; (S)-enantiomer: 20.8 min; 95% ee; 
[α]
D
23=-67° (c=0.97, CH2Cl2). 
(S)-5-chloro-2-phenyl-2H-thiochromene (1.45l). Prepared from 1.44l (26 mg, 0.086 mmol). 
Colorless oil (12 mg, 54% yield, 24 h, 0.5% EtOAc/hexanes). 1H NMR (300 
MHz, CDCl3): 7.34-7.25 (m, 5H), 7.15-6.98 (m, 4H), 6.14 (dd, J1 = 10.4 
Hz, J2 = 5.3 Hz, 1H), 4.86 (dd, J1 = 5.3 Hz, J2 = 1.6 Hz, 1H); 13C NMR (75 
MHz, CDCl3): 141.09, 133.55, 133.45, 129.01, 128.93, 128.69, 128.16, 127.90, 127.41, 126.88, 
125.65, 125.37, 42.81; IR (cm-1): 3082, 3059, 3029, 2955, 2922, 2851, 1599, 1574, 1547, 1491, 
1431, 1380, 1262, 1190, 1098, 1076, 1030, 881, 844, 773, 759, 699; MS: HR-ESI calculated for 
[C15H11ClS+Na]
+: 281.0162, found: 281.0171; HPLC: (hexanes): (R)-enantiomer: 34.5 min; (S)-
enantiomer: 37.3 min; 98% ee; [α]
D
23=+230° (c=0.68, CH2Cl2). 
(S)-6-nitro-2-phenyl-2H-thiochromene (1.45m). Prepared from 1.44m (27 mg, 0.0862 mmol). 
Colorless oil (12.3 mg, 53% yield, 24 h, 0.5% EtOAc/hexanes). 1H 
NMR (300 MHz, CDCl3): 7.98 (d, J = 2.4 Hz, 1H), 7.94 (dd, J1 = 8.5 
Hz, J2 = 2.4 Hz, 1H), 7.30-7.21 (m, 6H), 6.72 (dd, J1 = 10.3 Hz, J2 = 1.6 Hz, 1H), 6.11 (dd, J1 = 
10.3 Hz, J2 = 5.3 Hz, 1H), 4.97 (dd, J1 = 5.3 Hz, J2 = 1.6 Hz, 1H), 3.89 (s, 3H); 13C NMR (125 
MHz, CDCl3): 141.13, 140.57, 131.27, 129.22, 128.52, 127.77, 127.70, 127.28, 127.15, 123.20, 




+: 270.0583, found: 270.0584; HPLC: (0.5% isopropanol/hexanes): (R)-
enantiomer: 40.4 min; (S)-enantiomer: 49.0 min; 97% ee; [α]
D
23=+217° (c=0.45, CH2Cl2). 
(S)-5,8-dibromo-2-phenyl-2H-thiochromene (1.45n). Prepared from 1.44n (60.1 mg, 0.141 
mmol). Colorless oil (43.6 mg, 81% yield, 24 h, 2% EtOAc/hexanes). 1H 
NMR (300 MHz, CDCl3): 7.38-7.18 (m, 7H), 7.03 (dd, J1 = 10.3 Hz, J2 = 
1.9 Hz, 1H), 6.07 (dd, J1 = 10.3 Hz, J2 = 4.9 Hz, 1H), 4.97 (dd, J1 = 4.9 Hz, 
J2 = 1.9 Hz, 1H); 13C NMR (75 MHz, CDCl3): 140.41, 136.18, 132.87, 132.07, 130.26, 129.08, 
128.60, 128.39, 128.24, 128.00, 122.90, 120.17, 44.24; IR (cm-1): 3082, 3058, 3028, 2919, 2868, 
2850, 1598, 1490, 1452, 1425, 1382, 1361, 1082, 897, 798, 759, 695; MS: HR-EI calculated for 
[C15H10Br2S•]+: 381.8844, found: 381.8904; HPLC: (hexanes): (R)-enantiomer: 41.3 min; (S)-
enantiomer: 45.3 min; 96% ee; [α]
D
22=+62.0° (c=3.35, CH2Cl2). 
(S)-7,8-dimethoxy-2-phenyl-2H-thiochromene (1.45o). Prepared from 1.44o (27 mg, 0.0822 
mmol). Colorless oil (21 mg, 90% yield, 24 h, 5% EtOAc/hexanes). 1H 
NMR (300 MHz, CDCl3): 7.37-7.23 (m, 5H), 6.86 (d, J = 8.4 Hz, 
1H), 6.63 (d, J = 8.4 Hz, 1H), 6.57 (dd, J1 = 10.2 Hz, J2 = 1.6 Hz, 1H), 5.84 (dd, J1 = 10.2 Hz, J2 
= 4.9 Hz, 1H), 4.89 (dd, J1 = 4.9 Hz, J2 = 1.6 Hz, 1H), 3.83 (s, 3H), 3.76 (s, 3H); 13C NMR (75 
MHz, CDCl3): 153.01, 144.51, 142.47, 128.84, 128.45, 128.00, 127.83, 126.54, 125.03, 
124.36, 123.30, 108.76, 60.24, 56.02, 42.76; IR (cm-1): 2997, 2934, 2835, 1592, 1483, 1444, 1406, 
1274, 1046, 1015, 754; MS: HR-ESI calculated for [C17H16O2S+Na]: 307.0763, found: 307.0767; 
HPLC: (5% isopropanol/hexanes): (R)-enantiomer: 12.0 min; (S)-enantiomer: 13.1 min; 99% ee; 
[α]
D
22=-6.8° (c=0.76, CH2Cl2). 
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(S)-2-phenyl-2H-thiopyrano[2,3-b]quinoline (1.45p). Prepared from 1.44p (46 mg, 0.144 
mmol). White solid (26 mg, 66% yield, 24 h, 5:5:90 
EtOAc/CH2Cl2/hexanes). 1H NMR (300 MHz, CDCl3): 7.89 (d, J = 
8.4 Hz, 1H), 7.72 (s, 1H), 7.70 (d, J = 9.4 Hz, 1H), 7.60 (ddd, J1 = 8.4 Hz, J2 = 6.9 Hz, J3 = 1.4 
Hz, 1H), 7.44-7.24 (m, 6H), 6.73 (dd, J1 = 10.3 Hz, J2 = 1.6 Hz, 1H), 6.14 (dd, J1 = 10.3 Hz, J2 = 
4.9 Hz, 1H), 5.26 (dd, J1 = 4.9 Hz, J2 = 1.6 Hz, 1H); 13C NMR (75 MHz, CDCl3): 156.86, 148.05, 
141.83, 133.37, 130.10, 129.12, 128.22, 128.20, 128.16, 127.92, 127.90, 127.27, 126.99, 126.12, 
125.11, 46.08; IR (cm-1): 3058, 3027, 2923, 2858, 1614, 1584, 1556, 1487, 1394, 1137, 1063, 750, 
698; MS: HR-ESI calculated for [C18H13NS+Na]
+: 298.0661, found: 298.0668; HPLC: (20% 
isopropanol/hexanes): (R)-enantiomer: 14.1 min; (S)-enantiomer: 25.9 min; >99% ee; 
[α]
D
22=-47° (c=0.81, CH2Cl2). 
(S)-7-methoxy-2-phenyl-2H-thiopyrano[2,3-b]quinoline (1.45q). Prepared from 1.44q (89.1 
mg, 0.255 mmol). Yellow crystalline solid (59.6 mg, 77% yield, 
24 h, 5:5:90 EtOAc/CH2Cl2/hexanes). 1H NMR (300 MHz, 
CDCl3): 7.79(d, J = 9.2 Hz, 1H), 7.61(s, 1H), 7.38-7.23(m, 6H), 
6.98(d, J = 2.8 Hz, 1H) 6.70(dd, J1 = 10.3 Hz, J2 = 1.7 Hz, 1H), 6.13(dd, J1 = 10.3 Hz, J2 = 5.0 Hz, 
1H), 5.22(dd, J1 = 5.0 Hz, J2 = 1.7 Hz, 1H), 3.89(s, 3H); 13C NMR (125 MHz, CDCl3): 
157.57153.62, 144.12, 141.83, 132.43, 129.63, 129.06, 128.41, 128.09, 127.89, 127.87, 127.40, 
125.43, 122.23, 105.87, 55.73, 45.92; IR (cm-1): 3059, 3027, 3003, 2959, 2931, 1619, 1584, 1492, 
1452, 1370, 1346, 1288, 1252, 1229, 1167, 1070, 1028, 956, 912, 830, 755, 698; MS: HR-ESI 
calculated for [C19H15NOS+H]
+: 306.0947, found: 306.0953; mp: 152-154 °C; HPLC: (20% 
isopropanol/hexanes): (R)-enantiomer: 10.2 min; (S)-enantiomer: 31.9 min; 99% ee; 
[α]
D
22=+6.57° (c=2.04, CH2Cl2). 
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4-methyl-2-phenyl-2H-thiochromene (1.74). Prepared from 1.73 (32 mg, 0.11 mmol) with 
DHPB 1.63a. Colorless oil (trace yield, 72 h, 2% EtOAc/hexanes). 1H NMR 
(300 MHz, CDCl3): 7.44-7.14 (m, 9H),  6.00 (dd, J1 = 5.3 Hz, J2 = 1.4 Hz, 
1H), 4.85 (dd, J1 = 5.3 Hz, J2 = 1.4 Hz, 1H), 2.25 (s, 3H). 
3-fluoro-2-phenyl-2H-thiochromene (1.76). Prepared from 1.75 using catalyst 1.63a (40 mg, 
0.14 mmol). Colorless oil (9 mg, 28% yield, 72 h, 0.5% EtOAc/hexanes). 1H 
NMR (500 MHz, CDCl3): 7.31-7.25 (m, 5H), 7.19-7.17 (m, 1H), 7.15-7.09 
(m, 3H), 6..42 (d, J = 14.6 Hz, 1H), 4.77 (d, J = 12.6 Hz, 1H); 13C NMR (125 
MHz, CDCl3):  (d, J = 272.8 Hz), 139.77, 130.62 (d, J = 8.1 Hz), 129.03, 128.38, 127.89, 
127.88 (d, J = 8.7 Hz), 126.95, 126.46, 126.12, 107.55 (d, J = 22.8 Hz), 43.11 (d, J = 28.7 Hz); IR 
(cm-1): 2997, 2934, 2835, 1592, 1483, 1444, 1406, 1274, 1046, 1015, 754; MS: HR-ESI calculated 
for [C15H11FS+H]












1.5.7 X-Ray structure of 1.45q. 
 
Table 1.5: Crystal data and structure refinement for 1.45q. 
Identification code  v23315/lt/x8/Birman-NAA-III-23 
Empirical formula  C19 H15 N O S 
Formula weight  305.38 
Temperature  100(2) K 
Wavelength  0.71073 Å 
Crystal system  Orthorhombic 
Space group  P212121 
Unit cell dimensions a = 5.5711(2) Å = 90°. 
 b = 6.5999(2) Å = 90°. 
 c = 40.0657(12) Å  = 90°. 
Volume 1473.16(8) Å3 
Z 4 
Density (calculated) 1.377 Mg/m3 
Absorption coefficient 0.220 mm-1 
F(000) 640 
Crystal size 0.459 x 0.372 x 0.283 mm3 
Theta range for data collection 2.033 to 40.295°. 
Index ranges -10≤h≤10, -11≤k≤12, -72≤l≤72 
Reflections collected 74764 
Independent reflections 9271 [R(int) = 0.033] 
Completeness to theta = 25.242° 99.9 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.8628 and 0.8254 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 9271 / 0 / 259 
Goodness-of-fit on F2 1.085 
Final R indices [I>2sigma(I)] R1 = 0.0317, wR2 = 0.0832 
R indices (all data) R1 = 0.0335, wR2 = 0.0841 
Absolute structure parameter -0.020(9) 
Largest diff. peak and hole 0.525 and -0.193 e.Å-3 
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Table 1.6: Atomic coordinates ( x 104) and equivalent  isotropic displacement parameters (Å2 x 
103) for 1.45q.  U(eq) is defined as one third of  the trace of the orthogonalized Uij tensor. 
_____________________________________________________________________________________ 
 x y z U(eq) 
______________________________________________________________________________ 
S(15) -583(1) 9299(1) 6255(1) 15(1) 
O(22) 10260(1) 4125(1) 5273(1) 17(1) 
N(1) 2817(1) 8362(1) 5854(1) 14(1) 
C(2) 1477(2) 7558(1) 6088(1) 13(1) 
C(3) 1760(2) 5551(1) 6214(1) 14(1) 
C(4) 3554(2) 4388(1) 6073(1) 14(1) 
C(5) 5045(2) 5182(1) 5819(1) 13(1) 
C(6) 6952(2) 4069(1) 5671(1) 15(1) 
C(7) 8357(2) 4986(1) 5431(1) 14(1) 
C(8) 7884(2) 6999(1) 5327(1) 15(1) 
C(9) 6047(2) 8082(1) 5466(1) 15(1) 
C(10) 4590(2) 7206(1) 5717(1) 13(1) 
C(11) 10808(2) 2073(2) 5354(1) 22(1) 
C(12) 267(2) 4790(1) 6485(1) 16(1) 
C(13) -1558(2) 5786(2) 6628(1) 17(1) 
C(14) -2524(2) 7828(1) 6534(1) 15(1) 
C(16) -2984(2) 9190(1) 6832(1) 14(1) 
C(17) -1295(2) 9322(2) 7088(1) 16(1) 
C(18) -1666(2) 10610(2) 7357(1) 19(1) 
C(19) -3726(2) 11811(2) 7371(1) 21(1) 
C(20) -5405(2) 11695(2) 7116(1) 20(1) 




 Table 1.7: Bond lengths (Å) and angles (°) for 1.45q. 
    
S(15)-C(2)  1.7561(9) C(4)-H(4)  0.98(2) C(11)-H(11A)  0.954(19) C(16)-C(17)  1.3945(12) 
S(15)-C(14)  1.8325(10) C(5)-C(10)  1.4199(12) C(11)-H(11B)  0.89(2) C(17)-C(18)  1.3876(14) 
O(22)-C(7)  1.3603(11) C(5)-C(6)  1.4201(12) C(11)-H(11C)  0.966(17) C(17)-H(17)  0.88(2) 
O(22)-C(11)  1.4256(13) C(6)-C(7)  1.3802(13) C(12)-C(13)  1.3390(14) C(18)-C(19)  1.3960(16) 
N(1)-C(2)  1.3126(12) C(6)-H(6)  0.961(19) C(12)-H(12)  0.96(2) C(18)-H(18)  0.95(2) 
N(1)-C(10)  1.3633(12) C(7)-C(8)  1.4168(13) C(13)-C(14)  1.4994(14) C(19)-C(20)  1.3897(16) 
C(2)-C(3)  1.4258(12) C(8)-C(9)  1.3665(13) C(13)-H(13)  0.974(18) C(19)-H(19)  0.94(2) 
C(3)-C(4)  1.3806(12) C(8)-H(8)  1.006(18) C(14)-C(16)  1.5176(13) C(20)-C(21)  1.3943(14) 
C(3)-C(12)  1.4576(12) C(9)-C(10)  1.4141(12) C(14)-H(14)  0.955(19) C(20)-H(20)  0.92(2) 
C(4)-C(5)  1.4155(12) C(9)-H(9)  0.968(17) C(16)-C(21)  1.3926(13) C(21)-H(21)  0.95(2) 
 
C(2)-S(15)-C(14) 105.73(4) O(22)-C(11)-H(11C) 110.3(12) 
C(7)-O(22)-C(11) 117.23(8) H(11A)-C(11)-H(11C) 109.8(15) 
C(2)-N(1)-C(10) 118.30(8) H(11B)-C(11)-H(11C) 111.1(16) 
N(1)-C(2)-C(3) 124.43(8) C(13)-C(12)-C(3) 125.64(9) 
N(1)-C(2)-S(15) 112.32(6) C(13)-C(12)-H(12) 115.8(12) 
C(3)-C(2)-S(15) 123.09(7) C(3)-C(12)-H(12) 118.5(12) 
C(4)-C(3)-C(2) 116.91(8) C(12)-C(13)-C(14) 127.34(9) 
C(4)-C(3)-C(12) 121.75(8) C(12)-C(13)-H(13) 116.8(11) 
C(2)-C(3)-C(12) 121.32(8) C(14)-C(13)-H(13) 115.9(11) 
C(3)-C(4)-C(5) 120.87(8) C(13)-C(14)-C(16) 113.25(8) 
C(3)-C(4)-H(4) 120.9(11) C(13)-C(14)-S(15) 114.66(7) 
C(5)-C(4)-H(4) 118.0(11) C(16)-C(14)-S(15) 105.43(6) 
C(4)-C(5)-C(10) 116.79(8) C(13)-C(14)-H(14) 109.6(11) 
C(4)-C(5)-C(6) 123.16(8) C(16)-C(14)-H(14) 108.4(11) 
C(10)-C(5)-C(6) 120.03(8) S(15)-C(14)-H(14) 105.0(11) 
C(7)-C(6)-C(5) 119.16(8) C(21)-C(16)-C(17) 119.20(8) 
C(7)-C(6)-H(6) 122.5(11) C(21)-C(16)-C(14) 120.56(8) 
C(5)-C(6)-H(6) 118.2(11) C(17)-C(16)-C(14) 120.19(8) 
O(22)-C(7)-C(6) 125.72(8) C(18)-C(17)-C(16) 120.58(9) 
O(22)-C(7)-C(8) 113.59(8) C(18)-C(17)-H(17) 119.8(12) 
C(6)-C(7)-C(8) 120.70(8) C(16)-C(17)-H(17) 119.6(12) 
C(9)-C(8)-C(7) 120.66(8) C(17)-C(18)-C(19) 120.16(9) 
C(9)-C(8)-H(8) 120.5(10) C(17)-C(18)-H(18) 118.2(12) 
C(7)-C(8)-H(8) 118.8(10) C(19)-C(18)-H(18) 121.6(12) 
C(8)-C(9)-C(10) 120.35(8) C(20)-C(19)-C(18) 119.45(9) 
C(8)-C(9)-H(9) 121.7(10) C(20)-C(19)-H(19) 120.9(13) 
C(10)-C(9)-H(9) 118.0(10) C(18)-C(19)-H(19) 119.6(13) 
N(1)-C(10)-C(9) 118.21(8) C(19)-C(20)-C(21) 120.31(9) 
N(1)-C(10)-C(5) 122.69(8) C(19)-C(20)-H(20) 118.7(13) 
C(9)-C(10)-C(5) 119.09(8) C(21)-C(20)-H(20) 121.0(13) 
O(22)-C(11)-H(11A) 106.4(12) C(16)-C(21)-C(20) 120.30(9) 
O(22)-C(11)-H(11B) 111.2(13) C(16)-C(21)-H(21) 118.2(13) 
H(11A)-C(11)-H(11B) 108.0(16) C(20)-C(21)-H(21) 121.4(13) 
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Table 1.8: Anisotropic displacement parameters (Å2 x 103) for 1.45q. The anisotropic 
displacement factor exponent takes the form:  -22[ h2 a*2U11 + ...  + 2 h k a* b* U12 ] 
_____________________________________________________________________________________________ 
 U11 U22  U33 U23 U13 U12 
______________________________________________________________________________  
S(15) 17(1)  13(1) 16(1)  1(1) 3(1)  2(1) 
O(22) 18(1)  14(1) 19(1)  2(1) 4(1)  3(1) 
N(1) 15(1)  13(1) 14(1)  1(1) 1(1)  1(1) 
C(2) 14(1)  12(1) 13(1)  0(1) -1(1)  0(1) 
C(3) 15(1)  11(1) 14(1)  1(1) 0(1)  -1(1) 
C(4) 16(1)  11(1) 15(1)  1(1) 2(1)  0(1) 
C(5) 15(1)  11(1) 14(1)  1(1) 0(1)  0(1) 
C(6) 16(1)  12(1) 15(1)  1(1) 1(1)  1(1) 
C(7) 14(1)  13(1) 14(1)  0(1) 0(1)  1(1) 
C(8) 17(1)  14(1) 15(1)  2(1) 2(1)  1(1) 
C(9) 17(1)  13(1) 15(1)  3(1) 1(1)  1(1) 
C(10) 14(1)  11(1) 13(1)  1(1) -1(1)  1(1) 
C(11) 22(1)  15(1) 27(1)  1(1) 6(1)  4(1) 
C(12) 20(1)  12(1) 16(1)  1(1) 3(1)  -1(1) 
C(13) 20(1)  14(1) 18(1)  0(1) 4(1)  -3(1) 
C(14) 14(1)  15(1) 15(1)  -2(1) 1(1)  -2(1) 
C(16) 13(1)  14(1) 13(1)  0(1) 1(1)  -1(1) 
C(17) 15(1)  18(1) 15(1)  -2(1) -2(1)  0(1) 
C(18) 21(1)  21(1) 16(1)  -3(1) -2(1)  -1(1) 
C(19) 24(1)  20(1) 18(1)  -4(1) 3(1)  0(1) 
C(20) 19(1)  19(1) 21(1)  -2(1) 2(1)  2(1) 




Table 1.9: Hydrogen coordinates ( x 104) and isotropic displacement parameters (Å2 x 103) for 
1.45q. 
_____________________________________________________________________________________ 
 x  y  z  U(eq) 
______________________________________________________________________________ 
  
H(4) 3920(30) 3030(30) 6159(5) 25(4) 
H(6) 7260(30) 2720(30) 5752(5) 23(4) 
H(8) 8930(30) 7620(30) 5150(4) 21(4) 
H(9) 5710(30) 9460(30) 5400(4) 16(4) 
H(11A) 12220(30) 1740(30) 5232(5) 22(4) 
H(11B) 9640(40) 1240(30) 5288(5) 26(4) 
H(11C) 11100(30) 1940(30) 5591(4) 20(4) 
H(12) 540(40) 3440(30) 6564(5) 28(5) 
H(13) -2380(30) 5100(30) 6810(4) 21(4) 
H(14) -3990(30) 7670(30) 6414(4) 20(4) 
H(17) 30(40) 8600(30) 7077(4) 27(5) 
H(18) -450(30) 10680(30) 7525(5) 26(4) 
H(19) -3960(40) 12690(30) 7553(5) 31(5) 
H(20) -6750(40) 12510(30) 7126(5) 30(5) 




Table 1.10: Torsion angles (°) for 1.45q. 
______________________________________________________________________________ 
C(10)-N(1)-C(2)-C(3) 0.69(13) C(8)-C(9)-C(10)-C(5) -0.77(14) 
C(10)-N(1)-C(2)-S(15) 176.17(6) C(4)-C(5)-C(10)-N(1) 0.07(13) 
C(14)-S(15)-C(2)-N(1) 172.73(7) C(6)-C(5)-C(10)-N(1) -178.67(8) 
C(14)-S(15)-C(2)-C(3) -11.73(9) C(4)-C(5)-C(10)-C(9) 179.21(8) 
N(1)-C(2)-C(3)-C(4) -0.92(13) C(6)-C(5)-C(10)-C(9) 0.47(13) 
S(15)-C(2)-C(3)-C(4) -175.93(7) C(4)-C(3)-C(12)-C(13) -177.58(10) 
N(1)-C(2)-C(3)-C(12) 177.36(9) C(2)-C(3)-C(12)-C(13) 4.22(15) 
S(15)-C(2)-C(3)-C(12) 2.35(12) C(3)-C(12)-C(13)-C(14) 2.72(17) 
C(2)-C(3)-C(4)-C(5) 0.70(13) C(12)-C(13)-C(14)-C(16) -134.92(11) 
C(12)-C(3)-C(4)-C(5) -177.58(8) C(12)-C(13)-C(14)-S(15) -13.86(14) 
C(3)-C(4)-C(5)-C(10) -0.32(13) C(2)-S(15)-C(14)-C(13) 16.16(8) 
C(3)-C(4)-C(5)-C(6) 178.38(8) C(2)-S(15)-C(14)-C(16) 141.43(6) 
C(4)-C(5)-C(6)-C(7) -178.20(8) C(13)-C(14)-C(16)-C(21) -138.40(9) 
C(10)-C(5)-C(6)-C(7) 0.46(13) S(15)-C(14)-C(16)-C(21) 95.46(9) 
C(11)-O(22)-C(7)-C(6) 2.20(14) C(13)-C(14)-C(16)-C(17) 44.18(12) 
C(11)-O(22)-C(7)-C(8) -177.83(9) S(15)-C(14)-C(16)-C(17) -81.96(10) 
C(5)-C(6)-C(7)-O(22) 178.87(8) C(21)-C(16)-C(17)-C(18) 0.57(15) 
C(5)-C(6)-C(7)-C(8) -1.10(13) C(14)-C(16)-C(17)-C(18) 178.02(9) 
O(22)-C(7)-C(8)-C(9) -179.16(9) C(16)-C(17)-C(18)-C(19) -0.90(16) 
C(6)-C(7)-C(8)-C(9) 0.82(14) C(17)-C(18)-C(19)-C(20) 0.42(17) 
C(7)-C(8)-C(9)-C(10) 0.14(14) C(18)-C(19)-C(20)-C(21) 0.37(17) 
C(2)-N(1)-C(10)-C(9) -179.40(8) C(17)-C(16)-C(21)-C(20) 0.23(14) 
C(2)-N(1)-C(10)-C(5) -0.25(13) C(14)-C(16)-C(21)-C(20) -177.22(9) 





 Projection view of 1.45q with 50% probability ellipsoids: 
 
1.5.8 Thiolate promoted synthesis of 1.45a. 
 
A mixture of 1.44a (32 mg, 0.119 mmol), triethylamine (0.119 mmol), 2-mercaptobenzaldehyde 
(0.119 mmol), and THF (0.6 mL, 0.2 M) was stirred at room temperature for 20 h and concentrated 
under reduced pressure. The residue was purified by flash chromatography (0.5% EtOAc/hexanes) 






1.5.9 Preparation of isothiocyanates 1.104d and 1.104e.37 
 
The starting nitroarene 1.103d38 or e39 was hydrogenated in methanol over 5% Pd/C (ca. 50 mg 
per 1 mmol of substrate) at 20-40 psi in a Parr shaker apparatus. The resulting solution was filtered 
through Celite to remove the catalyst and rotary evaporated to give the crude aniline as thick brown 
oil, which was protected from air and dissolved in 95% ethanol (ca. 0.15 M).  The solution was 
treated with triethylamine (1 equiv) and carbon disulfide (10 equiv) at room temperature.  After 
1.5 h, the reaction mixture was cooled to 0 °C and treated with a solution of Boc2O (1 equiv) and 
DMAP (3 mol %) in ethanol (1 mL per 1 mmol) added dropwise.  The resulting mixture was stirred 
for a 0.5 h at 0 °C, then at room temperature for 3.5 h, and rotary evaporated.  The evaporation 
residue was loaded directly onto a silica gel column and eluted with ethyl acetate in hexanes.   
1.104d: Isolated as a pale-yellow powder (672 mg; 89% yield,) after 
chromatography (5% EtOAc/hexanes).  1H NMR (300 MHz, CDCl3): δδ 
7.08 (d, J = 9.0 Hz, 2H), 6.43 (d, J = 9.0 Hz, 2H), 3.34 – 3.22 (m, 4H), 2.06 
– 1.96 (m, 4H); 13C NMR (125 MHz, CDCl3): δ 146.87, 131.77, 126.84, 117.59, 111.80, 47.69, 
25.55; IR (cm-1): 2969, 2090, 1776, 1739, 1598, 1512, 1482, 1369, 1137, 1081, 916, 827, 804, 
676, 505, 458; MS: HR-ESI calculated for [C11H12N2S+H]
+: 205.0794, found: 205.0815; mp 76-
79 °C.  
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1.104e: Isolated as a pale yellow viscous liquid (1.85 g; 71% yield) after 
chromatography (515% EtOAc/hexanes). 1H NMR (500 MHz, CDCl3) δ 
6.52 (dd, J = 8.4, 2.3 Hz, 1H), 6.38 (d, J = 8.5 Hz, 1H), 6.35 (d, J = 2.3 Hz, 
1H), 3.35 – 3.26 (m, 8H), 1.18 – 1.13 (m, 6H); 13C NMR (125 MHz, CDCl3) δ 135.32, 134.70, 
130.81, 119.45, 115.19, 109.96, 107.50, 46.30, 46.06, 45.41, 45.32, 10.34, 10.22; IR (cm-1): 2968, 
2117, 1592, 1513, 1358, 1310, 1250, 1174, 1092, 993, 827, 770, 593; MS: HR-ESI calculated for 
[C13H17N3S]
+: 247.1138, found: 247.1162. 
1.5.10 Preparation of thioureas 1.105c-e. 
 
A solution of a 3-amino-1-propanol (1 equiv) was treated with the corresponding isothiocyanate 
1.104c-e(1 equiv) in refluxing THF (0.4 M) overnight and rotary evaporated. The residue was 
purified by column chromatography on silica gel under conditions outlined below.  
1.105c: Isolated as a light-brown solid (1.67 g; 99% yield) 
after chromatography (15% i-PrOH/Dichloromethane).  1H 
NMR (500 MHz, CDCl3): δ 7.82 (s, 1H), 7.00 (d, J = 8.7 Hz, 2H), 6.65 (d, J = 8.7 Hz, 2H), 6.25 
(s, 1H), 3.71 (q, J = 6.0 Hz, 2H), 3.57 (t, J = 5.5 Hz, 2H), 2.91 (s, 6H), 1.63 (t, J = 6.0 Hz, 2H); 13C 
NMR (125 MHz, CDCl3): δδ 181.31, 149.86, 127.51, 113.04, 59.08, 42.22, 40.46, 32.05, 25.27;  
IR (cm-1): 1519, 1165, 905, 725, 646; MS: HR-ESI calculated for [C12H19N3OS+H]
+: 254.1322, 
found: 254.1347; mp: 96-99 °C.  
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1.105d: Isolated as an orange solid (58 mg, 70% yield) after 
chromatography (525% EtOAc/hexanes). 1H NMR (300 
MHz, CDCl3): δ 7.45 (s, 1H), 7.03 (d, J = 8.8 Hz, 2H), 6.53 
(d, J = 8.8 Hz, 2H), 6.08 (s, 1H), 3.85-3.74 (m, 2H), 3.69-3.59 (m, 2H), 3.34 – 3.22 (m, 4H), 3.01-
2.92 (m, 1H), 2.09 – 1.94 (m, 4H), 1.72-1.61 (m, 3H); 13C NMR (125 MHz, CDCl3): δ182.06, 
147.72, 128.18, 122.68, 112.43, 59.07, 47.81, 42.19, 32.48, 25.65. IR (cm-1): 3375, 3294, 2812, 
1605, 1553, 1519, 1366, 1165, 1112, 1061, 994, 947, 853, 819, 739, 660, 607, 496; MS: HR-ESI 
calculated for [C14H21N3OS+H]
+: 280.1478, found: 280.1519. mp 124-125 °C. 
1.105e: Isolated as a light-brown semisolid (2.10 g; 88% yield) 
after chromatography (15% EtOAc in MeOH). 1H NMR (600 
MHz, CDCl3) δ 7.47 (s, 1H), 6.47 (d, J = 8.4 Hz, 1H), 6.41 (d, J 
= 8.5 Hz, 1H), 6.29 (s, 1H), 6.21 (d, J = 6.3 Hz, 1H), 3.80 (q, J = 6.2 Hz, 2H), 3.63 (q, J = 5.7 Hz, 
2H), 3.35 – 3.24 (m, 8H), 3.17 (t, J = 6.6 Hz, 1H), 1.67 (p, J = 5.7 Hz, 2H), 1.21 – 1.04 (m, 6H); 
13C NMR (150 MHz, CDCl3) δ 181.65, 136.09, 134.89, 124.90, 115.26, 110.59, 108.49, 58.63, 
46.28, 46.23, 45.44, 45.38, 41.79, 32.68, 10.37, 10.20; IR (cm-1): 3351, 2931, 1509, 1245, 1168, 
1076, 936, 790, 720, 612, 427; MS: HR-ESI calculated for [C16H26N4OS]








1.5.11 Preparation of aminobenzothiazoles 1.106c and 1.106e.40 
 
A solution of thiourea 1.105c or 1.105e (1 equiv) in CH2Cl2 (ca. 0.125 M) was cooled to –10 °C 
and treated with solid NBS (1 equiv) added in one portion.  The reaction mixture was stirred at for 
1 h and then treated with DBU (2 equiv) added dropwise.  After stirring at the same temperature 
for 1.5 h, the reaction was quenched with 5% aqueous Na2S2O3. The organic layer was separated, 
dried over Na2SO4, and rotary evaporated. The residue was loaded directly onto a silica gel column 
and eluted as outlined below.   
1.106c:  Isolated as a light-brown solid (573 mg; 71% yield) 
after chromatography (15% i-PrOH/Dichloromethane).  1H 
NMR (300 MHz, CDCl3): 7.40 (d, J = 8.8 Hz, 1H), 6.94 (d, J = 2.6 Hz, 1H), 6.79 (dd, J = 8.8, 2.6 
Hz, 1H), 5.11 (broad s, 1H), 4.18 (broad s, 1H), 3.81 – 3.57 (m, 4H), 2.93 (s, 6H), 1.81 (tt, J = 6.7, 
5.1 Hz, 2H); 13C NMR (125 MHz, CDCl3): δ 165.40, 147.19, 143.76, 131.74, 119.04, 113.15, 
105.08, 59.20, 41.88, 41.80, 33.06;  IR (cm-1): 3234, 3044, 2942, 2885, 2825, 2785, 1590, 1544, 
1470, 1329, 1225, 1073, 1049, 942, 835, 797, 587; MS: HR-ESI calculated for [C12H17N3OS+H]
+: 
252.1165, found: 252.1163; mp: 126-129 °C. 
 1.106e:  Isolated as a light-brown semisolid (1.55 g; 76% yield) 
after chromatography (20% i-PrOH+5% NEt3/CH2Cl2). 1H 
NMR (600 MHz, CDCl3) δ 6.77 (s, 1H), 6.68 (s, 1H), 5.63 (s, 
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1H), 4.80 (s, 1H), 3.68 (t, J = 5.5 Hz, 2H), 3.55 (t, J = 6.0 Hz, 2H), 3.47 – 3.08 (m, 8H), 1.75 (p, J 
= 5.3, 4.6 Hz, 2H), 1.38 – 0.94 (m, 6H), 6H); 13C NMR (151 MHz, CDCl3) δ 165.98, 144.38, 
135.23, 132.09, 118.01, 102.73, 101.60, 59.06, 46.64, 46.51, 45.90, 45.59, 41.77, 32.99, 10.34, 
10.16; IR (cm-1): 3244, 2816, 1581, 1538, 1477, 1338, 1211, 1173, 1111, 1052, 938, 910, 868, 
839, 792, 733, 702, 580. MS: HR-ESI calculated for [C16H24N4OS]
+: 320.1665, found: 320.1690. 
1.5.12 Preparation of aminobenzothiazole 1.106d.41 
 
To a solution of thiourea 1.105d (140 mg, 0.500 mmol) in 2.5 mL of DMSO stirring at rt was 
added a solution of DDQ (136 mg, 0.6 mmol) in 1.5 mL of DMSO. After stirring for 3d, the 
mixture was quenched with 5% aqueous Na2S2O3 and extracted with EtOAc (×3). The organic 
extract was washed with 5% aqueous Na2S2O3 (×3), NaCl, and 10% Na2CO3 and dried over 
MgSO4. Chromatography (25% i-PrOH/hexanes) afforded the product as an off-white solid (60 
mg, 43% yield). 1H NMR (300 MHz, CDCl3): δ 7.38 (d, J = 8.7 Hz, 1H), 6.74 (d, J = 2.4 Hz, 1H), 
6.58 (dd, J = 8.8, 2.4 Hz, 1H), 5.12 (s, 1H), 3.71 (t, J = 5.6 Hz, 2H), 3.65 (t, J = 5.9 Hz, 2H), 3.37 
– 3.10 (m, 4H), 2.06-1.95 (m, 4H), 1.87 – 1.76 (m, 2H); 13C NMR (125 MHz, CDCl3): δ 164.40, 
144.62, 142.52, 132.04, 119.40, 111.33, 102.98, 59.07, 48.34, 41.64, 33.40, 25.59; IR (cm-1): 
3202, 2834, 1607, 1570, 1540, 1477, 1367, 1246, 1217, 1094, 1064, 1041, 981, 934, 906, 888, 
813, 796, 730, 633, 585, 570, 510; MS: HR-ESI calculated for [C14H19N3OS+H]
+: 278.1322, 
found: 278.1354. mp 167-170°C dec. 
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1.5.13 Preparation of DHPB derivatives, general procedure.14d 
 
The starting material was partially dissolved in CH2Cl2 at 0 °C (10 mL per 1 mmol of the 
aminobenzothiazole) and treated with NEt3 (3 equiv) and then MsCl (1.5 equiv) added dropwise.  
After stirring for 45 minutes at 0 °C, the reaction mixture was brought to rt and treated with 
methanol (9 equiv) and additional NEt3 (3 equiv).  After refluxing overnight, the mixture was 
cooled to rt, rinsed with water, dried with Na2SO4, and rotary evaporated.  The crude product was 
purified by column chromatography using the eluent shown below.  
1.63b: Previously reported without characterization.28 Isolated as a pale-
yellow solid (124 mg; 62% yield) after chromatography (1:4:15 NEt3/i-
PrOH/ CH2Cl2). 1H NMR (500 MHz, CDCl3) δ 6.88 (d, J = 2.5 Hz, 1H), 
6.73 (dd, J = 8.7, 2.5 Hz, 1H), 6.63 (d, J = 8.7 Hz, 1H), 3.77 (s, 3H), 3.73 (t, J = 6.0 Hz, 2H), 3.54 
(t, J = 5.6 Hz, 2H), 2.00 (p, J = 5.9 Hz, 2H); 13C NMR (125 MHz, CDCl3) δ 158.25, 155.27, 
135.17, 123.63, 111.63, 108.20, 107.67, 56.06, 45.32, 42.13, 19.72. IR (cm-1): 2936, 2836, 1612, 
1579, 1487, 1438, 1328, 1265, 1225, 1185, 1104, 1071, 1030, 961, 826, 708, 657, 558; MS: HR-
ESI calculated for [C11H12N2OS+H]
+: 221.0743, found: 221.0775; mp 89-93°C. 
1.63c:  Isolated as a light-brown solid (218 mg; 41% yield) after 
chromatography (5% i-PrOH+1% NEt3/Hexanes).  1H NMR (300 MHz, 
CDCl3): δ 6.75 (dd, J = 1.9, 1.0 Hz, 1H), 6.64 – 6.51 (m, 2H), 3.70 (t, J = 
6.2 Hz, 2H), 3.53 (t, J = 6.6, Hz, 2H), 2.87 (s, 6H), 1.97 (dt, J = 11.9, 5.8 Hz, 2H); 13C NMR (75 
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MHz, CDCl3): δ 158.18, 146.96, 132.98, 123.65, 111.17, 107.64, 107.47, 45.57, 41.97, 41.71, 
19.83;  IR (cm-1): 2931, 2874, 2845, 2805, 1617, 1565, 1503, 1447, 1336, 1227, 1199, 1101, 1067, 
986, 955, 824, 788, 704, 640, 559, 474; MS: HR-ESI calculated for [C12H15N3S+H]
+: 234.1059, 
found: 234.1093; mp: 142-145 °C dec. 
1.63d:  Isolated as a white powder (43 mg, 83% yield) after 
chromatography (25% i-PrOH+2% NEt3/hexane).  1H NMR (300 MHz, 
CDCl3): δ 6.63 (d, J = 8.6 Hz, 1H), 6.56 (d, J = 2.3 Hz, 1H), 6.40 (dd, J = 
8.6, 2.4 Hz, 1H), 3.72 (t, J = 6.1 Hz, 2H), 3.54 (t, J = 5.6 Hz, 2H), 3.30 – 3.14 (m, 4H), 2.06-1.95 
(m, J = 6.8, 3.8 Hz, 6H); 13C NMR (500 MHz, CDCl3): δ 158.52, 144.43, 131.63, 123.89, 109.30, 
108.06, 105.49, 48.31, 45.34, 42.02, 25.52, 19.86; IR (cm-1): 3445, 2844, 1604, 1565, 1497, 1369, 
1340, 1238, 1184, 1103, 1068, 992, 958, 871, 824, 792, 701, 628, 589, 556, 480, 427; MS: HR-
ESI calculated for [C14H17N3S+H]
+: 260.1216, found: 260.1242; mp 165-168°C (dec). 
1.63e:  Isolated as a light-brown amorphous solid (1.2 g; 82% yield) after 
chromatography (20% i-PrOH+1% NEt3/CH2Cl2). 1H NMR (600 MHz, 
CDCl3) δ 6.51 (s, 1H), 6.03 (s, 1H), 3.69 (t, J = 6.1 Hz, 2H), 3.52 (t, J = 5.5 
Hz, 2H), 3.35 – 3.28 (m, 4H), 3.27 – 3.18 (m, 4H), 1.96 (p, J = 4.9 Hz, 2H), 1.24 – 1.06 (m, 6H); 
13C NMR (150 MHz, CDCl3) δ 159.46, 134.70, 133.43, 130.99, 108.60, 105.62, 92.24, 46.78, 
46.28, 46.15, 45.80, 45.53, 42.04, 19.92, 10.54, 10.40; IR (cm-1): 2836, 1603, 1567, 1503, 1305, 







1.5.14 Preparation of bicyclic isothioureas 1.91a-d and 1.92a-d.42 
 
Method A. A mixture of a 2-bromoketone43 (1 equiv) and a cyclic thiourea (n = 0, 1; 1.2 equiv) 
in EtOH (0.1 M in bromoketone) was refluxed for a minimum of 20 hours.  The reaction mixture 
was allowed to cool to room temperature, concentrated down, and the residue taken up in CH2Cl2. 
The mixture was washed with saturated aqueous Na2SO3 and basified with 1M NaOH.  The organic 
layer was then dried over Na2SO4 salt and evaporated, yielding a colorless to light-tan oil, which 
crystallized on standing.  The crude product was pure enough by 1H NMR to be used without 
further purification.   
 
Method B. A mixture of a substituted acetophenone44 (1.0 equiv), iodine (2.15 equiv), and a cyclic 
thiourea (n = 0, 1; 2 equiv) in EtOH (0.1 M in ketone) was refluxed for a minimum of 20 hours.  
The reaction mixture was worked up as described above.   
1.91a: Prepared by Method A in 72% yield. Previously reported without full 
characterization.45 1H NMR (300 MHz, CDCl3): δ 7.42 – 7.29 (m, 5H), 5.60 
(s, 1H), 3.57 (t, J = 6.0 Hz, 2H), 3.46 (t, J = 5.5 Hz, 2H), 1.79 (tt, J = 5.8 Hz, 
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5.7 Hz, 2H); 13C NMR (125 MHz, CDCl3): δ 160.89, 139.97, 130.97, 128.93, 128.69, 128.26, 
95.05, 45.42, 44.76, 20.09; IR (cm-1): 2940, 1606, 1491, 1442, 1363, 1269, 1180, 1092, 1048, 974, 
766, 702, 555, 449; MS: HR-ESI calculated for [C12H12N2S+H]
+: 217.0794, found: 217.0808. mp 
107-110 °C. 
1.91b: Prepared by Method A in 96% yield. Previously reported without 
full characterization.46 1H NMR (300 MHz, CDCl3): δ 7.23 (d, J = 8.3 
Hz, 2H), 6.90 (d, J = 8.4 Hz, 2H), 5.52 (s, 1H), 3.80 (s, 3H), 3.54 (t, J = 
6.0 Hz, 2H), 3.44 (t, J = 5.5 Hz, 2H), 1.77 (tt, J = 5.7H, 5.8 Hz, 2H); 13C NMR (125 MHz, CDCl3): 
δ 161.00, 160.13, 139.72, 129.70, 123.32, 114.11, 94.15, 55.40, 45.36, 44.66, 20.11; IR (cm-1): 
2937, 2837, 1599, 1507, 1455, 1360, 1272, 1247, 1177, 1092, 1028, 975, 841, 817, 732, 698, 632, 
586, 555, 477; MS: HR-ESI calculated for [C13H14N2OS+H]
+: 247.0900, found: 247.0915. mp 97-
98 °C. 
1.91c: Prepared via Method B in 25% yield.  1H NMR (300 MHz, 
CDCl3): δ 7.19 (d, J = 8.8 Hz, 2H), 6.70 (d, J = 8.8 Hz, 2H), 5.49 (s, 
1H), 3.59 (t, J = 6.0 Hz, 2H), 3.47 (t, J = 5.5 Hz, 2H), 2.99 (s, 4H), 1.79 
(p, J = 5.8, 5.7 Hz, 2H); 13C NMR (125 MHz, CDCl3): δ 161.39, 150.75, 140.58, 129.39, 118.48, 
111.97, 93.14, 45.46, 44.77, 40.40, 20.25; IR (cm-1): 2933, 2844, 1600, 1517, 1445, 1354, 1270, 
1230, 1183, 1092, 1069, 975, 944, 815, 731, 660, 634, 602, 554, 483; MS: HR-ESI calculated for 
[C14H17N3S+H]
+: 260.1216, found: 260.1237. mp 145-148 °C (dec). 
1.91d: Prepared via Method B in 36% yield. 1H NMR (300 MHz, 
CDCl3): δ 7.16 (d, J = 8.7 Hz, 2H), 6.54 (d, J = 8.7 Hz, 2H), 5.47 (s, 
1H), 3.59 (t, J = 5.9 Hz, 2H), 3.46 (t, J = 5.6 Hz, 2H), 3.30 (t, J = 6.6 
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Hz, 4H), 2.07 – 1.97 (m, 4H), 1.79 (tt, J = 5.7, 5.7 Hz, 2H); 13C NMR (125 MHz, CDCl3): 161.43, 
148.17, 140.83, 129.47, 117.51, 111.39, 92.76, 47.65, 45.47, 44.74, 25.58, 20.26; IR (cm-1): 2840, 
1600, 1517, 1485, 1376, 1270, 1187, 975, 810, 730, 555; MS: HR-ESI calculated for 
[C16H19N3S+H]
+: 286.1372, found: 286.1403. mp 142-146 °C (dec).  
1.92a: Prepared via method A in quantitative yield.  The NMR spectra 
matched those reported in the literature.42a 
1.92b: Prepared via Method A in 96% yield. Previously reported without 
full characterization.28 1H NMR (300 MHz, CDCl3): δ 7.35 (d, J = 8.7 
Hz, 2H), 6.92 (d, J = 8.8 Hz, 2H), 5.58 (s, 1H), 4.24 (t, J = 9.2 Hz, 2H), 
3.89-3.75 (m, 5H); 13C NMR (125 MHz, CDCl3): δ 170.46, 160.18, 137.14, 127.87, 123.59, 
114.36, 96.44, 60.60, 55.45, 48.37; IR (cm-1): 2932, 1590, 1505, 1455, 1419, 1371, 1293, 1248, 
1178, 1112, 1030, 971, 835, 807, 729, 684, 632, 584, 519; MS: HR-ESI calculated for 
[C12H12N2OS+H]
+: 233.0743, found: 233.0758. mp 89-90 °C. 
1.92c: Prepared via Method B in 25% yield. Previously reported without 
full characterization28 1H NMR (300 MHz, CDCl3): δ 7.29 (d, J = 8.7 
Hz, 2H), 6.70 (d, J = 8.7 Hz, 2H), 5.50 (s, 1H), 4.24 (t, J = 9.2 Hz, 2H), 
3.85 (t, J = 9.2 Hz, 2H), 2.99 (s, 6H). 13C NMR (125 MHz, CDCl3): δ 170.83, 150.79, 137.84, 
127.55, 118.76, 112.18, 94.90, 60.50, 48.46, 40.40. IR (cm-1): 2888, 1592, 1515, 1444, 1364, 1293, 
1231, 1200, 1066, 946, 823, 666, 633, 520. MS: HR-ESI calculated for [C13H15N3S+H]
+: 
246.1059, found: 246.1080. mp 149-152 °C (dec). 
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1.92d: Prepared via Method A in 52% yield. 1H NMR (300 MHz, 
CDCl3): δ 7.27 (d, J = 8.9 Hz, 2H), 6.54 (d, J = 8.8 Hz, 2H), 5.47 (s, 1H), 
4.23 (t, J = 9.3 Hz, 2H), 3.84 (t, J = 9.2 Hz, 2H), 3.36 – 3.25 (m, 4H), 
2.05 – 1.95 (m, 4H); 13C NMR (125 MHz, CDCl3): δ 170.87, 148.23, 138.09, 127.66, 117.93, 
111.64, 94.30, 60.66, 48.49, 47.69, 25.63; IR (cm-1): 2836, 1585, 1513, 1374, 1182, 962, 814, 726, 
663, 631, 513; MS: HR-ESI calculated for [C15H17N3S+H]
+: 272.1216, found: 272.1261; mp 143-
144 °C.  
1.5.15 Preparation of chiral catalyst 1.94. 
 
Thiourea 1.112. Prepared analogously to thioureas 1.105c-e starting with chiral aminoalcohol 
1.11147. Isolated as a light-brown solid (602 mg; 99% yield) after chromatography (15% i-
PrOH+1% NEt3/Hexanes).  1H NMR (500 MHz, CDCl3): δ 7.48 (s, 1H), 7.39 – 7.17 (m, 2H), 7.16 
– 6.97 (m, 5H), 6.74 (d, J = 8.9 Hz, 2H), 6.60 (d, J = 9.9 Hz, 1H), 5.96 (d, J = 9.8 Hz, 1H), 3.60 – 
3.28 (m, 3H), 3.00 (s, 6H), 2.47 – 2.11 (m, 1H), 0.56 (d, J = 7.0 Hz, 3H); 13C NMR (125 MHz, 
CDCl3): δ 181.75, 150.41, 139.78, 128.58, 128.12, 127.17, 126.63, 113.14, 64.53, 58.69, 40.87, 
40.53, 10.97;  IR (cm-1): 3195, 2958, 2877, 2803, 1609, 1515, 1166, 1029, 946, 813, 700, 551; 
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MS: HR-ESI calculated for [C19H25N3OS+H]
+: 344.1791, found: 344.1811; mp: 123-125 °C; 
[α]
D
23= -0.98° (c= 0.58, CH2Cl2). 
1.113.  Prepared analogously to benzothiazoles 1.106c and e. Isolated as a light-brown solid (122 
mg; 22% yield) after chromatography (40% EtOAc/Hexanes).  1H NMR (300 MHz, CDCl3): δ 
7.55 – 7.26 (m, 6H), 6.97 (d, J = 2.5 Hz, 1H), 6.83 (dd, J = 8.8, 2.5 Hz, 1H), 6.25 (broad s, 1H), 
5.29 (d, J = 3.3 Hz, 1H), 4.90 (broad s, 1H), 3.83 – 3.43 (m, 2H), 2.96 (s, 6H), 2.43 (m, 1H), 0.85 
(d, J = 7.0 Hz, 3H); 13C NMR (75 MHz, CDCl3): δ 165.19, 147.24, 143.38, 140.22, 131.79, 128.60, 
127.38, 127.07, 119.14, 113.23, 105.01, 64.69, 59.95, 41.80, 41.32, 11.33;  IR (cm-1): 3259, 2933, 
2917, 2873, 2861, 2788, 1603, 1522, 1487, 1337, 1212, 1090, 1046, 909, 806, 734, 696, 531, 489; 
MS: HR-ESI calculated for [C19H23N3OS+H]
+: 342.1635, found: 342.1660; mp: 185-190 °C dec.; 
[α]
D
23= +0.66° (c= 0.7, CH2Cl2). 
Dimethylamino-HBTM-2 (1.94). Prepared analogously to catalysts 1.63b-e  Isolated as a light-
brown solid (56 mg; 57% yield) after chromatography (20→40% EtOAc/Hexanes).  1H NMR 
(500 MHz, CDCl3): δ 7.32 – 7.09 (m, 5H), 6.74 (d, J = 2.2 Hz, 1H), 6.65 – 6.47 (m, 2H), 4.64 (d, 
J = 4.2 Hz, 1H), 3.73 (dd, J = 11.4, 4.9 Hz, 1H), 3.24 (dd, J = 11.4, 7.5 Hz, 1H), 2.83 (s, 6H), 2.42 
– 2.21 (m, 1H), 0.73 (d, J = 7.0 Hz, 3H); 13C NMR (125 MHz, CDCl3):  158.11, 147.19, 141.32, 
132.68, 128.12, 127.92, 126.89, 124.20, 111.27, 107.96, 107.55, 62.92, 46.38, 41.75, 29.37, 14.07; 
IR (cm-1): 2964, 2876, 2786, 1600, 1572, 1496, 1335, 1240, 1197, 978, 957, 860, 796, 752, 700, 
583, 528; MS: HR-ESI calculated for [C19H21N3S+H]
+: 324.1529, found: 324.1555; mp: 122-
123 °C; [α]
D




1.5.16 Preparation of chiral catalyst 1.95. 
 
(a) A solution of carbamate 1.11423a (3.00 g, 10.3 mmol) in 60 mL of CH2Cl2 at 0 oC, was treated 
with NEt3 (2.20 mL, 15.5 mmol) followed by methanesulfonyl chloride (0.88 mL, 11 mmol). 
The reaction mixture was stirred for 1 h at 0 °C and 1 hat rt and quenched by adding saturated 
aqueous NH4Cl. The organic phase was separated, dried over Na2SO4 and evaporated. The 
crude mesylate was dissolved in DMF (30 mL) and treated with NaN3 (3.10 g, 47.2 mmol). 
stirring at 80 °C for 16 h, the reaction mixture was cooled to rt, quenched by adding saturated 
NH4Cl and the extracted with Et2O. The organic layer was washed with saturated NH4Cl, brine 
and dried over Na2SO4. The solvent was evaporated to give the azide 1.115 (2.86 g, 96% yield) 
in sufficiently pure form for the next step. 1H NMR (300 MHz, CDCl3) δ 7.34 – 7.23 (m, 2H), 
7.23 – 7.15 (m, 3H), 5.08 (s, 1H), 4.76 (d, J = 5.3 Hz, 1H), 3.26 – 2.99 (m, 2H), 1.96 – 1.66 
(m, 2H), 1.33 (s, 9H), 0.98 (d, J = 6.9 Hz, 3H), 0.87 (d, J = 6.8 Hz, 3H); 13C NMR (125 MHz, 
CDCl3) δ 155.12, 141.11, 128.71, 127.47, 127.11, 79.59, 55.47, 50.24, 48.84, 28.46, 27.29, 
21.95, 18.67; IR (cm-1): 3390, 2963, 2096, 1682, 1517, 1363, 1251, 1167, 1081, 751. 
 
(b) A solution of azide 1.115 (954 mg, 3.00 mmol) and CS2 (0.90 mL, 15 mmol) in 10 mL of 
CH2Cl2 was treated with solid PPh3 (865 mg, 3.3 mmol) and stirred at 50 °C for 16 h. The 
solvent was evaporated and 10 mL of a 1:1 Et2O/hexanes mixture was added. The resulting 
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white precipitate (Ph3P=S) was filtered off and the filtrate evaporated to give the crude 
isothiocyanate, which was dissolved in 20 mL of CH2Cl2 and treated with TFA (1 mL) at rt. 
The reaction mixture was stirred overnight and then neutralized with 1M NaOH. The organic 
layer was separated, dried over Na2SO4 and evaporated. The evaporation residue was purified 
by chromatography (20→60% EtOAc/hexanes to afford the product 1.116 as a white solid 
(397 mg; 56% yield). 1H NMR (500 MHz, CDCl3) δ 7.37 (s, 1H), 7.35 – 7.25 (m, 3H), 7.20 
(s, 1H), 7.19 – 7.15 (m, 2H), 4.60 (t, J = 4.1 Hz, 1H), 3.40 – 3.29 (m, 1H), 3.03 (t, J = 12.4 Hz, 
1H), 1.93 – 1.83 (m, 1H), 1.16 – 1.09 (m, 1H), 1.07 (d, J = 6.0 Hz, 3H), 0.73 (d, J = 6.4 Hz, 
3H); 13C NMR (125 MHz, CDCl3) δ 176.27, 139.21, 128.68, 128.13, 127.75, 56.94, 41.44, 
40.65, 26.39, 21.79, 19.89; IR (cm-1): 3161, 2954, 1569, 1525, 1453, 1370, 1268, 1225, 774, 
702; MS: HR-ESI calculated for [C13H18N2S+H]
+: 235.1263, found: 235.1290. 
(c) Catalyst 1.95 was prepared analogously to achiral isothioureas 1.91 and 1.92, except 10% 
excess of bromoketone 1.107c was used. Isolated as a light yellow solid (324 mg, 57% yield) 
after chromatography (1→20% MeOH/EtOAc). 1H NMR (500 MHz, CDCl3) δ 7.34 (t, J = 7.6 
Hz, 2H), 7.30 – 7.25 (m, 3H), 7.23 (d, J = 8.5 Hz, 2H), 6.71 (d, J = 8.4 Hz, 2H), 5.66 (s, 1H), 
4.88 (d, J = 4.1 Hz, 1H), 3.65 (dd, J = 12.4, 4.8 Hz, 1H), 3.31 (t, J = 11.6 Hz, 1H), 3.00 (s, 
6H), 1.79 – 1.71 (m, 1H), 1.29 – 1.20 (m, 1H), 1.06 (d, J = 6.5 Hz, 3H), 0.66 (d, J = 6.7 Hz, 
3H); 13C NMR (125 MHz, CDCl3) δ 161.88, 150.43, 141.18, 140.42, 128.86, 127.97, 127.75, 
126.73, 117.67, 111.67, 93.80, 60.21, 44.22, 40.89, 39.99, 26.34, 21.98, 19.76. IR (cm-1): 
2961, 1599, 1518, 1354, 1264, 1196, 945, 814, 730; MS: HR-ESI calculated for 
[C23H27N3S+H]
+: 378.1998, found: 378.2028; mp: 88-91 °C; 
[α]
D




1.5.17 Preparation of chiral catalyst 1.96. 
 
(a) Thiourea 1.118 was prepared analogously to 1.116 via the known (R)-N-Boc-2-azido-1-
phenylethylamine 1.11748 Isolated as a pale pink powder (411 mg, 52% yield) after 
chromatography (1:1 hexane/CH2Cl2  1:9 EtOAc/ CH2Cl2). Previously reported without 
characterization.28 1H NMR (300 MHz, CDCl3): δ 7.45-7.29 (m, 5H), 6.45 (s, 1H), 6.38 (s, 
1H), 5.08 (dd, J = 9.9, 7.6 Hz, 1H), 4.12 (t, J = 9.8 Hz, 1H), 3.59 (dd, J = 9.7, 7.6 Hz, 1H); 13C 
NMR (125 MHz, CDCl3): δ 184.37, 140.02, 129.28, 128.85, 126.30, 61.14, 53.64; IR (cm-1): 
3212, 1746, 1521, 1478, 1463, 1446, 1372, 1301, 1257, 1182, 1032, 917, 756, 724, 694, 589, 
531, 505; MS: HR-ESI calculated for [C13H17N3S+H]
+: 179.0637, found: 179.0649. mp 148-
150 °C; [α]
D
23= +0.071° (c= 0.31, CH2Cl2).  
(b) Catalyst 1.96 was prepared analogously to achiral isothioureas 1.91 and 1.92. Isolated as a pale 
orange powder (225 mg; 73% yield). Previously reported without full characterization.28 1H 
NMR (300 MHz, CDCl3): δ 7.43 – 7.33 (m, 4H), 7.32 – 7.25 (m, 3H), 6.69 (d, J = 8.8 Hz, 2H), 
5.63 – 5.56 (m, 2H), 4.32 (t, J = 9.6 Hz, 1H), 3.71 (t, J = 9.0 Hz, 1H), 2.99 (s, 6H); 13C NMR 
(500 MHz, CDCl3): δ 170.62, 150.82, 143.67, 137.80, 128.70, 127.55, 127.43, 126.68, 118.62, 
112.18, 95.11, 75.62, 56.14, 40.40; IR (cm-1): 1592, 1515, 1445, 1356, 1227, 826, 743, 698, 
665, 643, 581, 528; MS: HR-ESI calculated for [C19H19N3S+H]
+: 322.1372, found: 322.1401; 
mp 140-143 °C; [α]
D
23= +2.51° (c= 0.31, CH2Cl2). 
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1.5.18 Synthesis of the enone substrates. 
 
Method A. A round bottom flask equipped with a magnetic stir bar was charged with an o-
(acylthio)benzaldehyde (1.0 equiv), a Wittig Reagent (1.3 equiv), and dichloromethane (0.33 M in 
the aldehyde). The mixture was stirred for 24 to 48 h at rt and concentrated under reduced pressure. 
The residue was purified by flash chromatography using the eluent indicated to afford the 
corresponding enone 1.84. 
Method B. The reaction was carried out as described above, but with a larger excess of the Wittig 
reagent (2.0 equiv), and heating in toluene (0.33 M) at 80 °C for 24 h.  
1.84a: Prepared using Method A. Isolated as a white solid (103 mg, 53% 
yield) after chromatography (5% EtOAc/15%CH2Cl2/hexanes).  1H 
NMR (300 MHz, CDCl3): δ 8.16 (d, J = 15.8 Hz, 1H), 8.04 – 7.96 (m, 
2H), 7.90 (dd, J = 7.7, 1.5 Hz, 1H), 7.69 (d, J = 15.8 Hz, 1H), 7.62 – 
7.38 (m, 12H), 6.82 (d, J = 15.3 Hz, 1H); 13C NMR (125 MHz, CDCl3): 190.69, 186.75, 142.26, 
142.16, 138.84, 138.02, 137.07, 133.93, 132.85, 130.98, 130.61, 130.42, 129.12, 129.09, 128.71, 
128.65, 128.64, 127.36, 124.88, 123.99; IR (cm-1): 3055, 3020, 2919, 2851, 1682, 1659, 1599, 
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1446, 1304, 1270, 1213,1013, 977, 880, 752, 724, 683, 568, 497; MS: HR-ESI calculated for 
[C24H18O2S+Na]
+: 393.0920, found: 393.0952; mp: 132-135 °C. 
1.84b: Prepared using Method B. Isolated as a white solid (141 mg, 93% 
yield) after chromatography (5→10% EtOAc/hexanes). 1H NMR (500 
MHz, CDCl3): δ 8.15 (d, J = 15.7 Hz, 1H), 7.92 (d, J = 8.6 Hz, 2H), 7.88 
(dd, J = 7.8, 1.4 Hz, 1H), 7.68 (d, J = 15.8 Hz, 1H), 7.62 – 7.36 (m, 
11H), 6.81 (d, J = 15.8 Hz, 1H); 13C NMR (125 MHz, CDCl3): δ 189.58, 186.84, 142.77, 142.47, 
139.36, 138.75, 137.18, 136.42, 133.97, 131.10, 130.85, 130.52, 130.20, 129.29, 129.18, 129.05, 
128.73, 127.43, 124.47, 124.01; IR (cm-1): 3060, 3025, 2953, 2923, 2855, 1687, 1662, 1598, 1461, 
1329, 1265, 1207, 1089, 1010, 881, 832, 750, 686, 568, 534, 497; MS: HR-ESI calculated for 
[C24H17ClO2S+Na]
+: 427.0530, found: 427.0567; mp: 114-116 °C. 
1.84c: Prepared using Method B. Isolated as a white solid (275 mg, 61% 
yield) after chromatography 5% EtOAc/15%CH2Cl2/hexanes). 1H 
NMR (300 MHz, CDCl3): δ 1H NMR (300 MHz, CDCl3): 8.42 (s, 2H), 
8.24 (d, J = 15.7 Hz, 1H), 8.06 (s, 1H), 7.92 (dd, J = 7.6, 1.7 Hz, 1H), 
7.68 (d, J = 15.8 Hz, 1H), 7.63 – 7.37 (m, 9H), 6.81 (d, J = 15.8 Hz, 
1H); 13C NMR (125 MHz, CDCl3): δ 187.90, 186.63, 144.84, 142.69, 139.69, 138.29, 137.32, 
133.94, 132.46 (q, J = 33.9 Hz), 131.42, 131.17, 130.64, 129.70, 129.19, 128.75, 128.74 (q, J = 
2.8 Hz), 127.66, 126.06 (sept, J = 3.7 Hz), 123.85, 123.32, 123.08 (q, J = 273.2 Hz); IR (cm-1): 
2957, 2922, 2852, 1681, 1613, 1586, 1445, 1313, 1281, 1167, 1130, 1019, 984, 904, 878, 848, 
758, 694, 681, 570, 484, 442; MS: HR-ESI calculated for [C26H16F6O2S+Na]
+: 529.0667, found: 
529.0658; mp: 148-151 °C. 
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1.84d: Prepared using Method A. Isolated as a white solid (143 mg, 
89% yield) after chromatography (10→20→30% EtOAc/hexanes). 1H 
NMR δ 8.15 (d, J = 15.6 Hz, 1H), 8.00 (ddd, J = 8.7, 2.8, 0.2 Hz, 2H), 
7.87 (dd, J = 7.7, 1.8 Hz, 1H), 7.68 (d, J = 15.8 Hz, 1H), 7.59 – 7.33 
(m, 9H), 6.92 (ddd, J = 8.7, 2.8, 0.2 Hz, 2H), 6.81 (d, J = 15.8 Hz, 1H), 3.78 (s, 3H); 13C NMR 
(150 MHz, CDCl3): δ 188.77, 186.74, 163.41, 142.08, 141.10, 138.93, 136.96, 133.83, 130.97, 
130.90, 130.80, 130.36, 130.33, 129.01, 128.87, 128.57, 127.26, 124.68, 123.93, 113.83, 55.39; 
IR (cm-1): 3055, 2961, 2924, 2838, 1687, 1653, 1604, 1509, 1461, 1335, 1306, 1257, 1215, 1163, 
1020, 973, 880, 827, 751, 685, 632, 569, 502; MS: HR-ESI calculated for [C25H20O3S+Na]
+: 
423.1025, found: 423.1063; mp: 107-109 °C. 
1.84e: Prepared using Method B. Isolated as a light-yellow solid (108 
mg, 78% yield) after chromatography (10→40% EtOAc/hexanes).  1H 
NMR (300 MHz, CDCl3): δ 8.76 (dd, J = 4.5, 1.6 Hz, 2H), 8.14 (d, J = 
15.8 Hz, 1H), 7.89 (dd, J = 7.4, 1.8 Hz, 1H), 7.79 – 7.62 (m, 3H), 7.61 
– 7.38 (m, 8H), 7.35 (d, J = 15.8 Hz, 1H), 6.80 (d, J = 15.8 Hz, 1H); 13C NMR (125 MHz, CDCl3): 
190.45, 186.68, 150.83, 144.36, 144.33, 142.62, 138.30, 137.17, 133.86, 131.26, 131.20, 130.59, 
129.55, 129.21, 128.74, 127.48, 124.13, 123.84, 121.83; IR (cm-1): 1669, 1613, 1465, 1327, 1211, 
1031 975, 884, 764, 713, 619, 572; MS: HR-ESI calculated for [C23H17NO2S+H]
+: 372.1053, 
found: 372.1073; mp:124 -127 °C 
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1.84f: Prepared using Method A. Isolated as a white solid (115 mg, 99% 
yield) after chromatography (5→10→20% EtOAc/hexanes). 1H NMR 
(500 MHz, CDCl3): δ 7.90 (d, J = 16.2 Hz, 1H), 7.76 (dd, J = 7.7, 1.6 
Hz, 1H), 7.69 (d, J = 15.8 Hz, 1H), 7.56 (dt, J = 7.8, 2.0 Hz, 2H), 7.50 
– 7.36 (m, 5H), 6.82 (d, J = 15.8 Hz, 1H), 6.68 (d, J = 16.3 Hz, 1H), 2.34 (s, 3H); 13C NMR (125 
MHz, CDCl3): δ 198.23, 186.51, 142.31, 140.62, 138.23, 136.93, 133.78, 131.03, 130.60, 130.45, 
129.43, 129.07, 128.71, 128.62, 127.25, 123.73, 27.48; IR (cm-1): 3063, 3023, 2919, 1681, 1664, 
1613, 1446, 1253, 1202, 1018, 968, 878, 752, 689, 567, 482, 438; MS: HR-ESI calculated for 
[C19H16O2S+H]
+: 309.0944, found: 309.0943; mp: 95-97 °C. 
1.84g: Prepared using Method A. Isolated as a white solid (389 
mg, 78% yield) after chromatography (5→10% EtOAc/hexanes). 
1H NMR (300 MHz, CDCl3): δ 8.14 (d, J = 15.7 Hz, 1H), 8.01 
(dd, J = 1.4, 1.4 Hz, 1H), 8.00 – 7.97 (m, 3H), 7.94 – 7.87 (m, 2H), 
7.68 (d, J = 15.8 Hz, 1H), 7.62 – 7.43 (m, 7H), 6.93 (d, J = 15.7 
Hz, 1H); 13C NMR (125 MHz, CDCl3): δ190.37, 186.32, 141.80, 138.97, 138.25, 138.06, 137.04, 
136.25, 133.08, 132.77 (q, J = 33.8 Hz), 130.84, 130.81, 128.79, 128.76, 128.41, 128.21, 128.18, 
127.57, 125.01, 124.06 – 123.64 (m), 123.08 (q, J = 273.0 Hz); IR (cm-1): 3070, 3050, 1685, 1657, 
1578, 1377, 1274, 1223, 1172, 1123, 1015, 977, 944, 898, 845, 820, 756, 726, 681, 658, 581; MS: 
HR-ESI calculated for [C26H16F6O2S+Na]
+: 529.0667, found: 529.0711; mp: 186-190 °C. 
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1.84h: Prepared using Method A. Isolated as a white solid (50 mg, 
49% yield) after chromatography (5→10% EtOAc/hexanes). 1H 
NMR (300 MHz, CDCl3): δ 8.00 (s, 2H), 7.92 (s, 1H), 7.87 (d, J 
= 16.2 Hz, 1H), 7.81 – 7.75 (m, 1H), 7.70 (d, J = 15.8 Hz, 1H), 
7.62 – 7.38 (m, 3H), 6.95 (d, J = 15.8 Hz, 1H), 6.71 (d, J = 16.2 
Hz, 1H), 2.35 (s, 3H); 13C NMR (125 MHz, CDCl3): δ 198.13, 186.12, 140.26, 138.38, 138.32, 
136.94, 136.15, 132.79 (q, J = 33.7 Hz), 130.90, 130.83, 129.65, 128.20 (q, J = 3.9 Hz), 128.03, 
127.52, 127.33, 124.03 (sept, J = 7.6 Hz), 123.06 (q, J = 273.0 Hz), 27.88; IR (cm-1): 1672, 1610, 
1467, 1378, 1276, 1173, 1129, 1020, 973, 900, 821, 755, 699, 683, 583; MS: HR-ESI calculated 
for [C21H14F6O2S+Na]
+: 467.0511, found: 467.0539; mp: 109-112 °C. 
1.84i:  Prepared using Method A. Isolated as a white amorphous 
solid (282 mg, 52% yield) after chromatography (5→10→15% 
EtOAc/hexanes). 1H NMR (300 MHz, CDCl3): δ 8.17 (d, J = 15.7 
Hz, 1H), 8.06 – 7.94 (m, 2H), 7.88 (dd, J = 7.6, 1.8 Hz, 1H), 7.64 
(d, J = 15.7 Hz, 1H), 7.60 – 7.38 (m, 9H), 6.92 (d, J = 8.8 Hz, 2H), 6.69 (d, J = 15.7 Hz, 1H), 3.83 
(s, 3H); 13C NMR (125 MHz, CDCl3): δ 190.76, 186.60, 162.02, 142.32, 142.06, 138.83, 138.04, 
137.11, 132.81, 130.56, 130.45, 130.30, 129.41, 128.71, 128.64, 127.31, 126.58, 124.80, 121.58, 
114.57, 55.47; IR (cm-1): 3059, 2933, 2838, 1663, 1597, 1511, 1464, 1312, 1256, 1215, 1174, 
1024, 805, 755; MS: HR-ESI calculated for [C25H20O3S+NH]
+: 401.1206, found: 401.1199. 
1.84j: Prepared using Method A. Isolated as a greenish-yellow oil (94 
mg, 68% yield) after chromatography (1→5% EtOAc/hexanes). 1H 
NMR (300 MHz, CDCl3): δ 8.13 (d, J = 15.7 Hz, 1H), 8.04 – 7.93 (m, 
2H), 7.87 (dd, J = 7.7, 1.5 Hz, 2H), 7.66 – 7.35 (m, 10H), 6.95 (dd, J = 
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15.6, 6.7 Hz, 1H), 6.15 (dd, J = 15.7, 1.4 Hz, 1H), 2.22 – 2.09 (m, 1H), 1.87 – 1.56 (m, 5H), 1.43 
– 1.07 (m, 5H); 13C NMR (125 MHz, CDCl3): δ 190.78, 187.28, 152.49, 142.36, 138.93, 138.13, 
137.18, 132.88, 130.59, 130.31, 129.37, 128.77, 128.70, 127.33, 125.49, 124.81, 40.73, 31.66, 
26.00, 25.80; IR (cm-1): 2926, 2851, 1665, 1604, 1448, 1314, 1271, 1214, 1015, 975, 817, 754, 
692; MS: HR-ESI calculated for [C24H24O2S+H]
+: 377.1570, found: 377.1569. 
1.84k: Prepared using Method A. Isolated as a greenish-yellow oil 
(144 mg, 48% yield) after chromatography (1→5% EtOAc/hexanes). 
1H NMR (300 MHz, CDCl3): δ 7.85 (d, J = 16.2 Hz, 1H), 7.73 (dd, J 
= 7.4, 1.9 Hz, 1H), 7.54 – 7.34 (m, 3H), 6.95 (dd, J = 15.6, 6.7 Hz, 
1H), 6.65 (d, J = 16.2 Hz, 1H), 6.15 (dd, J = 15.6, 1.4 Hz, 1H), 2.33 (s, 3H), 2.27 – 2.10 (m, 1H), 
1.87 – 1.62 (m, 5H), 1.38 – 1.07 (m, 5H); 13C NMR (125 MHz, CDCl3): δ 190.78, 187.28, 152.49, 
142.36, 138.93, 138.13, 137.18, 132.88, 130.59, 130.31, 129.37, 128.77, 128.70, 127.33, 125.49, 
124.81, 40.73, 31.66, 26.00, 25.80; IR (cm-1): 2925, 2851, 1672, 1624, 1448, 1358, 1256, 1178, 
1012, 973, 816, 754; MS: HR-ESI calculated for [C19H22O2S+H]
+: 315.1413, found: 315.1410. 
1.84l: Prepared using Method B. Isolated as a White solid (140 
mg, 47% yield, 5→10% EtOAc/hexanes). 1H NMR (300 MHz, 
CDCl3): δ 8.41 (s, 2H), 8.20 (d, J = 15.6 Hz, 1H), 8.07 (s, 1H), 
7.99 (s, 2H), 7.94 (dd, J = 7.8, 1.5 Hz, 1H), 7.92 (s, 1H), 7.69 (d, 
J = 15.8 Hz, 1H), 7.62 – 7.50 (m, 3H), 7.45 (d, J = 15.6 Hz, 1H), 
6.94 (d, J = 15.8 Hz, 1H); 13C NMR (125 MHz, CDCl3): δ 187.70, 
186.10, 144.36, 139.60, 138.51, 138.23, 137.15, 136.12, 132.80 (q, J = 33.9 Hz), 132.49 (q, J = 
33.9 Hz), 131.52, 130.96, 128.84, 128.70 (q, J = 3.9 Hz), 128.21 (q, J = 4.0 Hz), 127.80, 127.30, 
126.15 (sept, J = 3.7 Hz), 124.07 (sept, J = 3.8 Hz), 123.48, 123.07 (q, J = 272.9 Hz); IR (cm-1): 
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1672, 1617, 1378, 1275, 1126, 1020, 902, 843, 734, 698, 681, 583; MS: HR-ESI calculated for 
[C28H14F12O2S+H]
+: 643.0596, found: 643.0.550; mp: 1159-162 °C dec. 
1.5.19 Achiral catalyst survey. 
 
Each experiment was performed in duplicate.  A stock solution containing 0.00675 mmol of a 
catalyst in freshly distilled CDCl3 was added into an NMR tube containing 0.0675 mmol of 
substrate 1.84a in enough CDCl3  to produce 0.675 mL total volume (final concentration: 0.100 M 
in the substrate, 0.010 M in the catalyst). The reaction was monitored by 1H NMR. The conversion 
was measured by comparing the peaks of the product and the catalyst. The results are summarized 
in plots shown below.   The reaction rates relative to that of DHPB (1.63a) shown in Table 1.3 





























































1.5.20 Enantioselective synthesis of thiochromanes, general procedure. 
 
A solution of substrate 1.84 and catalyst (R)-1.85b (10 mol%) in freshly distilled chloroform (0.2 
M in the substrate) was stirred at room temperature under argon until the reaction was complete 
by TLC. The reaction mixture was concentrated under reduced pressure and purified by flash 
chromatography using the eluent indicated below. The resulting thiochromane 1.85 was analyzed 
































1.5.21 Preparative Scale Synthesis of 1.85a. 
A solution of substrate 1.84a (1.000 g, 2.70 mmol) and catalyst (R)-1.29b (10 mol%, 53 mg) in 
freshly distilled chloroform (13.5 mL) was stirred at room temperature under argon for 48 h. The 
reaction mixture was concentrated under reduced pressure and purified by flash chromatography 
(2% EtOAc in hexane) to give 1.85a (861 mg, 86% yield, 97:3 dr, 95% ee). 
1.5.22 Characterization data for the thiochromane products. 
1.85a:  Isolated as a white solid (49 mg; 93% yield) after chromatography (2% 
EtOAc in hexane). 1H NMR (300 MHz, CDCl3): δ 7.75 – 7.60 (m, 2H), 7.59 – 
7.03 (m, 12H), 6.10 (d, J = 5.3 Hz, 1H), 4.79 (d, J = 8.2 Hz, 1H), 4.21 (dd, J = 
7.0, 5.3 Hz, 1H), 3.68 (dd, J = 8.2, 7.1 Hz, 1H); 13C NMR (75 MHz, CDCl3): δ 167.88, 150.22, 
139.36, 135.35, 134.59, 131.87, 129.63, 129.09, 128.77, 128.49, 128.39, 128.22, 128.09, 127.90, 
126.40, 124.89, 102.98, 49.48, 45.45, 37.00. IR (cm-1): 2927, 1754, 1459, 1276, 1231, 1142, 1075, 
1001, 949, 819, 759, 738, 687, 605, 549; MS: ESI calculated for [C24H18O2S+H]
+: 371.1100, 
found: 371.1124; mp: 157-161 °C; HPLC: (3% isopropanol/hexanes): Minor enantiomer: 22.192 
min; Major enantiomer: 26.039 min; 95% ee; [α]
D
23= -1.5° (c= 0.44, CH2Cl2). 
1.85b: Isolated as a white solid (36 mg; 89% yield) after chromatography 
(5→15% EtOAc/hexanes). 1H NMR (500 MHz, CDCl3) δ 7.60 (d, J = 8.7 Hz, 
2H), 7.49 (d, J = 6.9 Hz, 2H), 7.41 – 7.27 (m, 7H), 7.26 – 7.18 (m, 2H), 6.08 
(d, J = 5.3 Hz, 1H), 4.76 (d, J = 8.1 Hz, 1H), 4.21 (t, J = 6.2 Hz, 1H), 3.67 (dd, 
J = 8.1, 7.0 Hz, 1H); 13C NMR (125 MHz, CDCl3) δ 167.59, 149.30, 139.24, 
135.63, 135.35, 134.36, 130.34, 129.12, 129.04, 128.56, 128.37, 128.29, 128.04, 127.99, 126.45, 
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126.18, 103.44, 49.41, 45.44, 37.00. IR (cm-1): 1762, 1544, 1492, 1264, 732, 700; MS: HR-ESI 
calculated for [C24H17ClO2S+H]
+: 405.0711, found: 405.0719; mp: 166-169 °C; HPLC: (3% 
isopropanol/hexanes): Minor enantiomer:  19.78 min; Major enantiomer: 35.94 min; 93% ee; 
[α]
D
23= -1.5° (c= 0.61, CH2Cl2). 
1.85c:  Isolated as a white solid (39 mg, 74% yield) after chromatography 
(5% EtOAc/hexanes). 1H NMR (500 MHz, CDCl3): δ 8.02 (s, 2H), 7.82 (s, 
1H), 7.50 – 6.99 (m, 9H), 6.22 (d, J = 5.3 Hz, 1H), 4.68 (d, J = 8.1 Hz, 1H), 
4.20 (dd, J = 6.2 Hz, 1H), 3.63 (dd, J = 7.6 Hz, 1H); 13C NMR (125 MHz, 
CDCl3): δ 166.86, 147.70, 138.95, 135.32, 133.99, 133.63, 132.49 (q, J = 33.7 
Hz), 129.20, 128.69, 128.43, 128.31, 128.26, 127.96, 126.59, 124.91 (q, J = 3.8 Hz), 123.24 – 
122.82 (m), 123.17 (q, J = 273.0 Hz), 106.40, 49.26, 45.36, 37.00; IR (cm-1): 1773, 1384, 1278, 
1132, 899, 752, 698; MS: HR-ESI calculated for [C26H16F6O2S+Na]
+: 529.0667, found: 529.0709; 
mp: 187-190 °C; HPLC: (1% isopropanol/hexanes): Minor enantiomer: 9.761 min; Major 
enantiomer: 41.15 min; 96% ee; [α]
D
23= +0.39° (c= 0.14, CH2Cl2). 
1.85d:  Isolated as a white solid (41 mg, 69% yield) after chromatography (5% 
EtOAc/hexanes). 1H NMR (300 MHz, CDCl3): δ 7.61 (d, J = 8.9 Hz, 2H), 7.50 
(dd, J = 8.1, 1.6 Hz, 2H), 7.43 – 7.28 (m, 5H), 7.21 (td, J = 6.8, 1.9 Hz, 2H), 
6.92 (d, J = 8.9 Hz, 2H), 5.95 (d, J = 5.3 Hz, 1H), 4.78 (d, J = 8.1 Hz, 1H), 4.18 
(dd, J = 7.0, 5.3 Hz, 1H), 3.84 (s, 3H), 3.66 (dd, J = 8.1, 7.0 Hz, 1H; 13C NMR 
(125 MHz, CDCl3): δ 168.08, 160.76, 150.05, 139.44, 135.35, 134.85, 131.89, 129.07, 128.46, 
128.41, 128.19, 128.13, 127.83, 126.37, 114.15, 113.97, 100.97, 55.53, 49.58, 45.48, 37.00; IR 




+: 423.1025, found: 423.1063; mp: 122-125 °C; HPLC: (3% 
isopropanol/hexanes): Minor enantiomer: 34.388 min; Major enantiomer: 38.702 min; 98% ee; 
[α]
D
23= -0.98° (c= 1.03, CH2Cl2). 
1.85e:  Isolated as a light yellow solid (34 mg; 92% yield) after chromatography 
(50→80% EtOAc/hexanes). 1H NMR (500 MHz, CDCl3) δ 8.67 (d, J = 6.3 Hz, 
2H), 7.54 (d, J = 6.3 Hz, 2H), 7.49 (d, J = 6.9 Hz, 2H), 7.40 – 7.31 (m, 4H), 
7.29 – 7.26 (m, 2H), 7.21 (td, J = 7.4, 1.4 Hz, 1H), 6.34 (d, J = 5.3 Hz, 1H), 
4.74 (d, J = 8.2 Hz, 1H), 4.26 (dd, J = 7.0, 5.3 Hz, 1H), 3.69 (dd, J = 8.2, 7.1 Hz, 1H); 13C NMR 
(125 MHz, CDCl3) δ 167.06, 150.54, 148.09, 139.09, 139.03, 135.35, 133.77, 129.16, 128.64, 
128.39, 128.33, 128.17, 127.94, 126.54, 118.75, 106.83, 49.28, 45.41, 36.99; IR (cm-1): 1764, 
1596, 1410, 1265, 1242, 1166, 1072, 1041, 809, 732, 696. MS: HR-ESI calculated for 
[C23H17NO2S+H]
+: 372.1053, found: 372.1058; mp: 124-127 °C; HPLC: (30% 
isopropanol/hexanes): Major enantiomer:  24.98 min; Minor enantiomer: 32.19 min; 96% ee; 
[α]
D
23= -0.97° (c= 0.24, CH2Cl2). 
1.85f:  Isolated as a yellow oil (40 mg, 64% yield) after chromatography (5% 
EtOAc/hexanes). 1H NMR (500 MHz, CDCl3): δ 7.49 (dd, J = 7.5, 1.7 Hz, 2H), 
7.42 – 7.30 (m, 5H), 7.20 (td, J = 7.0, 1.7 Hz, 2H), 5.34 (d, J = 4.6 Hz, 1H), 
4.71 (d, J = 7.7 Hz, 1H), 3.95 (t, J = 6.3 Hz, 1H), 3.57 (t, J = 7.7 Hz, 1H), 2.00 (s, 3H); 13C NMR 
(125 MHz, CDCl3): δ 168.43, 149.94, 139.79, 135.49, 135.28, 129.05, 128.36, 128.35, 128.31, 
127.81, 127.77, 127.69, 126.38, 126.36, 102.78, 49.76, 45.83, 36.46, 18.80; IR (cm-1): 2923, 2853, 
1766, 1462, 1278, 1152, 1073, 749, 698;  IR (cm-1): 2923, 2853, 1766, 1462, 1278, 1152, 1073, 
749, 698; MS: HR-ESI calculated for [C19H16O2S+Na]
+: 331.0763, found: 331.0776; HPLC: 
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(0.25% isopropanol/hexanes): Minor enantiomer: 48.147 min; Major enantiomer: 69.56 min; 80% 
ee; [α]
D
23=-0.11° (c= 0.46, CH2Cl2). 
1.85g:  Isolated as a white solid (86 mg, 86% yield) after 
chromatography (5% EtOAc/hexanes). 1H NMR (500 MHz, CDCl3): δ 
7.92 (s, 2H), 7.77 (s, 1H), 7.65 – 7.53 (m, 2H), 7.53 – 7.32 (m, 4H), 
7.30 – 7.25 (m, 1H), 7.25 – 7.07 (m, 2H), 6.09 (d, J = 5.9 Hz, 1H), 4.76 
(d, J = 8.1 Hz, 1H), 4.15 (dd, J = 7.7, 5.9 Hz, 1H), 3.62 (dd, J = 8.0 Hz, 
1H); 13C NMR (125 MHz, CDCl3): δ 167.76, 151.00, 142.57, 135.46, 134.89, 132.47 (q, J = 33.7 
Hz), 131.57, 129.90, 129.06, 128.88, 128.79 – 128.60 (m), 128.22, 127.69, 127.42, 124.92, 123.20 
(q, J = 272.8 Hz), 122.70 – 122.26 (m), 101.49, 50.21, 46.34, 37.19; IR (cm-1): 2254, 1764,1378, 
1279, 1177, 1142, 904, 726; MS: HR-ESI calculated for [C26H16F6O2S+H]
+: 507.0848, found: 
507.0804; mp: 87-91 °C; HPLC: (3% isopropanol/hexanes): Minor enantiomer: 9.829 min; Major 
enantiomer: 12.077 min; 98% ee; [α]
D
23= -0.79° (c= 7.15, CH2Cl2). 
 1.85h:  Isolated as a clear oil (16 mg, 83% yield) after chromatography 
(5% EtOAc/hexanes). 1H NMR (300 MHz, CDCl3): 7.97 (s, 2H), 7.84 
(s, 1H), 7.46 – 7.35 (m, 1H), 7.34 – 7.11 (m, 3H), 5.41 (dq, J = 5.7, 1.0 
Hz, 1H), 4.74 (d, J = 8.1 Hz, 1H), 3.96 (t, J = 7.0 Hz, 1H), 3.58 (td, J = 
8.1, 0.8 Hz, 1H), 2.04 (d, J = 1.0 Hz, 3H); 13C NMR (125 MHz, CDCl3): 
168.21, 150.72, 142.86, 136.01, 135.04, 132.42 (q, J = 33.6 Hz), 130.12, 129.11, 128.72 (q, J = 
3.8 Hz), 128.02, 127.41, 127.37, 122.85 (q, J = 272.7 Hz), 122.36 (sept, J = 3.8 Hz), 50.37, 46.65, 




467.0511, found: 467.0537. HPLC: (0.25% isopropanol/hexanes): Minor enantiomer: 13.251 
min; Major enantiomer: 26.708 min; 92% ee; [α]
D
23= -0.42° (c= 0.1, CH2Cl2). 
 1.85i:  Isolated as a racemic, white solid from catalyst 18c (14 mg, 
79% yield) after chromatography (5% EtOAc/hexanes). 1H NMR (300 
MHz, CDCl3): δ 7.85 – 7.56 (m, 2H), 7.50 – 7.37 (m, 5H), 7.34 – 7.14 
(m, 4H), 6.90 (d, J = 8.8 Hz, 2H), 6.05 (dd, J = 5.0, 0.6 Hz, 1H), 4.74 
(d, J = 8.6 Hz, 1H), 4.23 (dd, J = 6.8, 5.0 Hz, 1H), 3.81 (s, 3H), 3.64 (dd, J = 8.4, 6.7 Hz, 1H; 13C 
NMR (125 MHz, CDCl3): δ 167.86, 159.71, 149.96, 135.42, 134.24, 131.90, 130.94, 129.62, 
129.56, 128.78, 128.31, 127.99, 127.88, 126.26, 124.88, 114.47, 103.36, 55.46, 49.32, 44.53, 
37.25; IR (cm-1): 1760, 1510, 1438, 1239, 1179, 1025, 826, 809, 753, 720, 685, 631, 537; MS: 
HR-ESI calculated for [C25H20O3S+Na]
+: 423.1025, found: 423.1060; mp: 157-160 °C dec. 
1.85j:  Isolated as a white solid (33 mg; 87% yield), after chromatography 
(5→15% EtOAc/hexanes). 1H NMR (500 MHz, CDCl3) δ 7.71 (dd, J = 7.9, 
1.8 Hz, 2H), 7.45 – 7.39 (m, 3H), 7.35 (d, J = 7.8 Hz, 1H), 7.24 (d, J = 7.5 
Hz, 1H), 7.19 (t, J = 7.3 Hz, 1H), 7.14 (t, J = 7.4 Hz, 1H), 6.13 (d, J = 5.8 Hz, 
1H), 3.91 (t, J = 6.5 Hz, 1H), 3.68 (dd, J = 7.2, 5.1 Hz, 1H), 3.41 (t, J = 7.2 Hz, 1H), 2.06 – 1.96 
(m, 1H), 1.86 – 1.77 (m, 3H), 1.76 – 1.67 (m, 2H), 1.36 – 1.18 (m, 5H); 13C NMR (125 MHz, 
CDCl3) δ 169.13, 150.63, 136.00, 135.13, 131.98, 129.56, 129.23, 128.76, 127.74, 127.25, 126.23, 
124.89, 102.74, 47.84, 45.43, 42.09, 36.91, 31.26, 29.51, 26.54, 26.41, 26.37; IR (cm-1): 1759, 
1445, 1278, 1136, 1063, 759, 689, 597. MS: HR-ESI calculated for [C24H24O2S+H]
+: 377.1570, 
found: 377.1573; mp: 116-119 °C; HPLC: (0.20% isopropanol/hexanes): Major enantiomer:  
36.78 min; Minor enantiomer: 47.47 min; 99% ee; [α]
D
23= -1.7° (c= 0.87, CH2Cl2). 
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1.85k:  Isolated as a clear oil (79 mg, 67% yield), after chromatography (5% 
EtOAc/hexanes). 1H NMR (500 MHz, CDCl3): δ 7.36 – 7.29 (m, 1H), 7.23 
– 7.08 (m, 3H), 5.35 (d, J = 5.7 Hz, 1H), 3.71 – 3.59 (m, 1H), 3.59 (dd, J = 
5.5 Hz, 1H), 3.29 (t, J = 7.4 Hz, 1H), 2.02 (s, 3H), 1.98 – 1.63 (m, 7H), 1.40 
– 0.71 (m, 7H); 13C NMR (125 MHz, CDCl3): δ 169.62, 150.18, 136.46, 135.12, 129.22, 127.52, 
127.05, 126.13, 102.67, 48.08, 45.42, 42.03, 36.32, 31.31, 29.63, 26.56, 26.44, 26.40, 18.79; IR 
(cm-1): 2925, 1763, 1702, 1445, 1148, 472, 451, 432; MS: HR-ESI calculated for 
[C19H22O2S+Na]
+: 337.1233, found: 337.1236; HPLC: (0.25% isopropanol/hexanes): Minor 
enantiomer: 16.581 min; Major enantiomer: 21.232 min; 96% ee; [α]
D
23= -0.97° (c= 1.93, CH2Cl2). 
1.96:  Isolated as a white amorphous solid (50 mg, 81% yield) after 
chromatography (5% EtOAc/hexanes). 1H NMR (500 MHz, CDCl3): δ 
8.00 (s, 2H), 7.94 (s, 1H), 7.72 (s, 1H), 7.70 (s, 2H),  7.60 (dd, J = 8.0, 
1.1 Hz, 1H), 7.45 (dd, J = 7.8, 1.3 Hz, 1H), 7.39 (td, J = 7.3, 1.3 Hz, 1H), 
7.30 (td, J = 8.0, 1.4 Hz, 1H), 5.69 (dd, J = 12.3, 3.6 Hz, 1H), 5.69 (s, 
1H),  3.54 (dd, J = 18.0, 3.6 Hz, 1H), 2.92 (ddd, J = 18.0, 12.3, 0.7 Hz, 
1H); 13C NMR (125 MHz, CDCl3): δ 164.03, 145.18, 143.41, 140.71, 133.03, 132.37 (q, J = 33.7 
Hz),  132.17, 132.10 (q, J = 33.4 Hz), 129.49, 128.89, 127.32, 127.07 – 127.04 (m), 126.81, 126.59 
– 126.56 (m), 123.15 (q, J = 272.9 Hz), 123.12 (sept, J = 3.7 Hz), 122.02 (sept, J = 3.8 Hz), 119.82, 
76.55, 37.06, 32.95; IR (cm-1): 1715, 1372, 1278, 1134; MS: HR-ESI calculated for 
[C28H14F12O2S+H]
+: 643.0596, found: 643.0547; HPLC: (1% isopropanol/hexanes): Major 
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1 133.03     3, 5, 9  
2 128.89 
7.45 (dd, J = 7.8, 
1.3 Hz, 1H) 
3, 4 3, 4, 5 2 3  
3 126.81 
7.30 (td, J = 8.0, 
1.4 Hz, 1H) 
2, 4 2, 4, 5 3 2, 4  
4 132.17 
7.39 (td, J = 7.3, 
1.3 Hz, 1H) 
3, 5 2, 3, 5 4 5  
5 127.32 
7.60 (dd, J = 8.0, 
1.1 Hz, 1H) 
3, 4 2, 3, 4 5 4 16’ 
6 129.49     2, 4  
7 145.18     
5, 9, 16, 
16’, 17 
 
8 119.82     9, 16, 16’  
9 37.06 5.69 (s, 1H)   9 11  
10 143.41     9  
11 
127.07 – 127.04 
(m) 
7.70 (s, 2H)   11   
12 
132.37 (q, J = 
33.7 Hz) 
      
13 
122.02 (sept, J 
= 3.8 Hz) 
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1H (ppm), 


















123.15 (q, J = 
272.9 Hz) 
    11, 13  
15 164.03       
16 32.95 
2.92 (ddd, J = 18.0, 
12.3, 0.7 Hz, 1H) 
16’, 17 16’, 17 16  16 
16’ 32.95 
3.54 (dd, J = 18.0, 
3.6 Hz, 1H) 
16, 17 16, 17 16  5, 16 
17 76.55 
5.69 (dd, J = 12.3, 
3.6 Hz, 1H) 
 19 17 16, 19  
18 140.71     16  
19 
126.59 – 126.56 
(m) 
8.00 (s, 2H)  17 19 17  
20 
132.10 (q, J = 
33.4 Hz) 
      
21 
123.12 (sept, J 
= 3.7 Hz) 
7.94 (s, 1H)   21 19  
22 
123.15 (q, J = 
272.9 Hz) 










1.5.23 Methanolysis of thiochromane product 1.85g. 
 
A solution of substrate 1.84g (122 mg, 0.24 mmol) and DHPB (10 mol%) in freshly distilled 
chloroform (0.2 M in the substrate) was stirred at room temperature under argon for 48h. Methanol 
(2 mL) was added and the mixture was stirred for an additional 48h. The reaction mixture was 
concentrated under reduced pressure and chromatographed (5% EtOAc/hexanes) to give 1.89 as a 
yellow oil (84 mg, 77%). 1H NMR (600 MHz, CDCl3): δ 7.92-7.91 (m, 2H), 7.89 (s, 2H), 7.79 (s, 
1H), 7.55 (dd, J = 7.4, 1.3 Hz, 1H), 7.46 – 7.43 (m, 2H), 7.38 (dd, J = 7.7, 1.4 Hz, 1H), 7.22 – 7.17 
(m, 2H), 7.09 (td, J = 7.3, 1.5 Hz, 1H), 4.98 (d, J = 11.8 Hz, 1H), 4.27 – 4.24 (m, 1H), 3.59 (dd, J 
= 17.4, 4.5 Hz, 1H), 3.56 (s, 3H), 3.54 (dd, J = 17.4, 4.5 Hz, 1H), 3.22 (dd, J = 11.8, 2.9 Hz, 1H); 
13C NMR (125 MHz, CDCl3): δ 197.43, 172.2, 143.97, 136.91, 136.90, 133.46, 132.06 (q, J = 
33.5 Hz), 131.27, 130.13, 128.86 – 128.84 (m), 128.77, 128.18, 128.11, 126.39, 125.46, 123.23 
(q, J = 272.8 Hz), 122.17 – 122.12 (m), 52.62, 50.50, 43.29, 38.05, 37.80; IR (cm-1): 1731, 1686, 





1.5.24 Computational studies. 
Geometry optimization of the structures of all the catalysts shown in Figure 1 and the 
corresponding N-acetyl cations was performed at the B3LYP/6-31G* level of theory49 using a 
nonpolar solvent model. Single point energies calculations were then conducted on the lowest 
energy conformer identified in each case at B3LYP/6-311+G(2d,p) level of theory. The results are 







ΔHAc (Cat) = 
ΔH[Cat-Ac+] – ΔH[Cat] 
(a.u.) 
ΔHAc(rel) = 
ΔHAc (Cat) – ΔHAc (9a) 
a.u. Kcal/mol 
1.63a -894.961284 -1048.11526 -153.153976 0 0 
1.63b -1009.52043 -1162.67717 -153.15674 -0.002764 -1.73441 
1.63c -1028.96613 -1182.12592 -153.15979 -0.005814 -3.648285 
1.63d -1106.41125 -1259.57217 -153.16092 -0.006944 -4.35736 
1.63e -1240.42151 -1393.58722 -153.16571 -0.011734 -7.363085 
1.90a -972.381199 -1125.54239 -153.161191 -0.007215 -4.5274125 
1.90b -1086.94349 -1240.10576 -153.16227 -0.008294 -5.204485 
1.90c -1106.39051 -1259.55441 -153.1639 -0.009924 -6.22731 
1.90d -1183.83625 -1337.0004 -153.16415 -0.010174 -6.384185 
1.91a -933.047734 -1086.20824 -153.160506 -0.00653 -4.097575 
1.91b -1047.61014 -1200.77175 -153.16161 -0.007634 -4.790335 
1.91c -1067.05721 -1220.2209 -153.16369 -0.009714 -6.095535 
1.91d -1144.50315 -1297.66699 -153.16384 -0.009864 -6.18966 
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Chapter 2: Fused Imidazoline Ligands 
2.1 Introduction. 
 Asymmetric catalysis using chiral metal complexes is a fundamentally important area of 
organic synthesis. Synthetic chiral catalysts can exhibit good levels of enantioselectivities for a 
broad range of substrates, and both enantiomers can be accessed depending on the chirality of the 
catalyst. Dubbed “privileged,” certain classes of synthetic catalysts even retain their 
enantioselectivities across a broad range of reactions. Privileged chiral ligands (Figure 2.1) offer 
effective asymmetric environments for mechanistically different metal-catalyzed reactions.1 
Despite the wide range of known catalysts, there are still many important synthetic transformations 
that have no asymmetric alternative. 
 




2.2  New ligand design. 
 Over the last decade, our group has developed amidine-based catalysts (ABCs) in the field 
of organocatalysis (Figure 2.2).10 These catalysts have proven to be highly effective for 
enantioselective acyl transfer reactions.11 Seeking to diversify our asymmetric catalysis portfolio, 
we envisioned a new chiral ligand for metal catalysis using a fused-imidazoline moiety. 
 
Figure 2.2: Evolution of amidine-based catalyst design in our group. 
 Of the above mentioned privileged ligands, Bis(oxazoline) ligands (BOX) (2.3) served as 
our primary inspiration for our design due to their ability to coordinate with a wide range of metals 
and their C2-axis, a feature that has shown to be valuable in designing asymmetric processes due 
to the equivalency of structures upon rotation by 180o reducing the number of possible transition 
states. Furthermore, the reliable mechanistic understanding of BOX-metal complexes in many 
asymmetric processes corroborated by X-ray structure analysis provides insight into how these 
and similar ligands operate.12 
 One design feature that we sought to improve upon from BOX ligand was the electronic 
tunability of the donor nitrogen atoms of the ligand. Despite a report by Nishiyama13 demonstrating 
that electronic control of PyBOX 2.4a-e (Figure 2.3) affects the catalytic activity and 
enantioselectivity in PyBOX-Rhodium catalyzed cyclopropanation, relatively little exploration 
into the electronic effects on BOX ligands have been explored possibly due to the synthetic 
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difficulty of introducing in conjugation with the donor nitrogen atoms. Evans et al.14 disclosed that 
para electron-donating or -withdrawing groups had only a slight effect on hetero-Diels-Alder 
reactions catalyzed by BOX-metal complexes (2.3a-c). This was unsurprising since the remote 
electronic changes in the phenyl groups were not in conjugation with the donor nitrogen atoms. 
Pagenkopf et al.15 disclosed an m-(tert-butyl)-o-methoxyphenyl BOX ligand (2.3e) that showed 
improved performance in an asymmetric aldol reaction. This improvement in enantioselectivity 
can most likely be attributed to steric factors rather than electronic factors since removing the m-
(tert-butyl) group severely diminishes the ee. Beginning in 2005, Burke et al. explored a series of 
BOX ligands with conjugation to the donor nitrogens. First, they reported isobutylene 
bis(oxazoline) (IsBut-BOX 2.12)16 with an isopropylidene in place of the gem-dimethyl groups 
resulting in poor ee in cyclopropanation. Further modification led them to synthesize 
bis(oxazolines) with an arylidene bridging unit (Arylid-BOX 2.13a-e)17 that contained either ortho 
or para electron-donating and -withdrawing groups. This new design produced up to 89% ee with 
modest yields and only slight effects observed by electronic changes in the ligand most likely due 




Figure 2.3: Electronic tuning of PyBOX and BOX ligands. 
  With the added factor of electronic tunability in mind, we looked to Cl-PIQ (2.9)10b as a 
building block for designing new chiral ligands due to its efficacy and synthetic accessibility. We 
envisioned that aldehyde 2.14 could serve as a key intermediate to a variety of chiral ligands for 
metal catalysis with electronic tuning groups (R1 and R2) shown in Figure 2.4. In our proposed 
design, the aldehyde gives the added synthetic flexibility of varying the denticity as well as the 
types of donor atoms and groups in potential ligands (Figure 2.5).   
 




Figure 2.5: Proposed synthetic transformations of key aldehyde 2.14.  
 Prior to our work, few examples of asymmetric reactions using ligands containing a fused-
imidazoline moiety were reported in the literature. In 2011, Deng et al.18 reported a planar chiral 
Ferrocene ligand 2.24 combining the structures of Fu’s planar chiral DMAP catalyst (2.23)19 and 
our CF3-PIP catalyst (2.8)
10a shown in Figure 2.6. The complex, new N,O-ligand (2.24) relies on 
both planar chirality and a chiral carbon next to the nitrogen donor atom to achieve up to 95% ee 




Figure 2.6: Deng’s planar chiral N,O-ligand. 
2.2.1  Synthesis of key aldehyde intermediate. 
 Our first objective was to develop a flexible synthetic scheme to produce aldehyde 2.14 
with various substituents. Basing our synthesis on Cl-PIQ and other ABCs from our lab,10 we 
began by testing a series of amino alcohols (2.25) in a nucleophilic aromatic substitution on 
chloroaldehyde 2.26 followed by mesylation and spontaneous cyclization shown in Figure 2.7. 
Summarized in Table 2.1, the initial nucleophilic aromatic substitution proceeded with poor to 
moderate yields to give yellow, crystalline amino aldehyde 2.27 for all amino alcohols tested 
except trans-1-amino-2-indanol. Shown in Table 2.2, the subsequent cyclization with mesyl 
chloride occurred spontaneously with near quantitative yields to give the cyclized aldehyde (2.14) 
as a deep red product.  
 
Figure 2.7: Synthesis of key aldehyde intermediate. 
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Table 2.1: Nucleophilic aromatic substitution of 2.26.a 
 
entry product R1 R2 yield, % 
1 2.27a H H 63 
2 2.27b Me Me 20 
3 2.27c i-Pr H 75 
4 2.27d Ph H 9 
5 2.27e H CHPh2 32 

















Table 2.2: Cyclization of 2.27.a 
 
entry product R1 R2 yield, % 
1 2.14a H H 89 
2 2.14b Me Me 84 
3 2.14c i-Pr H 99 
4 2.14d Ph H 71 
5 2.14e H CHPh2 95 
6 2.14f t-Bu H 93 
aConditions: 1.0 equivalent 2.27, 1.5 equivalent MsCl, 3.0 equivalent NEt3, CDCl3 (0.1 M), 0 
oC 
to rt, 1 h 
2.2.2 Fused imidazoline imine ligand design. 
 With aldehyde 2.14 in hand, we turned our attention to converting the aldehyde moiety to 
a group that would transform 2.14 into a ligand for metal catalysis. Rather than attempting to create 
a ligand with pseudo-C2-symmetry, our initial design was a fused imidazoline imine ligand (2.29) 
derived from anilines with ortho substituents orthogonal to the plane of the fused imidazoline 
moiety. These ortho groups function to block an entire face of the ligand-metal complex limiting 
the desired transition states to one rather than two due to a lack of equivalency of structures as 
observed in BOX ligands with a C2-axis (Figure 2.8).
12 The new ligands (2.29) were easily 




Figure 2.8: Synthesis of fused imidazoline imine ligand and comparison to BOX ligand. 
2.3  Evaluation of ligand in the Henry reaction. 
2.3.1 Optimization of chiral ligand. 
 To evaluate the efficacy of the new ligands (2.29), we selected the asymmetric Henry 
reaction between nitromethane and an aldehyde (2.30) catalyzed by Cu(II) salts which had been 
previously shown by Evans to proceed with excellent enantioselectivity in the presence of BOX 
ligands.20 A series of fused imidazoline imine ligands (2.29) were tested in the Henry reaction of 
benzaldehyde (2.30a) to produce nitroalkanol 2.31a summarized in Table 2.3. Varying the imine 
group only (entries 1-4), o-isopropyl groups (2.29b) produced the best combination of yield and 
enantioselectivity. Bulkier (diphenyl)methyl groups (2.29c-d) shut down the reactivity of the 
resulting copper complexes giving poor yields without an improvement in enantioselectivity.  
Keeping the o-isopropyl groups constant and varying the chiral group only (entries 2, 5-7), 
isopropyl and (diphenyl)methyl groups (2.29b and 2.29f) produced comparable but modest yields 
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and enantioselectivities. Poor yield and enantioselectivity were observed when a phenyl group 
(2.29e) was used. Finally, a ligand with a tert-butyl group (2.29g) produced the best 
enantioselectivity (82% ee) while maintaining a similar yield (55%). 
Table 2.3: Chiral ligand survey.a 
 
entry ligand R1 R2 R3 R4 R5 yield, % ee, % 
1 2.29a i-Pr H Me Me Me 42 65 
2 2.29b i-Pr H i-Pr i-Pr H 58 75 
3 2.29c i-Pr H Me CHPh2 Me 23 71 
4 2.29d i-Pr H CHPh2 CHPh2 Me 6 74 
5 2.29e Ph H i-Pr i-Pr H 36 44 
6 2.29f H CHPh2 i-Pr i-Pr H 60 -73 
7 2.29g t-Bu H i-Pr i-Pr H 55 82 
aConditions: 1 mmol 2.30a, 10 mmol MeNO2, 0.055 mmol 2.31a-g, 0.05 mmol Cu(OAc)2∙H2O, 
1.5 mL absolute ethanol, 24 h. 
 
2.3.2 Optimization of reaction conditions. 
 With improving the enantioselectivity of the reaction in mind, we proceeded to vary the 
reaction conditions with our best ligand (2.29g) as shown in Table 2.4. Using isopropanol as the 
solvent produced a poor yield with only a slight improvement in enantioselectivity (entry 1). 
Surprisingly, reducing the temperature produced an even worse ee to go with the expected drop in 
yield over the same reaction time (entry 2). Varying the counter ion of the copper salt produced a 
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slight improvement in enantioselectivity (entries 3-4), but only the pivalate also maintained the 
previously achieved yields. Ultimately, we decided to proceed with the original reaction conditions 
(Table 2.3) for the remaining studies due to the only modest improvements in enantioselectivity 
and the commercial availability of copper acetate salts. 
 Table 2.4: Optimization of reaction conditions.a 
 
entry Cu salt solvent temperature, oC yield, % ee, % 
1 Cu(OAc)2∙H2O i-PrOH 23 32 86 
2 Cu(OAc)2∙H2O i-PrOH 0 18 76 
3 Cu(OPiv)2 EtOH 23 61 86 
4 Cu(O(4-Cl-Bz))2 EtOH 23 15 86 
aConditions: 1 mmol 2.30a, 10 mmol MeNO2, 0.055 mmol 2.29g, 0.05 mmol Cu salt, 1.5 mL 
solvent, 24 h. 
2.3.3 Exploration of substrate scope. 
 Shown in Figure 2.9, a limited series of aromatic aldehydes were subjected to nitromethane 
in the presence of copper-ligand 2.29g complex. Ortho substituents (2.31b-c) drastically 
diminished the yields of the reaction while only the o-methoxy substrate reduced the ee (2.31c).  





Figure 2.9: Substrate scope. 
2.4 Conclusions and future directions. 
 Our results thus far with the asymmetric Henry reaction indicate that our fused imidazoline 
ligand design could serve as a promising ligand in asymmetric reactions catalyzed by metal-
complexes. Intriguingly, our imine ligands (2.29) with a simple blocking group on the aniline 
compared favorably in enantioselectivity to BOX ligands with the same chiral groups. Evans 
achieved the highest enantioselectivities (up to 94%) with indanyl BOX ligand.20 Unfortunately, 
efforts to synthesize indanyl substituted ligands were unsuccessful with our current methods. 
Additionally, electronically tuned derivatives of our ligand design have yet to be fully explored. 
Ms. Masha Elkin investigated the synthesis of some methoxy substituted ligands but found the 
nucleophilic aromatic substitution to form complex mixtures. Perhaps, a more rigorous exploration 
of conditions to form 2.27 including metal catalyzed couplings is needed to fully develop our ideas.  
 In the future development of these ligands, electronic tuning and variation of the donor 
group derived from the aldehyde moiety of 2.14 as outlined in Figure 2.5 would be interesting to 





All reagents were obtained commercially and used as received unless specified otherwise.  
Cu(OPiv)2 and Cu(O(4-Cl-Bz))2 were prepared following a literature procedure.
21 Chloroform and 
dichloromethane were freshly distilled from calcium hydride. Solvents used for chromatography 
were ACS or HPLC grade, as appropriate. Reactions were carried out under argon and monitored 
by thin layer chromatography (TLC) and by 1H NMR. Uniplate HLF (250 μm) silica gel plates 
were used for TLC analyses. Flash column chromatography was performed over Sorbent 
Technologies silica gel (40-63 mm). HPLC analyses were performed on a Shimadzu LC system 
using Chiralcel OD-H, analytical chiral stationary phase column (4.6x250 mm, Chiral 
Technologies, Inc.) with UV detectors at 254 nm and 204 nm and a 1.0 mL/min flow rate. 1H and 
13C NMR spectra were recorded on a Mercury 300 MHz and DD2 500 MHz Agilent spectrometer.  
The chemical shifts are reported as values (ppm) relative to TMS using residual CHCl3 peak 
(7.26 ppm) as the reference. Melting points were measured on a Stuart SMP10 melting point 
apparatus. High-Resolution mass spectral analyses were performed at Washington University MS 
Center on a Bruker MaXis QTOF mass spectrometer using Electrospray Ionization (ESI) and 
Electron Impact (EI) methods.22 Infrared spectra were recorded on a Bruker Alpha Platinum-ATR. 
Optical rotations were determined on a Rudolph Autopol III polarimeter.  
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2.5.1 Preparation of amino aldehydes 2.27. 
 
To a pressure tube with stir bar, was added 2-chloro-3-quinolinecarboxaldehyde23 (1.0 equiv) 
followed by DIPEA (1 equiv) and the requisite amino alcohol (2.1 equiv). The resulting 
heterogeneous mixture was flushed with Argon and stirred for a 24 h at 120 °C. The crude mixture 
was washed with 1 M HCl, basified with 2 M NaOH, then extracted with dichloromethane and 
dried with sodium sulfate.  The evaporation residue was chromatographed with dichloromethane 
to afford the 2-amino-3-quinolinecarboxaldehyde 2.20.   
2-((2-hydroxyethyl)amino)quinoline-3-carbaldehyde (2.27a): Isolated as a yellow solid (355 
mg; 63% yield,) after chromatography (dichloromethane).  1H NMR 
(300 MHz, CDCl3): δ 10.00 (s, 1H), 8.48 (broad s, 1H), 8.30 (s, 1H), 
7.76 – 7.64 (m, 3H), 7.35 – 7.25 (m, 1H), 5.59 (broad s, 1H), 4.00 – 3.91 (m, 2H), 3.90 – 3.80 (m, 
2H); 13C NMR (75 MHz, CDCl3): δ 192.83, 155.65, 149.76, 148.99, 134.06, 129.30, 125.81, 
123.14, 122.06, 117.70, 64.46, 45.16; IR (cm-1): 3341, 2952, 1663, 1618, 1575, 1537, 1467, 1393, 
1345, 1169, 1077, 1051, 760, 729, 602, 552, 480, 423; MS: HR-ESI calculated for 
[C12H12N2O2+H]
+: 217.0972, found: 217.0977; mp  93-95 °C.  
2-((1-hydroxy-2-methylpropan-2-yl)amino)quinoline-3-carbaldehyde (2.27b): Isolated as a 
yellow solid (127 mg; 20% yield) after chromatography 
(dichloromethane). 1H NMR (300 MHz, CDCl3) δ 9.96 (s, 1H), 8.38 
(broad s, 1H), 8.29 (s, 1H), 7.92 (broad s, 1H), 7.73 – 7.60 (m, 3H), 7.33 – 7.22 (m, 1H), 3.75 (s, 
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2H), 1.51 (s, 6H); 13C NMR (75 MHz, CDCl3) δ 192.89, 153.85, 149.73, 148.93, 134.20, 129.27, 
125.34, 123.18, 121.63, 118.08, 71.63, 57.00, 25.35; IR (cm-1): 3333, 3309, 2962, 2919, 2850, 
1670, 1619, 1536, 1395, 1271, 1157, 1120, 1056, 923, 864, 779, 758, 727, 603, 553, 484, 424; 
MS: HR-ESI calculated for [C14H16N2O2+H]
+: 245.1285, found: 245.1289; mp 129-132 °C. 
(S)-2-((1-hydroxy-3-methylbutan-2-yl)amino)quinoline-3-carbaldehyde (2.27c): Isolated 
as a yellow solid (1.01 g; 75% yield) after chromatography (dichloromethane). 
1H NMR (300 MHz, CDCl3) δ 10.00 (s, 1H), 8.40 (broad d, J = 5.9 Hz, 1H), 
8.29 (s, 1H), 7.73 – 7.57 (m, 3H), 7.29 – 7.21 (m, 1H), 5.90 (broad s, 1H), 4.13 
– 4.02 (m, 1H), 3.94 (dd, J = 10.9, 2.1 Hz, 1H), 3.78 (dd, J = 10.9, 7.9 Hz, 1H), 2.13 (octet, J = 6.9 
Hz, 1H), 1.08 (dd, J = 6.9, 2.1 Hz, 6H); 13C NMR (75 MHz, CDCl3) δ 193.05, 155.86, 149.82, 
149.21, 134.11, 129.33, 125.79, 123.07, 122.04, 117.77, 67.28, 60.56, 30.15, 19.85, 18.53; IR (cm-
1): 3343, 3289, 2965, 2875, 1671, 1617, 1576, 1535, 1402, 1275, 1167, 1120, 1054, 869, 777, 756, 
728, 604, 579, 479, 452; MS: HR-ESI calculated for [C15H18N2O2+H]
+: 259.1441, found: 
259.1457; mp 156-158 °C; [α]
D
23= -0.64° (c= 0.38, CH2Cl2). 
(S)-2-((2-hydroxy-1-phenylethyl)amino)quinoline-3-carbaldehyde (2.27d): Isolated as a 
yellow solid (67 mg; 9% yield) after chromatography 
(dichloromethane). 1H NMR (300 MHz, CDCl3) δ 9.98 (s, 1H), 8.70 
(broad d, J = 5.7 Hz, 1H), 8.29 (s, 1H), 7.84 – 7.59 (m, 3H), 7.56 – 7.19 
(m, 6H), 5.49 (ddd, J = 7.3, 5.7, 3.6 Hz, 1H), 4.06 (dd, J = 11.5, 7.3 Hz, 1H), 4.01 (dd, J = 11.5, 
3.6 Hz, 1H); 13C NMR (125 MHz, CDCl3) δ 192.91, 155.07, 149.84, 149.03, 139.86, 134.08, 
129.32, 129.16, 128.04, 126.88, 126.10, 123.31, 122.26, 117.74, 69.57, 59.23; IR (cm-1): 3332, 
3266, 2916, 2866, 1668, 1620, 1572, 1524, 1398, 1168, 1058, 752, 739, 694, 583, 448; MS: HR-
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ESI calculated for [C18H16N2O2+H]
+: 293.1285, found: 293.1295; mp 123-125°C; 
[α]
D
23= +1.04° (c= 0.35, CH2Cl2). 
(R)-2-((3-hydroxy-1,1-diphenylpropan-2-yl)amino)quinoline-3-carbaldehyde (2.27e): 
Prepared from 2.18e.24 Isolated as a yellow solid (195 mg; 32% yield) after 
chromatography (dichloromethane). 1H NMR (300 MHz, CDCl3) δ 9.80 (s, 
1H), 8.23 (broad s, 1H), 8.20 (s, 1H), 7.86 – 7.57 (m, 3H), 7.59 – 7.01 (m, 
11H), 5.46 (broad s, 1H), 5.20 – 5.07 (m, 1H), 4.39 (d, J = 10.6 Hz, 1H), 
3.97 (dd, J = 11.1, 2.2 Hz, 1H), 3.72 (dd, J = 11.1, 6.6 Hz, 1H); 13C NMR (75 MHz, CDCl3) δ  
192.40, 148.99, 141.51, 134.08, 129.33, 129.01, 128.76, 128.57, 128.29, 127.00, 126.90, 126.02, 
123.28, 117.72, 66.63, 58.01, 53.30, 19.85, 18.53; IR (cm-1): 3309, 3060, 3029, 2958, 1660, 1619, 
1577, 1538, 1489, 1400, 1163, 1041, 752, 701, 603, 565, 472; MS: HR-ESI calculated for 
[C25H22N2O2+H]
+: 383.1754, found: 383.1768; mp  162-165 °C; [α]
D
23= -1.04° (c= 0.74, CH2Cl2). 
(S)-2-((1-hydroxy-3,3-dimethylbutan-2-yl)amino)quinoline-3-carbaldehyde (2.27e): 
Isolated as a yellow solid (650 mg; 46% yield) after chromatography 
(dichloromethane). 1H NMR (300 MHz, CDCl3) δ 10.02 (s, 1H), 8.53 (broad 
d, J = 6.4 Hz, 1H), 8.29 (d, J = 0.7 Hz, 1H), 7.76 – 7.56 (m, 3H), 7.30 – 7.21 
(m, 1H), 4.19 – 4.11 (m, 2H), 3.71 (dd, J = 11.2, 8.8 Hz, 1H), 1.13 (s, 9H); 13C NMR (125 MHz, 
CDCl3) δ 193.12, 156.22, 149.92, 149.20, 134.11, 129.33, 125.82, 123.02, 122.07, 117.72, 66.22, 
63.71, 33.62, 27.22; IR (cm-1): 3338, 2964, 2886, 2870, 2852, 1668, 1620, 1579, 1538, 1398, 1368, 
1165, 1122, 1043, 861, 757, 728, 582, 450; MS: HR-ESI calculated for [C16H20N2O2+H]
+: 
273.1598, found: 273.1602; mp  85-87 °C; [α]
D




2.5.2 Preparation of cyclized aldehydes 2.14. 
 
A solution of 2.27 (1.0 equiv) in chloroform (0.1 M)  was cooled to 0 oC and treated with 
triethylamine (3.0 equiv) followed by mesyl chloride (1.5 equiv) and stirred for 1h. The resulting 
deep red solution was quenched with water was washed with saturated Na2CO3 then extracted with 
dichloromethane and dried with sodium sulfate. The evaporation residue was dissolved in a 
minimal amount of dichloromethane, precipitated with hexane, and vacuum filtered to give 2.14. 
2.14 can also purified by column chromatography on silica gel (5% i-PrOH, 1% NEt3/hexanes).  
1,2-dihydroimidazo[1,2-a]quinoline-4-carbaldehyde (2.14a): Isolated as a red amorphous 
solid (491 mg; 89% yield,).  1H NMR (300 MHz, CDCl3): δ 10.11 (s, 1H), 7.77 
(s, 1H), 7.45 – 7.35 (m, 2H), 6.93 (t, J = 7.5 Hz, 1H), 6.67 (d, J = 8.2 Hz, 1H), 
4.13 (t, J = 10.2 Hz, 2H), 3.89 (t, J = 10.2 Hz, 2H); 13C NMR (125 MHz, CDCl3): δ 188.83, 154.88, 
141.67, 141.25, 134.02, 131.25, 123.42, 120.82, 119.46, 112.04, 53.79, 45.47; IR (cm-1): 2945, 
2927, 2873, 1688, 1629, 1572, 1554, 1455, 1273, 1210, 749, 514; MS: HR-ESI calculated for 
[C12H10N2O+H]
+: 199.0866, found: 199.0863.  
2,2-dimethyl-1,2-dihydroimidazo[1,2-a]quinoline-4-carbaldehyde (2.14b): Isolated as a red 
amorphous solid (135 mg; 84% yield). 1H NMR (300 MHz, CDCl3) 10.16 (s, 
1H), 7.88 (s, 1H), 7.57 – 7.27 (m, 2H), 6.94 (t, J = 7.6 Hz, 1H), 6.72 (d, J = 8.5 
Hz, 1H), 3.65 (s, 2H), 1.39 (s, 6H); 13C NMR (125 MHz, CDCl3) δ 189.06, 
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152.04, 141.21, 141.01, 134.00, 131.37, 122.84, 121.09, 119.57, 112.26, 66.03, 57.91, 29.86; IR 
(cm-1): 2966, 2925, 2867, 1689, 1625, 1554, 1456, 1277, 1197, 751, 727, 536; MS: HR-ESI 
calculated for [C14H14N2O+H]
+: 227.1179, found: 227.1187. 
(S)-2-isopropyl-1,2-dihydroimidazo[1,2-a]quinoline-4-carbaldehyde (2.14c): Isolated as a 
red amorphous solid (479 mg; 99% yield). 1H NMR (300 MHz, CDCl3) δ 
10.25 (s, 1H), 7.85 (s, 1H), 7.47 – 7.41 (m, 2H), 6.96 (dd, J = 7.5 Hz, 1H), 
6.73 (d, J = 8.5 Hz, 1H), 4.23 – 4.15 (m, 1H), 3.91 (dd, J = 10.7 Hz, 1H), 3.61 
(dd, J = 10.7, 8.4 Hz, 1H), 1.94 (octet, J = 6.7 Hz, 1H), 1.06 (d, J = 6.7 Hz, 3H), 0.96 (d, J = 6.7 
Hz, 3H); 13C NMR (125 MHz, CDCl3) δ 189.30, 154.09, 141.21, 140.73, 133.98, 131.49, 123.12, 
121.01, 119.77, 112.14, 71.12, 48.01, 33.61, 18.92, 17.86; IR (cm-1): 2956, 2929, 2870, 1689, 
1627, 1609, 1570, 1554, 1526, 1455, 1421, 1375, 1314, 1269, 1209, 1153, 1023, 951, 920, 750, 
534; MS: HR-ESI calculated for [C15H16N2O+H]
+: 241.1335, found: 241.1341; 
[α]
D
23= -3.01° (c= 0.34, CH2Cl2). 
(S)-2-phenyl-1,2-dihydroimidazo[1,2-a]quinoline-4-carbaldehyde (2.14d): Isolated as a red 
amorphous solid (311 mg; 71% yield). 1H NMR (300 MHz, CDCl3) δ 10.32 (s, 
1H), 7.93 (s, 1H), 7.48 – 7.26 (m, 7H), 6.99 (dd, J = 7.6, 0.9 Hz, 1H), 6.70 (d, 
J = 8.2 Hz, 1H), 5.46 (dd, J = 11.5, 8.4 Hz, 1H), 4.36 (dd, J = 11.5, 10.4 Hz, 
1H), 3.84 (dd, J = 11.5, 8.4 Hz, 1H); 13C NMR (125 MHz, CDCl3) δ 189.08, 155.05, 143.97, 
141.01, 140.50, 133.93, 131.47, 128.87, 127.59, 126.77, 123.12, 121.10, 119.78, 112.11, 68.59, 
53.57; IR (cm-1): 1690, 1627, 1554, 1494, 1455, 1268, 1209, 1174, 908, 727, 552; MS: HR-ESI 
calculated for [C18H14N2O+H]
+: 275.1179, found: 275.1186; [α]
D
23= -3.72° (c= 1.42, CH2Cl2). 
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(R)-2-benzhydryl-1,2-dihydroimidazo[1,2-a]quinoline-4-carbaldehyde (2.14e): Isolated as a 
red solid (202 mg; 95% yield). 1H NMR (500 MHz, CDCl3) δ 10.20 (s, 1H), 
7.83 (s, 1H), 7.45 – 7.07 (m, 15H), 6.93 (td, J = 7.5, 1.0 Hz, 1H), 6.59 (d, J 
= 8.2, 1H), 5.20 (ddd, J = 10.6, 8.9, 7.9 Hz, 1H), 4.12 (d, J = 8.9 Hz, 1H), 
3.97 (dd, J = 10.6 Hz, 1H), 3.63 (dd, J = 10.6, 7.9 Hz, 1H); 13C NMR (125 
MHz, CDCl3) δ 189.52, 154.88, 142.35, 142.23, 141.16, 139.54, 133.70, 131.47, 128.96, 128.86, 
128.78, 128.43, 126.86, 126.58, 123.22, 120.86, 119.63, 112.02, 69.06, 58.05, 50.04; IR (cm-1): 
2953, 2925, 2858, 1689, 1627, 1555, 1494, 1453, 1209, 908, 729, 699, 522; MS: HR-ESI 
calculated for [C25H20N2O+H]
+: 365.1648, found: 365.1676; mp  195-200 °C dec.; 
[α]
D
23=+4.68° (c= 0.25, CH2Cl2). 
(S)-2-(tert-butyl)-1,2-dihydroimidazo[1,2-a]quinoline-4-carbaldehyde (2.14f): Isolated as a 
red amorphous solid (201 m g; 93% yield). 1H NMR (500 MHz, CDCl3) δ 
10.28 (s, 1H), 7.83 (s, 1H), 7.50 – 7.33 (m, 2H), 6.95 (td, J = 7.6, 1.0 Hz, 1H), 
6.73 (dd, J = 8.2, 0.9 Hz, 1H), 4.10 (dd, J = 11.2, 8.4 Hz, 1H), 3.84 (dd, J = 
11.2, 10.5 Hz, 1H), 3.67 (dd, J = 10.5, 8.4 Hz, 1H), 0.99 (s, 9H); 13C NMR 
(125 MHz, CDCl3) δ 189.55, 154.26, 141.43, 139.65, 133.76, 131.49, 123.34, 120.72, 119.71, 
111.93, 75.18, 46.73, 34.80, 25.90; IR (cm-1): 2952, 2928, 2866, 1692, 1633, 1556, 1457, 1362, 
1273, 1208, 750; MS: HR-ESI calculated for [C16H18N2O+H]
+: 255.1492, found: 255.1501; 
[α]
D





2.5.3 Preparation of imine ligands 2.29. 
 
A solution of 2.14 (1.0 equiv) in chloroform (0.18 M) was treated with the requisite aniline 2.2825 
(1.0 equiv) and stirred at 50 oC for 5h. The mixture was dried with sodium sulfate and concentrated 
under reduced pressure to give 2.29 which was used as a crude ligand in the subsequent Henry 
reaction. Crude 1H NMR of 2.29g showing an imine peak at 8.53 ppm is provided as a 
representative example.  
2.5.4 Asymmetric Henry reaction, general procedure. 
 
Ligand 2.29a-g (0.055 mmol) and Cu salt (0.05 mmol) were added to a vial containing a stir bar. 
The solvent (1.5 mL) was added and the mixture was stirred for 1 h to form the ligand-metal 
complex in situ. To resulting dark colored solution, nitromethane (0.54 mL, 10 mmol) and 
aldehyde (1 mmol) were added and stirred for 24 h. The crude mixture was then evaporated under 
reduced pressure, purified by column chromatography, and analyzed by chiral HPLC using the 
conditions described by Evans.20 The absolute configurations were assigned by comparison of 
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Retention Time Area Area % Height Height % 
22.200 7455601 50.04 202251 52.72 
24.717 7443890 49.96 181394 47.28 
     
Totals     





    
Retention Time Area Area % Height Height % 
17.783 11026 0.04 304 0.05 
19.483 25611100 99.96 575834 99.95 
     
Totals     
 25622126 100.00 576138 100.00 
Minutes































































    
Retention Time Area Area % Height Height % 
26.917 8395567 49.90 136662 55.99 
34.525 8429322 50.10 107428 44.01 
     
Totals     






    
Retention Time Area Area % Height Height % 
30.058 26292 0.16 433 0.23 
38.400 16585675 99.84 190972 99.77 
     
Totals     
 16611967 100.00 191405 100.00 
 
Minutes
































































    
Retention Time Area Area % Height Height % 
58.008 2557287 50.02 23555 52.06 
63.933 2555451 49.98 21687 47.94 
     
Totals     






    
Retention Time Area Area % Height Height % 
56.100 53259258 99.59 407123 99.54 
62.467 218982 0.41 1888 0.46 
     
Totals     
 53478240 100.00 409011 100.00 
 
Minutes































































    
Retention Time Area Area % Height Height % 
16.842 25296210 49.98 0 0.00 
20.375 25313197 50.02 718795 100.00 
     
Totals     






    
Retention Time Area Area % Height Height % 
16.550 152465 1.47 4470 1.80 
18.942 10190414 98.53 243498 98.20 
     
Totals     
 10342879 100.00 247968 100.00 
Minutes
































































    
Retention Time Area Area % Height Height % 
11.875 499776 49.79 25128 52.04 
13.058 503905 50.21 23154 47.96 
     
Totals     






    
Retention Time Area Area % Height Height % 
12.433 20876 0.25 1254 0.43 
13.800 8426895 99.75 291060 99.57 
     
Totals     
 8447771 100.00 292314 100.00 
Minutes




























































































    
Retention Time Area Area % Height Height % 
35.658 4708733 49.85 60575 55.15 
45.025 4737319 50.15 49261 44.85 
     
Totals     






    
Retention Time Area Area % Height Height % 
34.967 58336 0.68 959 0.90 
42.375 8516655 99.32 105080 99.10 
     
Totals     
 8574991 100.00 106039 100.00 
 
Minutes






























































    
Retention Time Area Area % Height Height % 
14.400 19407837 48.88 585030 54.10 
16.817 20297396 51.12 496311 45.90 
     
Totals     






    
Retention Time Area Area % Height Height % 
16.942 52325 0.31 1964 0.51 
19.550 16891196 99.69 385081 99.49 
     
Totals     






































    
Retention Time Area Area % Height Height % 
12.967 7720906 49.92 241667 56.02 
16.233 7745431 50.08 189742 43.98 
     
Totals     






    
Retention Time Area Area % Height Height % 
14.942 89879 0.26 2527 0.39 
18.517 34537379 99.74 646789 99.61 
     
Totals     
 34627258 100.00 649316 100.00 
 
Minutes






























































    
Retention Time Area Area % Height Height % 
12.275 6903854 49.98 225947 56.95 
16.217 6909196 50.02 170803 43.05 
     
Totals     



































    
Retention Time Area Area % Height Height % 
12.092 13252676 99.57 467180 99.63 
15.375 57386 0.43 1724 0.37 
     
Totals     






































    
Retention Time Area Area % Height Height % 
16.458 5508264 49.98 166779 56.34 
20.442 5512219 50.02 129265 43.66 
     
Totals     






    
Retention Time Area Area % Height Height % 
19.258 50767 0.26 1153 0.31 
23.675 19328870 99.74 371356 99.69 
     
Totals     




































































    
Retention Time Area Area % Height Height % 
19.383 4492601 51.52 135160 53.66 
21.550 4226962 48.48 116707 46.34 
     
Totals     






    
Retention Time Area Area % Height Height % 
18.233 6914822 97.34 190639 97.28 
20.817 189131 2.66 5321 2.72 
     
Totals     



































































































    
Retention Time Area Area % Height Height % 
35.242 1088460 50.22 17080 52.27 
38.708 1078990 49.78 15596 47.73 
     
Totals     






    
Retention Time Area Area % Height Height % 
34.542 174604 0.76 2876 0.95 
37.275 22902082 99.24 298502 99.05 
     
Totals     








































    
Retention Time Area Area % Height Height % 
41.925 944502 50.26 14523 52.32 
45.575 934615 49.74 13235 47.68 
     
Totals     






    
Retention Time Area Area % Height Height % 
40.400 173640 1.51 2021 2.13 
48.967 11343697 98.49 92689 97.87 
     
Totals     




































































    
Retention Time Area Area % Height Height % 
40.775 4809959 50.23 58716 52.85 
46.025 4766452 49.77 52384 47.15 
     
Totals     






    
Retention Time Area Area % Height Height % 
41.250 439681 2.31 5324 2.74 
45.300 18595726 97.69 188794 97.26 
     
Totals     
 19035407 100.00 194118 100.00 
 
Minutes






























































    
Retention Time Area Area % Height Height % 
11.242 3595329 50.12 172312 54.55 
12.500 3577587 49.88 143589 45.45 
     
Totals     






    
Retention Time Area Area % Height Height % 
11.967 179886 0.50 8690 0.70 
13.133 35741844 99.50 1225960 99.30 
     
Totals     




































































    
Retention Time Area Area % Height Height % 
13.883 4212876 49.91 155882 66.35 
24.325 4227885 50.09 79066 33.65 
     
Totals     






    
Retention Time Area Area % Height Height % 
14.133 201230 0.26 7550 0.67 
25.867 77253063 99.74 1122574 99.33 
     
Totals     




































































    
Retention Time Area Area % Height Height % 
10.083 2459804 50.70 99332 75.21 
27.733 2391741 49.30 32749 24.79 
     
Totals     






    
Retention Time Area Area % Height Height % 
10.225 84265 0.33 2114 0.67 
31.900 25332360 99.67 313650 99.33 
     
Totals     










































































Sample Name:Phenyl Phenyl Thiochromane 3% ISP OD-H
Sample ID:Racemic






















Peak# Ret. Time Area Height
1 20.445 86677541 1438103
2 24.274 87312132 1390691
Total 173989672 2828794
Dataf ile Name:NAA-IV-86_Rxn01.lcd
Sample Name:Phenyl Pheny Thiochromane 3%ISP OD-H
Sample ID:DMA-HBTM-2




















Peak# Ret. Time Area Height Area%
1 22.239 19633363 294299 99.644
2 27.041 70217 1471 0.356

























Peak# Ret. Time Area Height Area%
1 19.532 5438050 93790 70.931
2 24.675 2228585 26713 29.069


















Sample Name:Ph Ph thiochromane from DMA-Ph-DHIT w ith 3% ISP
Sample ID:EVS-II-180-1try2




















Peak# Ret. Time Area Height Area%
1 22.212 357955 5952 2.04
2 25.989 17189449 276083 97.96
Total 17547404 282035 100
Dataf ile Name:EVS-II-180-2.lcd
Sample Name:Ph Ph thiochromane from HPIP w ith 3% ISP
Sample ID:EVS-II-180-1try2
























Peak# Ret. Time Area Height Area%
1 22.192 144628 2675 2.311
2 26.039 6114031 98882 97.689
Total 6258659 101557 100
Dataf ile Name:NAA-IV-141_run2_3%IPA_OD-H.lcd
Sample Name:Phenyl Phenyl Thiochromane H-PIP
Sample ID:3% IPA OD-H




















Peak# Ret. Time Area Height Area%
1 21.259 439909 8113 2.521
2 26.064 17012001 265052 97.479





































Peak# Ret. Time Area Height Area%
1 20.108 726815 12585 49.213
2 37.668 750054 7606 50.787


























Peak# Ret. Time Area Height Area%
1 19.782 5748020 107705 3.526
2 35.94 157270787 1328376 96.474























Sample Name:btfm Enone phenyl Thiochromane
Sample ID:racemic
























Peak# Ret. Time Area Height Area%
1 9.761 648293 24550 51.994
2 41.15 598572 5828 48.006
Total 1246866 30378 100
Dataf ile Name:NAA-IV-131_1%IPA_OD-H.lcd
Sample Name:btfm Enone phenyl Thiochromane
Sample ID:CHIRAL
























Peak# Ret. Time Area Height Area%
1 9.765 1693606 50465 2.108
2 40.049 78663177 588948 97.892


















Sample Name:Methoxy phenyl enone
Sample ID:racemic






















Peak# Ret. Time Area Height Area%
1 34.388 2366281 22972 50.809
2 38.702 2290952 21987 49.191
Total 4657233 44959 100
Dataf ile Name:NAA-IV-119.lcd
Sample Name:p-methoxy enone 3% IPA OD-H
Sample ID:HPIP





















Peak# Ret. Time Area Height Area%
1 33.754 92587 1656 1.19
2 37.292 7686697 70245 98.81


































Peak# Ret. Time Area Height Area%
1 25.131 82767729 456584 49.576
2 31.536 84182574 604137 50.424


























Peak# Ret. Time Area Height Area%
1 24.641 128523485 1270111 95.74
2 32.222 5718496 53606 4.26



























Peak# Ret. Time Area Height Area%
1 24.983 66706184 682738 97.83
2 32.197 1479657 13466 2.17























Sample Name:Methyl Enone Phenyl Thiochromane
Sample ID:racemate























Peak# Ret. Time Area Height Area%
1 48.147 2750760 16052 50.479
2 69.56 2698599 12559 49.521
Total 5449359 28611 100
Dataf ile Name:NAA-IV-120_run091317_0.25%IPA_OD-H.lcd
Sample Name:methyl Enone phenyl Thiochromane
Sample ID:chiral

























Peak# Ret. Time Area Height Area%
1 48.72 608807 4136 9.466
2 65.17 5822573 33239 90.534















Sample Name:Bistrif luoromethylcinnamate phenyl w ith 3% IPA OD-H
Sample ID:10 mol% HPIP



















Peak# Ret. Time Area Height Area%
1 9.829 14261380 575941 50.642
2 12.077 13899697 471783 49.358
Total 28161077 1047725 100
Dataf ile Name:NAA-IV-117_2.lcd
Sample Name:Bistrif luoromethylcinnamate phenyl w ith 3% IPA OD-H
Sample ID:H-PIP

















Peak# Ret. Time Area Height Area%
1 9.469 44077 2959 0.891
2 12.089 4904268 168239 99.109

















Sample Name:methyl Enone btfm Thiochromane
Sample ID:racemic

























Peak# Ret. Time Area Height Area%
1 12.846 2132123 34785 48.219
2 26.364 2289606 32411 51.781
Total 4421730 67196 100
Datafile Name:NAA-IV-134_run3_0.25%IPA_OD-H.lcd
Sample Name:methyl Enone btfm Thiochromane
Sample ID:chiral
























Peak# Ret. Time Area Height Area%
1 13.251 289009 4488 4.185
2 26.708 6616788 98310 95.815


















Sample Name:Ph-Bz-OH-DHT w ith 0.5% IPA OD-H
Sample ID:Ph-Bz-OH-DHT-10 mol% HPIP-D




















Peak# Ret. Time Area Height Area%
1 38.678 21175489 166722 50.412
2 51.754 20829768 121794 49.588
Total 42005257 288515 100
Dataf ile Name:pmp-246-chiral(0.20%IPA).lcd
Sample Name:Ph-Bz-OH-DHT w ith 0.5% IPA OD-H
Sample ID:Ph-Bz-OH-DHT-10 mol% HPIP-D





















Peak# Ret. Time Area Height Area%
1.00 36.78 230618535.00 1802746.00 99.44
2.00 47.47 1288615.00 14169.00 0.56















Sample Name:methyl Enone cyclohexyl Thiochromane
Sample ID:racemate





















Peak# Ret. Time Area Height Area%
1 16.581 1111531 30595 49.983
2 21.232 1112288 17985 50.017
Total 2223819 48579 100
Dataf ile Name:NAA-IV-126_run2_0.25%IPA_OD-H.lcd
Sample Name:methyl Enone cyclohexyl Thiochromane
Sample ID:CHIRAL





















Peak# Ret. Time Area Height Area%
1 16.222 175885 5690 2.124
2 19.61 8104633 156422 97.876
















Sample Name:btfml Enone btfm Thiochromane
Sample ID:racemate



















Peak# Ret. Time Area Height Area%
1 7.934 1371015 64003 49.946
2 39.076 1374004 11269 50.054
Total 2745019 75272 100
Dataf ile Name:NAA-IV-129_Rxn1_3%IPA_OD-H.lcd
Sample Name:btfml Enone btfm Thiochromane
Sample ID:H-PIP




















Peak# Ret. Time Area Height Area%
1 7.94 6750320 318039 98.971
2 39.706 70174 943 1.029
Total 6820494 318981 100
153 
 
2.31a racemate  
HPLC conditions: 10% isopropanol/hexanes 
Minutes


































    
Retention Time Area Area % Height Height % 
18.333 17299132 49.63 339903 56.36 
22.300 17555916 50.37 263154 43.64 
     
Totals 34855048 100.00 603057 100.00  
     
Minutes























    
Retention Time Area Area % Height Height % 
18.592 55215825 47.80 1078958 51.44 
22.275 60287082 52.20 1018634 48.56 
     
Totals     
 115502907 100.00 2097592 100.00 
154 
 
2.31a from ligand 2.29a 
Minutes



















































    
Retention Time Area Area % Height Height % 
18.200 23658 15.75 794 19.99 
22.258 126519 84.25 3177 80.01 
     
Totals     
 150177 100.00 3971 100.00 
     
     




    
Retention Time Area Area % Height Height % 
18.217 1147949 17.31 32955 20.75 
22.267 5484377 82.69 125891 79.25 
     
Totals     








2.31a from ligand 2.29b 
Minutes





















































    
Retention Time Area Area % Height Height % 
18.308 92588 11.98 2558 14.35 
21.883 680586 88.02 15263 85.65 
     
Totals     
 773174 100.00 17821 100.00 
     
     




    
Retention Time Area Area % Height Height % 
18.308 3522717 12.45 96874 15.41 
21.883 24767764 87.55 531769 84.59 
     
Totals     








2.31a from ligand 2.29c 
Minutes





















































    
Retention Time Area Area % Height Height % 
18.617 368661 9.63 9937 12.67 
22.675 3458046 90.37 68477 87.33 
     
Totals     
 3826707 100.00 78414 100.00 
     
     




    
Retention Time Area Area % Height Height % 
18.617 13755576 14.44 362383 23.66 
22.675 81504225 85.56 1169566 76.34 
     
Totals 95259801 100.00 1531949 100.00 








2.31a from ligand 2.29d 
Minutes



















































    
Retention Time Area Area % Height Height % 
18.458 236431 10.36 6408 12.75 
21.725 2045883 89.64 43833 87.25 
     
Totals     
 2282314 100.00 50241 100.00 
     
     




    
Retention Time Area Area % Height Height % 
18.467 8958442 12.91 238603 18.39 
21.733 60416112 87.09 1058678 81.61 
     
Totals     








2.31a from ligand 2.29e 
Minutes



















































    
Retention Time Area Area % Height Height % 
18.325 419705 26.32 11495 31.10 
22.367 1174861 73.68 25467 68.90 
     
Totals     
 1594566 100.00 36962 100.00 
     
     




    
Retention Time Area Area % Height Height % 
18.325 15624653 28.08 413887 34.14 
22.367 40017268 71.92 798493 65.86 
     
Totals 55641921 100.00 1212380 100.00 








2.31a from ligand 2.29f  
 
Minutes




















































    
Retention Time Area Area % Height Height % 
27.475 4413447 86.49 73788 87.82 
35.358 689442 13.51 10233 12.18 
     
Totals     
 5102889 100.00 84021 100.00 
     
     




    
Retention Time Area Area % Height Height % 
27.483 98216368 78.50 1127592 75.13 
35.358 26894472 21.50 373187 24.87 
     
Totals 125110840 100.00 1500779 100.00 





2.31a from ligand 2.29g 
 
Minutes



















































    
Retention Time Area Area % Height Height % 
27.750 46982 3.64 1270 6.27 
34.217 1245435 96.36 18986 93.73 
     
Totals     
 1292417 100.00 20256 100.00 
     
     




    
Retention Time Area Area % Height Height % 
27.750 4578187 8.80 72547 10.67 
34.217 47454774 91.20 607634 89.33 
     
Totals 52032961 100.00 680181 100.00 







2.31a from ligand 2.29g in i-PrOH 
 
Minutes























































    
Retention Time Area Area % Height Height % 
16.508 50126 5.95 1597 8.45 
20.667 792892 94.05 17312 91.55 
     
Totals     
 843018 100.00 18909 100.00 
     
     




    
Retention Time Area Area % Height Height % 
16.517 2142803 6.99 63040 10.13 
20.667 28509830 93.01 559179 89.87 
     
Totals 30652633 100.00 622219 100.00 






























































    
Retention Time Area Area % Height Height % 
16.883 99425 30.65 2821 34.81 
20.625 224987 69.35 5282 65.19 
     
Totals     
 324412 100.00 8103 100.00 
     
     




    
Retention Time Area Area % Height Height % 
16.775 912585 11.49 27922 14.86 
20.625 7032282 88.51 159994 85.14 
     
Totals     






2.31a from Cu(O(4-Cl-Bz))2 with ligand 2.29g 
Minutes





















































    
Retention Time Area Area % Height Height % 
20.408 266643 7.17 5761 8.55 
25.108 3453946 92.83 61590 91.45 
     
Totals     
 3720589 100.00 67351 100.00 
     
     




    
Retention Time Area Area % Height Height % 
20.392 6865369 10.58 157101 18.21 
25.100 58026457 89.42 705613 81.79 
     
Totals     








2.31a from Cu(OPiv)2 with ligand 2.29g 
Minutes





















































    
Retention Time Area Area % Height Height % 
14.792 188344 8.13 5558 9.79 
18.133 2129651 91.87 51222 90.21 
     
Totals     
 2317995 100.00 56780 100.00 
     
     




    
Retention Time Area Area % Height Height % 
14.792 4809449 11.73 154044 20.26 
18.133 36183907 88.27 606115 79.74 
     
Totals     




HPLC conditions: 10% isopropanol/hexanes 
Minutes



















































    
Retention Time Area Area % Height Height % 
19.333 2078149 9.84 45753 15.70 
30.808 19047137 90.16 245723 84.30 
     
Totals     
 21125286 100.00 291476 100.00 




    
Retention Time Area Area % Height Height % 
19.333 22608605 16.12 471788 31.51 
30.825 117685070 83.88 1025578 68.49 
     
Totals     




HPLC conditions: 10% isopropanol/hexanes 
Minutes





















































    
Retention Time Area Area % Height Height % 
13.992 271881 21.76 7674 20.40 
16.833 977694 78.24 29950 79.60 
     
Totals     
 1249575 100.00 37624 100.00 




    
Retention Time Area Area % Height Height % 
14.000 2365462 16.03 69327 16.35 
16.833 12394170 83.97 354628 83.65 
     
Totals     




HPLC conditions: 10% isopropanol/hexanes 
Minutes



















































    
Retention Time Area Area % Height Height % 
26.417 10379466 13.39 130741 17.81 
33.558 67164575 86.61 603487 82.19 
     
Totals     
 77544041 100.00 734228 100.00 




    
Retention Time Area Area % Height Height % 
26.417 14528627 14.00 182117 19.30 
33.558 89281954 86.00 761456 80.70 
     
Totals     
 103810581 100.00 943573 100.00 
168 
 


























































































































































































































































































































































































































































































































2.29g crude  
